id	sid	tid	token	lemma	pos
ejnm-305	1	1	https://doi.org/10.15218/ejnm.2025.03	https://doi.org/10.15218/ejnm.2025.03	PROPN
ejnm-305	1	2	erbil	erbil	PROPN
ejnm-305	1	3	j.	j.	PROPN
ejnm-305	1	4	nurs	nurs	PROPN
ejnm-305	1	5	.	.	PUNCT
ejnm-305	2	1	midwifery	midwifery	ADJ
ejnm-305	2	2	,	,	PUNCT
ejnm-305	2	3	vol	vol	NOUN
ejnm-305	2	4	.	.	PROPN
ejnm-305	2	5	8	8	NUM
ejnm-305	2	6	,	,	PUNCT
ejnm-305	2	7	no	no	INTJ
ejnm-305	2	8	.	.	PUNCT
ejnm-305	3	1	(	(	PUNCT
ejnm-305	3	2	1	1	NUM
ejnm-305	3	3	)	)	PUNCT
ejnm-305	3	4	,	,	PUNCT
ejnm-305	3	5	may	may	AUX
ejnm-305	3	6	2025	2025	NUM
ejnm-305	3	7	original	original	ADJ
ejnm-305	3	8	article	article	NOUN
ejnm-305	3	9	effect	effect	NOUN
ejnm-305	3	10	of	of	ADP
ejnm-305	3	11	serum	serum	NOUN
ejnm-305	3	12	lipid	lipid	NOUN
ejnm-305	3	13	profile	profile	NOUN
ejnm-305	3	14	and	and	CCONJ
ejnm-305	3	15	renal	renal	ADJ
ejnm-305	3	16	functions	function	NOUN
ejnm-305	3	17	during	during	ADP
ejnm-305	3	18	pregnancy	pregnancy	NOUN
ejnm-305	3	19	and	and	CCONJ
ejnm-305	3	20	its	its	PRON
ejnm-305	3	21	associated	associated	ADJ
ejnm-305	3	22	diseases	disease	NOUN
ejnm-305	3	23	in	in	ADP
ejnm-305	3	24	sulaimanyah	sulaimanyah	PROPN
ejnm-305	3	25	/	/	SYM
ejnm-305	3	26	kurdistan	kurdistan	PROPN
ejnm-305	3	27	region	region	NOUN
ejnm-305	3	28	abstract	abstract	ADJ
ejnm-305	3	29	background	background	NOUN
ejnm-305	3	30	and	and	CCONJ
ejnm-305	3	31	objective	objective	NOUN
ejnm-305	3	32	:	:	PUNCT
ejnm-305	3	33	the	the	DET
ejnm-305	3	34	physiological	physiological	ADJ
ejnm-305	3	35	function	function	NOUN
ejnm-305	3	36	of	of	ADP
ejnm-305	3	37	the	the	DET
ejnm-305	3	38	kidneys	kidney	NOUN
ejnm-305	3	39	poses	pose	VERB
ejnm-305	3	40	significant	significant	ADJ
ejnm-305	3	41	challenges	challenge	NOUN
ejnm-305	3	42	during	during	ADP
ejnm-305	3	43	pregnancy	pregnancy	NOUN
ejnm-305	3	44	,	,	PUNCT
ejnm-305	3	45	impacting	impact	VERB
ejnm-305	3	46	maternal	maternal	ADJ
ejnm-305	3	47	and	and	CCONJ
ejnm-305	3	48	fetal	fetal	ADJ
ejnm-305	3	49	health	health	NOUN
ejnm-305	3	50	.	.	PUNCT
ejnm-305	4	1	understanding	understand	VERB
ejnm-305	4	2	the	the	DET
ejnm-305	4	3	interplay	interplay	NOUN
ejnm-305	4	4	between	between	ADP
ejnm-305	4	5	renal	renal	ADJ
ejnm-305	4	6	functions	function	NOUN
ejnm-305	4	7	and	and	CCONJ
ejnm-305	4	8	serum	serum	NOUN
ejnm-305	4	9	lipid	lipid	NOUN
ejnm-305	4	10	profiles	profile	NOUN
ejnm-305	4	11	is	be	AUX
ejnm-305	4	12	crucial	crucial	ADJ
ejnm-305	4	13	for	for	ADP
ejnm-305	4	14	managing	manage	VERB
ejnm-305	4	15	maternal	maternal	ADJ
ejnm-305	4	16	health	health	NOUN
ejnm-305	4	17	.	.	PUNCT
ejnm-305	5	1	this	this	DET
ejnm-305	5	2	study	study	NOUN
ejnm-305	5	3	aims	aim	VERB
ejnm-305	5	4	to	to	PART
ejnm-305	5	5	investigate	investigate	VERB
ejnm-305	5	6	serum	serum	NOUN
ejnm-305	5	7	lipid	lipid	NOUN
ejnm-305	5	8	profiles	profile	NOUN
ejnm-305	5	9	and	and	CCONJ
ejnm-305	5	10	their	their	PRON
ejnm-305	5	11	association	association	NOUN
ejnm-305	5	12	with	with	ADP
ejnm-305	5	13	renal	renal	ADJ
ejnm-305	5	14	function	function	NOUN
ejnm-305	5	15	in	in	ADP
ejnm-305	5	16	pregnancy	pregnancy	NOUN
ejnm-305	5	17	and	and	CCONJ
ejnm-305	5	18	compare	compare	VERB
ejnm-305	5	19	them	they	PRON
ejnm-305	5	20	with	with	ADP
ejnm-305	5	21	non	non	ADJ
ejnm-305	5	22	-	-	ADJ
ejnm-305	5	23	pregnant	pregnant	ADJ
ejnm-305	5	24	status	status	NOUN
ejnm-305	5	25	.	.	PUNCT
ejnm-305	6	1	the	the	DET
ejnm-305	6	2	objective	objective	NOUN
ejnm-305	6	3	of	of	ADP
ejnm-305	6	4	this	this	DET
ejnm-305	6	5	study	study	NOUN
ejnm-305	6	6	was	be	AUX
ejnm-305	6	7	to	to	PART
ejnm-305	6	8	conduct	conduct	VERB
ejnm-305	6	9	a	a	DET
ejnm-305	6	10	prospective	prospective	ADJ
ejnm-305	6	11	analysis	analysis	NOUN
ejnm-305	6	12	of	of	ADP
ejnm-305	6	13	blood	blood	NOUN
ejnm-305	6	14	lipid	lipid	NOUN
ejnm-305	6	15	concentration	concentration	NOUN
ejnm-305	6	16	,	,	PUNCT
ejnm-305	6	17	namely	namely	ADV
ejnm-305	6	18	lipoprotein	lipoprotein	ADJ
ejnm-305	6	19	,	,	PUNCT
ejnm-305	6	20	as	as	ADV
ejnm-305	6	21	well	well	ADV
ejnm-305	6	22	as	as	ADP
ejnm-305	6	23	the	the	DET
ejnm-305	6	24	rates	rate	NOUN
ejnm-305	6	25	of	of	ADP
ejnm-305	6	26	urea	urea	NOUN
ejnm-305	6	27	and	and	CCONJ
ejnm-305	6	28	creatinine	creatinine	NOUN
ejnm-305	6	29	,	,	PUNCT
ejnm-305	6	30	in	in	ADP
ejnm-305	6	31	pregnant	pregnant	ADJ
ejnm-305	6	32	women	woman	NOUN
ejnm-305	6	33	,	,	PUNCT
ejnm-305	6	34	and	and	CCONJ
ejnm-305	6	35	thereafter	thereafter	ADV
ejnm-305	6	36	compare	compare	VERB
ejnm-305	6	37	these	these	DET
ejnm-305	6	38	measurements	measurement	NOUN
ejnm-305	6	39	with	with	ADP
ejnm-305	6	40	those	those	PRON
ejnm-305	6	41	of	of	ADP
ejnm-305	6	42	non	non	ADJ
ejnm-305	6	43	-	-	ADJ
ejnm-305	6	44	pregnant	pregnant	ADJ
ejnm-305	6	45	women	woman	NOUN
ejnm-305	6	46	.	.	PUNCT
ejnm-305	7	1	methods	method	NOUN
ejnm-305	7	2	:	:	PUNCT
ejnm-305	7	3	a	a	DET
ejnm-305	7	4	casecontrol	casecontrol	NOUN
ejnm-305	7	5	study	study	NOUN
ejnm-305	7	6	was	be	AUX
ejnm-305	7	7	conducted	conduct	VERB
ejnm-305	7	8	on	on	ADP
ejnm-305	7	9	pregnant	pregnant	ADJ
ejnm-305	7	10	women	woman	NOUN
ejnm-305	7	11	in	in	ADP
ejnm-305	7	12	sulaimanyah/	sulaimanyah/	NUM
ejnm-305	7	13	kurdistan	kurdistan	PROPN
ejnm-305	7	14	.	.	PUNCT
ejnm-305	8	1	both	both	DET
ejnm-305	8	2	serum	serum	NOUN
ejnm-305	8	3	lipid	lipid	NOUN
ejnm-305	8	4	profile	profile	NOUN
ejnm-305	8	5	tests	test	NOUN
ejnm-305	8	6	,	,	PUNCT
ejnm-305	8	7	including	include	VERB
ejnm-305	8	8	triglycerides	triglyceride	NOUN
ejnm-305	8	9	,	,	PUNCT
ejnm-305	8	10	cholesterol	cholesterol	NOUN
ejnm-305	8	11	,	,	PUNCT
ejnm-305	8	12	and	and	CCONJ
ejnm-305	8	13	lipoprotein	lipoprotein	ADJ
ejnm-305	8	14	levels	level	NOUN
ejnm-305	8	15	,	,	PUNCT
ejnm-305	8	16	and	and	CCONJ
ejnm-305	8	17	renal	renal	ADJ
ejnm-305	8	18	function	function	NOUN
ejnm-305	8	19	markers	marker	NOUN
ejnm-305	8	20	,	,	PUNCT
ejnm-305	8	21	such	such	ADJ
ejnm-305	8	22	as	as	ADP
ejnm-305	8	23	serum	serum	NOUN
ejnm-305	8	24	creatinine	creatinine	NOUN
ejnm-305	8	25	,	,	PUNCT
ejnm-305	8	26	urea	urea	NOUN
ejnm-305	8	27	,	,	PUNCT
ejnm-305	8	28	and	and	CCONJ
ejnm-305	8	29	estimated	estimate	VERB
ejnm-305	8	30	glomerular	glomerular	ADJ
ejnm-305	8	31	filtration	filtration	NOUN
ejnm-305	8	32	rate	rate	NOUN
ejnm-305	8	33	,	,	PUNCT
ejnm-305	8	34	were	be	AUX
ejnm-305	8	35	measured	measure	VERB
ejnm-305	8	36	at	at	ADP
ejnm-305	8	37	various	various	ADJ
ejnm-305	8	38	stages	stage	NOUN
ejnm-305	8	39	of	of	ADP
ejnm-305	8	40	pregnancy	pregnancy	NOUN
ejnm-305	8	41	.	.	PUNCT
ejnm-305	9	1	data	datum	NOUN
ejnm-305	9	2	was	be	AUX
ejnm-305	9	3	analyzed	analyze	VERB
ejnm-305	9	4	by	by	ADP
ejnm-305	9	5	the	the	DET
ejnm-305	9	6	statistical	statistical	ADJ
ejnm-305	9	7	package	package	NOUN
ejnm-305	9	8	for	for	ADP
ejnm-305	9	9	the	the	DET
ejnm-305	9	10	social	social	ADJ
ejnm-305	9	11	sciences	sciences	PROPN
ejnm-305	9	12	version	version	NOUN
ejnm-305	9	13	22.0	22.0	NUM
ejnm-305	9	14	to	to	PART
ejnm-305	9	15	identify	identify	VERB
ejnm-305	9	16	correlations	correlation	NOUN
ejnm-305	9	17	between	between	ADP
ejnm-305	9	18	serum	serum	NOUN
ejnm-305	9	19	lipid	lipid	NOUN
ejnm-305	9	20	profile	profile	NOUN
ejnm-305	9	21	,	,	PUNCT
ejnm-305	9	22	renal	renal	ADJ
ejnm-305	9	23	function	function	NOUN
ejnm-305	9	24	,	,	PUNCT
ejnm-305	9	25	and	and	CCONJ
ejnm-305	9	26	pregnancy	pregnancy	NOUN
ejnm-305	9	27	outcomes	outcome	NOUN
ejnm-305	9	28	.	.	PUNCT
ejnm-305	10	1	results	result	NOUN
ejnm-305	10	2	:	:	PUNCT
ejnm-305	10	3	this	this	DET
ejnm-305	10	4	study	study	NOUN
ejnm-305	10	5	highlights	highlight	VERB
ejnm-305	10	6	significant	significant	ADJ
ejnm-305	10	7	positive	positive	ADJ
ejnm-305	10	8	correlations	correlation	NOUN
ejnm-305	10	9	of	of	ADP
ejnm-305	10	10	low	low	ADJ
ejnm-305	10	11	-	-	PUNCT
ejnm-305	10	12	density	density	NOUN
ejnm-305	10	13	lipoprotein	lipoprotein	ADJ
ejnm-305	10	14	with	with	ADP
ejnm-305	10	15	gestation	gestation	NOUN
ejnm-305	10	16	age	age	NOUN
ejnm-305	10	17	,	,	PUNCT
ejnm-305	10	18	cholesterol	cholesterol	NOUN
ejnm-305	10	19	,	,	PUNCT
ejnm-305	10	20	triglyceride	triglyceride	ADJ
ejnm-305	10	21	,	,	PUNCT
ejnm-305	10	22	and	and	CCONJ
ejnm-305	10	23	high	high	ADJ
ejnm-305	10	24	-	-	PUNCT
ejnm-305	10	25	density	density	NOUN
ejnm-305	10	26	lipoprotein	lipoprotein	NOUN
ejnm-305	10	27	,	,	PUNCT
ejnm-305	10	28	alongside	alongside	ADP
ejnm-305	10	29	strong	strong	ADJ
ejnm-305	10	30	negative	negative	ADJ
ejnm-305	10	31	correlations	correlation	NOUN
ejnm-305	10	32	with	with	ADP
ejnm-305	10	33	total	total	ADJ
ejnm-305	10	34	serum	serum	NOUN
ejnm-305	10	35	bilirubin	bilirubin	NOUN
ejnm-305	10	36	and	and	CCONJ
ejnm-305	10	37	creatinine	creatinine	NOUN
ejnm-305	10	38	in	in	ADP
ejnm-305	10	39	pregnancy	pregnancy	NOUN
ejnm-305	10	40	.	.	PUNCT
ejnm-305	11	1	this	this	DET
ejnm-305	11	2	correlation	correlation	NOUN
ejnm-305	11	3	was	be	AUX
ejnm-305	11	4	not	not	PART
ejnm-305	11	5	found	find	VERB
ejnm-305	11	6	in	in	ADP
ejnm-305	11	7	non	non	ADJ
ejnm-305	11	8	-	-	ADJ
ejnm-305	11	9	pregnant	pregnant	ADJ
ejnm-305	11	10	status	status	NOUN
ejnm-305	11	11	.	.	PUNCT
ejnm-305	12	1	additionally	additionally	ADV
ejnm-305	12	2	,	,	PUNCT
ejnm-305	12	3	estimated	estimate	VERB
ejnm-305	12	4	glomerular	glomerular	ADJ
ejnm-305	12	5	filtration	filtration	NOUN
ejnm-305	12	6	rate	rate	NOUN
ejnm-305	12	7	exhibits	exhibit	VERB
ejnm-305	12	8	strong	strong	ADJ
ejnm-305	12	9	positive	positive	ADJ
ejnm-305	12	10	correlations	correlation	NOUN
ejnm-305	12	11	with	with	ADP
ejnm-305	12	12	cholesterol	cholesterol	NOUN
ejnm-305	12	13	and	and	CCONJ
ejnm-305	12	14	low	low	ADJ
ejnm-305	12	15	-	-	PUNCT
ejnm-305	12	16	density	density	NOUN
ejnm-305	12	17	lipoprotein	lipoprotein	ADJ
ejnm-305	12	18	and	and	CCONJ
ejnm-305	12	19	negative	negative	ADJ
ejnm-305	12	20	correlations	correlation	NOUN
ejnm-305	12	21	with	with	ADP
ejnm-305	12	22	total	total	ADJ
ejnm-305	12	23	serum	serum	NOUN
ejnm-305	12	24	bilirubin	bilirubin	NOUN
ejnm-305	12	25	and	and	CCONJ
ejnm-305	12	26	creatinine.in	creatinine.in	ADJ
ejnm-305	12	27	non	non	ADJ
ejnm-305	12	28	-	-	ADJ
ejnm-305	12	29	pregnant	pregnant	ADJ
ejnm-305	12	30	individuals	individual	NOUN
ejnm-305	12	31	,	,	PUNCT
ejnm-305	12	32	estimated	estimate	VERB
ejnm-305	12	33	glomerular	glomerular	ADJ
ejnm-305	12	34	filtration	filtration	NOUN
ejnm-305	12	35	rate	rate	NOUN
ejnm-305	12	36	moderately	moderately	ADV
ejnm-305	12	37	correlates	correlate	VERB
ejnm-305	12	38	with	with	ADP
ejnm-305	12	39	random	random	ADJ
ejnm-305	12	40	blood	blood	NOUN
ejnm-305	12	41	sugar	sugar	NOUN
ejnm-305	12	42	while	while	SCONJ
ejnm-305	12	43	strongly	strongly	ADV
ejnm-305	12	44	correlating	correlate	VERB
ejnm-305	12	45	negatively	negatively	ADV
ejnm-305	12	46	with	with	ADP
ejnm-305	12	47	urea	urea	NOUN
ejnm-305	12	48	and	and	CCONJ
ejnm-305	12	49	creatinine.mean	creatinine.mean	ADJ
ejnm-305	12	50	±	±	NOUN
ejnm-305	12	51	standard	standard	ADJ
ejnm-305	12	52	deviation	deviation	NOUN
ejnm-305	12	53	of	of	ADP
ejnm-305	12	54	urea	urea	NOUN
ejnm-305	12	55	and	and	CCONJ
ejnm-305	12	56	creatinine	creatinine	NOUN
ejnm-305	12	57	were	be	AUX
ejnm-305	12	58	significantly	significantly	ADV
ejnm-305	12	59	higher	high	ADJ
ejnm-305	12	60	in	in	ADP
ejnm-305	12	61	non	non	ADJ
ejnm-305	12	62	-	-	ADJ
ejnm-305	12	63	pregnant	pregnant	ADJ
ejnm-305	12	64	women	woman	NOUN
ejnm-305	12	65	while	while	SCONJ
ejnm-305	12	66	cholesterol	cholesterol	NOUN
ejnm-305	12	67	and	and	CCONJ
ejnm-305	12	68	estimated	estimate	VERB
ejnm-305	12	69	glomerular	glomerular	ADJ
ejnm-305	12	70	filtration	filtration	NOUN
ejnm-305	12	71	rate	rate	NOUN
ejnm-305	12	72	were	be	AUX
ejnm-305	12	73	significantly	significantly	ADV
ejnm-305	12	74	high	high	ADJ
ejnm-305	12	75	among	among	ADP
ejnm-305	12	76	pregnant	pregnant	ADJ
ejnm-305	12	77	women	woman	NOUN
ejnm-305	12	78	.	.	PUNCT
ejnm-305	13	1	conclusion	conclusion	NOUN
ejnm-305	13	2	:	:	PUNCT
ejnm-305	13	3	this	this	DET
ejnm-305	13	4	study	study	NOUN
ejnm-305	13	5	highlighted	highlight	VERB
ejnm-305	13	6	notable	notable	ADJ
ejnm-305	13	7	metabolic	metabolic	NOUN
ejnm-305	13	8	disparities	disparity	NOUN
ejnm-305	13	9	between	between	ADP
ejnm-305	13	10	pregnant	pregnant	ADJ
ejnm-305	13	11	and	and	CCONJ
ejnm-305	13	12	non	non	ADJ
ejnm-305	13	13	-	-	ADJ
ejnm-305	13	14	pregnant	pregnant	ADJ
ejnm-305	13	15	women	woman	NOUN
ejnm-305	13	16	,	,	PUNCT
ejnm-305	13	17	particularly	particularly	ADV
ejnm-305	13	18	in	in	ADP
ejnm-305	13	19	terms	term	NOUN
ejnm-305	13	20	of	of	ADP
ejnm-305	13	21	lipid	lipid	NOUN
ejnm-305	13	22	profiles	profile	NOUN
ejnm-305	13	23	and	and	CCONJ
ejnm-305	13	24	renal	renal	ADJ
ejnm-305	13	25	function	function	NOUN
ejnm-305	13	26	.	.	PUNCT
ejnm-305	14	1	changes	change	NOUN
ejnm-305	14	2	in	in	ADP
ejnm-305	14	3	hormone	hormone	NOUN
ejnm-305	14	4	levels	level	NOUN
ejnm-305	14	5	during	during	ADP
ejnm-305	14	6	pregnancy	pregnancy	NOUN
ejnm-305	14	7	can	can	AUX
ejnm-305	14	8	elevate	elevate	VERB
ejnm-305	14	9	lipid	lipid	NOUN
ejnm-305	14	10	profiles	profile	NOUN
ejnm-305	14	11	and	and	CCONJ
ejnm-305	14	12	renal	renal	ADJ
ejnm-305	14	13	function	function	NOUN
ejnm-305	14	14	,	,	PUNCT
ejnm-305	14	15	and	and	CCONJ
ejnm-305	14	16	these	these	DET
ejnm-305	14	17	metabolic	metabolic	NOUN
ejnm-305	14	18	and	and	CCONJ
ejnm-305	14	19	hormonal	hormonal	ADJ
ejnm-305	14	20	changes	change	NOUN
ejnm-305	14	21	could	could	AUX
ejnm-305	14	22	affect	affect	VERB
ejnm-305	14	23	kidney	kidney	NOUN
ejnm-305	14	24	function	function	NOUN
ejnm-305	14	25	indicators	indicator	NOUN
ejnm-305	14	26	.	.	PUNCT
ejnm-305	15	1	keywords	keyword	NOUN
ejnm-305	15	2	:	:	PUNCT
ejnm-305	15	3	renal	renal	ADJ
ejnm-305	15	4	function	function	NOUN
ejnm-305	15	5	(	(	PUNCT
ejnm-305	15	6	rf	rf	NOUN
ejnm-305	15	7	)	)	PUNCT
ejnm-305	15	8	;	;	PUNCT
ejnm-305	15	9	pregnancy	pregnancy	NOUN
ejnm-305	15	10	;	;	PUNCT
ejnm-305	15	11	estimated	estimate	VERB
ejnm-305	15	12	glomerular	glomerular	ADJ
ejnm-305	15	13	filtration	filtration	NOUN
ejnm-305	15	14	rate	rate	NOUN
ejnm-305	15	15	(	(	PUNCT
ejnm-305	15	16	egfr	egfr	NOUN
ejnm-305	15	17	)	)	PUNCT
ejnm-305	15	18	;	;	PUNCT
ejnm-305	15	19	serum	serum	NOUN
ejnm-305	15	20	lipid	lipid	NOUN
ejnm-305	15	21	profile	profile	NOUN
ejnm-305	15	22	(	(	PUNCT
ejnm-305	15	23	slp	slp	PROPN
ejnm-305	15	24	)	)	PUNCT
ejnm-305	15	25	.	.	PUNCT
ejnm-305	16	1	azad	azad	PROPN
ejnm-305	16	2	mohammed	mohammed	PROPN
ejnm-305	16	3	aziz	aziz	PROPN
ejnm-305	16	4	ahmed	ahmed	PROPN
ejnm-305	16	5	;	;	PUNCT
ejnm-305	16	6	department	department	NOUN
ejnm-305	16	7	of	of	ADP
ejnm-305	16	8	nursing	nursing	NOUN
ejnm-305	16	9	,	,	PUNCT
ejnm-305	16	10	darbandikhan	darbandikhan	PROPN
ejnm-305	16	11	technical	technical	PROPN
ejnm-305	16	12	institute	institute	PROPN
ejnm-305	16	13	,	,	PUNCT
ejnm-305	16	14	sulaimani	sulaimani	PROPN
ejnm-305	16	15	polytechnic	polytechnic	PROPN
ejnm-305	16	16	university	university	PROPN
ejnm-305	16	17	,	,	PUNCT
ejnm-305	16	18	sulaimani	sulaimani	NOUN
ejnm-305	16	19	,	,	PUNCT
ejnm-305	16	20	kurdistan	kurdistan	PROPN
ejnm-305	16	21	region	region	NOUN
ejnm-305	16	22	,	,	PUNCT
ejnm-305	16	23	iraq	iraq	PROPN
ejnm-305	16	24	.	.	PUNCT
ejnm-305	17	1	(	(	PUNCT
ejnm-305	17	2	correspondence	correspondence	NOUN
ejnm-305	17	3	:	:	PUNCT
ejnm-305	17	4	azad.aziz@spu.edu.iq	azad.aziz@spu.edu.iq	PROPN
ejnm-305	17	5	)	)	PUNCT
ejnm-305	17	6	amjad	amjad	PROPN
ejnm-305	17	7	mahmood	mahmood	PROPN
ejnm-305	17	8	qadir	qadir	PROPN
ejnm-305	17	9	;	;	PUNCT
ejnm-305	17	10	department	department	NOUN
ejnm-305	17	11	of	of	ADP
ejnm-305	17	12	general	general	ADJ
ejnm-305	17	13	science	science	PROPN
ejnm-305	17	14	,	,	PUNCT
ejnm-305	17	15	college	college	NOUN
ejnm-305	17	16	of	of	ADP
ejnm-305	17	17	basic	basic	ADJ
ejnm-305	17	18	education	education	NOUN
ejnm-305	17	19	,	,	PUNCT
ejnm-305	17	20	university	university	NOUN
ejnm-305	17	21	of	of	ADP
ejnm-305	17	22	halabja	halabja	PROPN
ejnm-305	17	23	,	,	PUNCT
ejnm-305	17	24	halabja	halabja	NOUN
ejnm-305	17	25	,	,	PUNCT
ejnm-305	17	26	kurdistan	kurdistan	PROPN
ejnm-305	17	27	region	region	NOUN
ejnm-305	17	28	,	,	PUNCT
ejnm-305	17	29	iraq	iraq	PROPN
ejnm-305	17	30	.	.	PUNCT
ejnm-305	18	1	jamal	jamal	PROPN
ejnm-305	18	2	kareem	kareem	PROPN
ejnm-305	18	3	shakor	shakor	PROPN
ejnm-305	18	4	;	;	PUNCT
ejnm-305	18	5	department	department	NOUN
ejnm-305	18	6	of	of	ADP
ejnm-305	18	7	nursing	nursing	NOUN
ejnm-305	18	8	,	,	PUNCT
ejnm-305	18	9	darbandikhan	darbandikhan	PROPN
ejnm-305	18	10	technical	technical	PROPN
ejnm-305	18	11	institute	institute	PROPN
ejnm-305	18	12	,	,	PUNCT
ejnm-305	18	13	sulaimani	sulaimani	PROPN
ejnm-305	18	14	polytechnic	polytechnic	PROPN
ejnm-305	18	15	university	university	PROPN
ejnm-305	18	16	,	,	PUNCT
ejnm-305	18	17	sulaimani	sulaimani	NOUN
ejnm-305	18	18	,	,	PUNCT
ejnm-305	18	19	kurdistan	kurdistan	PROPN
ejnm-305	18	20	region	region	NOUN
ejnm-305	18	21	,	,	PUNCT
ejnm-305	18	22	iraq	iraq	PROPN
ejnm-305	18	23	.	.	PUNCT
ejnm-305	19	1	musa	musa	PROPN
ejnm-305	19	2	zorab	zorab	PROPN
ejnm-305	19	3	;	;	PUNCT
ejnm-305	19	4	department	department	NOUN
ejnm-305	19	5	of	of	ADP
ejnm-305	19	6	physics	physics	PROPN
ejnm-305	19	7	,	,	PUNCT
ejnm-305	19	8	college	college	NOUN
ejnm-305	19	9	of	of	ADP
ejnm-305	19	10	science	science	NOUN
ejnm-305	19	11	,	,	PUNCT
ejnm-305	19	12	university	university	NOUN
ejnm-305	19	13	of	of	ADP
ejnm-305	19	14	halabja	halabja	NOUN
ejnm-305	19	15	,	,	PUNCT
ejnm-305	19	16	kurdistan	kurdistan	PROPN
ejnm-305	19	17	region	region	NOUN
ejnm-305	19	18	,	,	PUNCT
ejnm-305	19	19	iraq	iraq	PROPN
ejnm-305	19	20	.	.	PUNCT
ejnm-305	20	1	20	20	NUM
ejnm-305	20	2	received	receive	VERB
ejnm-305	20	3	:	:	PUNCT
ejnm-305	20	4	21/03/2024	21/03/2024	NUM
ejnm-305	20	5	accepted	accept	VERB
ejnm-305	20	6	:	:	PUNCT
ejnm-305	20	7	03/11/2024	03/11/2024	NUM
ejnm-305	20	8	published	publish	VERB
ejnm-305	20	9	:	:	PUNCT
ejnm-305	20	10	30/05/2025	30/05/2025	NUM
ejnm-305	20	11	copyright	copyright	NOUN
ejnm-305	20	12	©	©	PROPN
ejnm-305	20	13	2025	2025	NUM
ejnm-305	20	14	the	the	DET
ejnm-305	20	15	author(s	author(s	NOUN
ejnm-305	20	16	)	)	PUNCT
ejnm-305	20	17	.	.	PUNCT
ejnm-305	21	1	this	this	PRON
ejnm-305	21	2	is	be	AUX
ejnm-305	21	3	an	an	DET
ejnm-305	21	4	open	open	ADJ
ejnm-305	21	5	access	access	NOUN
ejnm-305	21	6	article	article	NOUN
ejnm-305	21	7	which	which	PRON
ejnm-305	21	8	licensed	license	VERB
ejnm-305	21	9	under	under	ADP
ejnm-305	21	10	the	the	DET
ejnm-305	21	11	terms	term	NOUN
ejnm-305	21	12	and	and	CCONJ
ejnm-305	21	13	conditions	condition	NOUN
ejnm-305	21	14	of	of	ADP
ejnm-305	21	15	the	the	DET
ejnm-305	21	16	creative	creative	ADJ
ejnm-305	21	17	commons	common	NOUN
ejnm-305	21	18	attribution	attribution	NOUN
ejnm-305	21	19	-	-	PUNCT
ejnm-305	21	20	noncommercial	noncommercial	ADJ
ejnm-305	21	21	-	-	PUNCT
ejnm-305	21	22	sharealike	sharealike	ADJ
ejnm-305	21	23	4.0	4.0	NUM
ejnm-305	21	24	international	international	ADJ
ejnm-305	21	25	license	license	NOUN
ejnm-305	21	26	.	.	PUNCT
ejnm-305	22	1	it	it	PRON
ejnm-305	22	2	permits	permit	VERB
ejnm-305	22	3	no	no	DET
ejnm-305	22	4	additional	additional	ADJ
ejnm-305	22	5	restrictions	restriction	NOUN
ejnm-305	22	6	on	on	ADP
ejnm-305	22	7	use	use	NOUN
ejnm-305	22	8	,	,	PUNCT
ejnm-305	22	9	distribution	distribution	NOUN
ejnm-305	22	10	,	,	PUNCT
ejnm-305	22	11	and	and	CCONJ
ejnm-305	22	12	reproduction	reproduction	NOUN
ejnm-305	22	13	in	in	ADP
ejnm-305	22	14	any	any	DET
ejnm-305	22	15	medium	medium	NOUN
ejnm-305	22	16	provided	provide	VERB
ejnm-305	22	17	the	the	DET
ejnm-305	22	18	original	original	ADJ
ejnm-305	22	19	work	work	NOUN
ejnm-305	22	20	is	be	AUX
ejnm-305	22	21	properly	properly	ADV
ejnm-305	22	22	cited	cite	VERB
ejnm-305	22	23	.	.	PUNCT
ejnm-305	23	1	mailto:azad.aziz@spu.edu.iq?subject=azad.aziz@spu.edu.iq	mailto:azad.aziz@spu.edu.iq?subject=azad.aziz@spu.edu.iq	PROPN
ejnm-305	23	2	mailto:jawdat.baker@hmu.edu.krd?subject=jawdat.baker@hmu.edu.krd%20%20%20	mailto:jawdat.baker@hmu.edu.krd?subject=jawdat.baker@hmu.edu.krd%20%20%20	PROPN
ejnm-305	23	3	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-305	23	4	https://doi.org/10.15218/ejnm.2025.03	https://doi.org/10.15218/ejnm.2025.03	PROPN
ejnm-305	23	5	erbil	erbil	PROPN
ejnm-305	23	6	j.	j.	PROPN
ejnm-305	23	7	nurs	nurs	PROPN
ejnm-305	23	8	.	.	PUNCT
ejnm-305	24	1	midwifery	midwifery	ADJ
ejnm-305	24	2	,	,	PUNCT
ejnm-305	24	3	vol	vol	NOUN
ejnm-305	24	4	.	.	PROPN
ejnm-305	24	5	8	8	NUM
ejnm-305	24	6	,	,	PUNCT
ejnm-305	24	7	no	no	INTJ
ejnm-305	24	8	.	.	PUNCT
ejnm-305	25	1	(	(	PUNCT
ejnm-305	25	2	1	1	NUM
ejnm-305	25	3	)	)	PUNCT
ejnm-305	25	4	,	,	PUNCT
ejnm-305	25	5	may	may	AUX
ejnm-305	25	6	2025	2025	NUM
ejnm-305	25	7	original	original	ADJ
ejnm-305	25	8	article	article	NOUN
ejnm-305	25	9	it	it	PRON
ejnm-305	25	10	is	be	AUX
ejnm-305	25	11	well	well	ADV
ejnm-305	25	12	-	-	PUNCT
ejnm-305	25	13	recognized	recognize	VERB
ejnm-305	25	14	that	that	SCONJ
ejnm-305	25	15	pregnancy	pregnancy	NOUN
ejnm-305	25	16	causes	cause	VERB
ejnm-305	25	17	significant	significant	ADJ
ejnm-305	25	18	bodily	bodily	ADJ
ejnm-305	25	19	changes	change	NOUN
ejnm-305	25	20	.	.	PUNCT
ejnm-305	26	1	in	in	ADP
ejnm-305	26	2	addition	addition	NOUN
ejnm-305	26	3	to	to	ADP
ejnm-305	26	4	raising	raise	VERB
ejnm-305	26	5	the	the	DET
ejnm-305	26	6	need	need	NOUN
ejnm-305	26	7	for	for	ADP
ejnm-305	26	8	metabolic	metabolic	ADJ
ejnm-305	26	9	fuels	fuel	NOUN
ejnm-305	26	10	for	for	ADP
ejnm-305	26	11	the	the	DET
ejnm-305	26	12	growing	grow	VERB
ejnm-305	26	13	fetus	fetus	NOUN
ejnm-305	26	14	and	and	CCONJ
ejnm-305	26	15	the	the	DET
ejnm-305	26	16	development	development	NOUN
ejnm-305	26	17	of	of	ADP
ejnm-305	26	18	its	its	PRON
ejnm-305	26	19	supporting	support	VERB
ejnm-305	26	20	structures	structure	NOUN
ejnm-305	26	21	,	,	PUNCT
ejnm-305	26	22	it	it	PRON
ejnm-305	26	23	also	also	ADV
ejnm-305	26	24	alters	alter	VERB
ejnm-305	26	25	hormone	hormone	NOUN
ejnm-305	26	26	levels	level	NOUN
ejnm-305	26	27	in	in	ADP
ejnm-305	26	28	the	the	DET
ejnm-305	26	29	body	body	NOUN
ejnm-305	26	30	,	,	PUNCT
ejnm-305	26	31	which	which	PRON
ejnm-305	26	32	may	may	AUX
ejnm-305	26	33	affect	affect	VERB
ejnm-305	26	34	the	the	DET
ejnm-305	26	35	lipid	lipid	NOUN
ejnm-305	26	36	profile	profile	NOUN
ejnm-305	26	37	throughout	throughout	ADP
ejnm-305	26	38	the	the	DET
ejnm-305	26	39	course	course	NOUN
ejnm-305	26	40	of	of	ADP
ejnm-305	26	41	the	the	DET
ejnm-305	26	42	pregnancy	pregnancy	NOUN
ejnm-305	26	43	's	's	PART
ejnm-305	26	44	many	many	ADJ
ejnm-305	26	45	trimesters	trimester	NOUN
ejnm-305	26	46	.	.	PUNCT
ejnm-305	27	1	examination	examination	NOUN
ejnm-305	27	2	of	of	ADP
ejnm-305	27	3	serum	serum	NOUN
ejnm-305	27	4	lipid	lipid	NOUN
ejnm-305	27	5	profiles	profile	NOUN
ejnm-305	27	6	throughout	throughout	ADP
ejnm-305	27	7	the	the	DET
ejnm-305	27	8	initial	initial	ADJ
ejnm-305	27	9	three	three	NUM
ejnm-305	27	10	months	month	NOUN
ejnm-305	27	11	of	of	ADP
ejnm-305	27	12	pregnancy	pregnancy	NOUN
ejnm-305	27	13	can	can	AUX
ejnm-305	27	14	potentially	potentially	ADV
ejnm-305	27	15	forecast	forecast	VERB
ejnm-305	27	16	the	the	DET
ejnm-305	27	17	occurrence	occurrence	NOUN
ejnm-305	27	18	and	and	CCONJ
ejnm-305	27	19	intensity	intensity	NOUN
ejnm-305	27	20	of	of	ADP
ejnm-305	27	21	pre	pre	NOUN
ejnm-305	27	22	-	-	NOUN
ejnm-305	27	23	eclampsia	eclampsia	NOUN
ejnm-305	28	1	[	[	X
ejnm-305	28	2	1	1	NUM
ejnm-305	28	3	]	]	PUNCT
ejnm-305	28	4	.	.	PUNCT
ejnm-305	29	1	the	the	DET
ejnm-305	29	2	anabolic	anabolic	NOUN
ejnm-305	29	3	phase	phase	NOUN
ejnm-305	29	4	during	during	ADP
ejnm-305	29	5	early	early	ADJ
ejnm-305	29	6	pregnancy	pregnancy	NOUN
ejnm-305	29	7	stimulates	stimulate	VERB
ejnm-305	29	8	lipogenesis	lipogenesis	NOUN
ejnm-305	29	9	and	and	CCONJ
ejnm-305	29	10	promotes	promote	VERB
ejnm-305	29	11	the	the	DET
ejnm-305	29	12	accumulation	accumulation	NOUN
ejnm-305	29	13	of	of	ADP
ejnm-305	29	14	fat	fat	NOUN
ejnm-305	29	15	in	in	ADP
ejnm-305	29	16	anticipation	anticipation	NOUN
ejnm-305	29	17	of	of	ADP
ejnm-305	29	18	the	the	DET
ejnm-305	29	19	rapid	rapid	ADJ
ejnm-305	29	20	growth	growth	NOUN
ejnm-305	29	21	of	of	ADP
ejnm-305	29	22	the	the	DET
ejnm-305	29	23	fetus	fetus	NOUN
ejnm-305	29	24	in	in	ADP
ejnm-305	29	25	late	late	ADJ
ejnm-305	29	26	pregnancy	pregnancy	NOUN
ejnm-305	30	1	[	[	X
ejnm-305	30	2	2	2	NUM
ejnm-305	30	3	]	]	PUNCT
ejnm-305	30	4	.	.	PUNCT
ejnm-305	31	1	insulin	insulin	NOUN
ejnm-305	31	2	resistance	resistance	NOUN
ejnm-305	31	3	causes	cause	VERB
ejnm-305	31	4	an	an	DET
ejnm-305	31	5	increase	increase	NOUN
ejnm-305	31	6	in	in	ADP
ejnm-305	31	7	lipolysis	lipolysis	NOUN
ejnm-305	31	8	,	,	PUNCT
ejnm-305	31	9	which	which	PRON
ejnm-305	31	10	results	result	VERB
ejnm-305	31	11	in	in	ADP
ejnm-305	31	12	a	a	DET
ejnm-305	31	13	greater	great	ADJ
ejnm-305	31	14	flow	flow	NOUN
ejnm-305	31	15	of	of	ADP
ejnm-305	31	16	fatty	fatty	ADJ
ejnm-305	31	17	acids	acid	NOUN
ejnm-305	31	18	to	to	ADP
ejnm-305	31	19	the	the	DET
ejnm-305	31	20	liver	liver	NOUN
ejnm-305	31	21	.	.	PUNCT
ejnm-305	32	1	this	this	PRON
ejnm-305	32	2	,	,	PUNCT
ejnm-305	32	3	in	in	ADP
ejnm-305	32	4	turn	turn	NOUN
ejnm-305	32	5	,	,	PUNCT
ejnm-305	32	6	stimulates	stimulate	VERB
ejnm-305	32	7	the	the	DET
ejnm-305	32	8	production	production	NOUN
ejnm-305	32	9	of	of	ADP
ejnm-305	32	10	very	very	ADV
ejnm-305	32	11	low	low	ADJ
ejnm-305	32	12	-	-	PUNCT
ejnm-305	32	13	density	density	NOUN
ejnm-305	32	14	lipoproteins	lipoprotein	NOUN
ejnm-305	32	15	(	(	PUNCT
ejnm-305	32	16	ldls	ldls	X
ejnm-305	32	17	)	)	PUNCT
ejnm-305	32	18	and	and	CCONJ
ejnm-305	32	19	leads	lead	VERB
ejnm-305	32	20	to	to	ADP
ejnm-305	32	21	higher	high	ADJ
ejnm-305	32	22	concentrations	concentration	NOUN
ejnm-305	32	23	of	of	ADP
ejnm-305	32	24	triglycerides	triglyceride	NOUN
ejnm-305	32	25	(	(	PUNCT
ejnm-305	32	26	tg	tg	NOUN
ejnm-305	32	27	)	)	PUNCT
ejnm-305	32	28	.	.	PUNCT
ejnm-305	33	1	due	due	ADP
ejnm-305	33	2	to	to	ADP
ejnm-305	33	3	a	a	DET
ejnm-305	33	4	reduction	reduction	NOUN
ejnm-305	33	5	in	in	ADP
ejnm-305	33	6	the	the	DET
ejnm-305	33	7	functioning	functioning	NOUN
ejnm-305	33	8	of	of	ADP
ejnm-305	33	9	lipoprotein	lipoprotein	ADJ
ejnm-305	33	10	lipase	lipase	NOUN
ejnm-305	33	11	,	,	PUNCT
ejnm-305	33	12	very	very	ADV
ejnm-305	33	13	low	low	ADJ
ejnm-305	33	14	-	-	PUNCT
ejnm-305	33	15	density	density	NOUN
ejnm-305	33	16	lipoprotein	lipoprotein	ADJ
ejnm-305	33	17	(	(	PUNCT
ejnm-305	33	18	vldl	vldl	NOUN
ejnm-305	33	19	)	)	PUNCT
ejnm-305	33	20	persists	persist	VERB
ejnm-305	33	21	in	in	ADP
ejnm-305	33	22	the	the	DET
ejnm-305	33	23	bloodstream	bloodstream	NOUN
ejnm-305	33	24	for	for	ADP
ejnm-305	33	25	an	an	DET
ejnm-305	33	26	extended	extended	ADJ
ejnm-305	33	27	period	period	NOUN
ejnm-305	33	28	,	,	PUNCT
ejnm-305	33	29	resulting	result	VERB
ejnm-305	33	30	in	in	ADP
ejnm-305	33	31	the	the	DET
ejnm-305	33	32	buildup	buildup	NOUN
ejnm-305	33	33	of	of	ADP
ejnm-305	33	34	lowdensity	lowdensity	NOUN
ejnm-305	33	35	lipoprotein	lipoprotein	ADJ
ejnm-305	33	36	(	(	PUNCT
ejnm-305	33	37	ldl	ldl	NOUN
ejnm-305	33	38	)	)	PUNCT
ejnm-305	33	39	.	.	PUNCT
ejnm-305	34	1	elevated	elevated	ADJ
ejnm-305	34	2	levels	level	NOUN
ejnm-305	34	3	of	of	ADP
ejnm-305	34	4	ldl	ldl	NOUN
ejnm-305	34	5	are	be	AUX
ejnm-305	34	6	linked	link	VERB
ejnm-305	34	7	to	to	ADP
ejnm-305	34	8	the	the	DET
ejnm-305	34	9	progression	progression	NOUN
ejnm-305	34	10	of	of	ADP
ejnm-305	34	11	atherosclerosis	atherosclerosis	NOUN
ejnm-305	34	12	[	[	X
ejnm-305	34	13	3	3	NUM
ejnm-305	34	14	]	]	PUNCT
ejnm-305	34	15	.	.	PUNCT
ejnm-305	35	1	disordered	disorder	VERB
ejnm-305	35	2	lipid	lipid	ADJ
ejnm-305	35	3	metabolism	metabolism	NOUN
ejnm-305	35	4	also	also	ADV
ejnm-305	35	5	appears	appear	VERB
ejnm-305	35	6	to	to	PART
ejnm-305	35	7	have	have	VERB
ejnm-305	35	8	a	a	DET
ejnm-305	35	9	significant	significant	ADJ
ejnm-305	35	10	role	role	NOUN
ejnm-305	35	11	in	in	ADP
ejnm-305	35	12	the	the	DET
ejnm-305	35	13	development	development	NOUN
ejnm-305	35	14	of	of	ADP
ejnm-305	35	15	pregnancy	pregnancy	NOUN
ejnm-305	35	16	-	-	PUNCT
ejnm-305	35	17	induced	induce	VERB
ejnm-305	35	18	hypertension	hypertension	NOUN
ejnm-305	35	19	(	(	PUNCT
ejnm-305	35	20	pih	pih	PROPN
ejnm-305	35	21	)	)	PUNCT
ejnm-305	35	22	.	.	PUNCT
ejnm-305	36	1	the	the	DET
ejnm-305	36	2	correlation	correlation	NOUN
ejnm-305	36	3	between	between	ADP
ejnm-305	36	4	blood	blood	NOUN
ejnm-305	36	5	lipids	lipid	NOUN
ejnm-305	36	6	and	and	CCONJ
ejnm-305	36	7	gestational	gestational	ADJ
ejnm-305	36	8	proteinuria	proteinuria	NOUN
ejnm-305	36	9	hypertension	hypertension	NOUN
ejnm-305	36	10	strongly	strongly	ADV
ejnm-305	36	11	indicates	indicate	VERB
ejnm-305	36	12	that	that	SCONJ
ejnm-305	36	13	lipid	lipid	NOUN
ejnm-305	36	14	profile	profile	NOUN
ejnm-305	36	15	analysis	analysis	NOUN
ejnm-305	36	16	can	can	AUX
ejnm-305	36	17	be	be	AUX
ejnm-305	36	18	used	use	VERB
ejnm-305	36	19	as	as	ADP
ejnm-305	36	20	a	a	DET
ejnm-305	36	21	diagnostic	diagnostic	ADJ
ejnm-305	36	22	tool	tool	NOUN
ejnm-305	36	23	[	[	X
ejnm-305	36	24	4	4	NUM
ejnm-305	36	25	]	]	PUNCT
ejnm-305	36	26	.	.	PUNCT
ejnm-305	37	1	throughout	throughout	ADP
ejnm-305	37	2	a	a	DET
ejnm-305	37	3	typical	typical	ADJ
ejnm-305	37	4	pregnancy	pregnancy	NOUN
ejnm-305	37	5	,	,	PUNCT
ejnm-305	37	6	there	there	PRON
ejnm-305	37	7	is	be	VERB
ejnm-305	37	8	an	an	DET
ejnm-305	37	9	increase	increase	NOUN
ejnm-305	37	10	in	in	ADP
ejnm-305	37	11	plasma	plasma	NOUN
ejnm-305	37	12	triglyceride	triglyceride	ADP
ejnm-305	37	13	and	and	CCONJ
ejnm-305	37	14	cholesterol	cholesterol	NOUN
ejnm-305	37	15	levels	level	NOUN
ejnm-305	37	16	,	,	PUNCT
ejnm-305	37	17	which	which	PRON
ejnm-305	37	18	eventually	eventually	ADV
ejnm-305	37	19	return	return	VERB
ejnm-305	37	20	to	to	ADP
ejnm-305	37	21	normal	normal	ADJ
ejnm-305	37	22	as	as	SCONJ
ejnm-305	37	23	the	the	DET
ejnm-305	37	24	pregnancy	pregnancy	NOUN
ejnm-305	37	25	advances	advance	VERB
ejnm-305	37	26	.	.	PUNCT
ejnm-305	38	1	pregnancy	pregnancy	NOUN
ejnm-305	38	2	-	-	PUNCT
ejnm-305	38	3	induced	induce	VERB
ejnm-305	38	4	hormonal	hormonal	ADJ
ejnm-305	38	5	fluctuations	fluctuation	NOUN
ejnm-305	38	6	impact	impact	NOUN
ejnm-305	38	7	lipid	lipid	NOUN
ejnm-305	38	8	metabolism	metabolism	NOUN
ejnm-305	38	9	.	.	PUNCT
ejnm-305	39	1	endogenous	endogenous	ADJ
ejnm-305	39	2	female	female	ADJ
ejnm-305	39	3	sex	sex	NOUN
ejnm-305	39	4	hormones	hormone	NOUN
ejnm-305	39	5	exert	exert	VERB
ejnm-305	39	6	a	a	DET
ejnm-305	39	7	substantial	substantial	ADJ
ejnm-305	39	8	impact	impact	NOUN
ejnm-305	39	9	on	on	ADP
ejnm-305	39	10	serum	serum	NOUN
ejnm-305	39	11	lipids	lipid	NOUN
ejnm-305	39	12	.	.	PUNCT
ejnm-305	40	1	during	during	ADP
ejnm-305	40	2	pregnancy	pregnancy	NOUN
ejnm-305	40	3	,	,	PUNCT
ejnm-305	40	4	there	there	PRON
ejnm-305	40	5	is	be	VERB
ejnm-305	40	6	an	an	DET
ejnm-305	40	7	elevation	elevation	NOUN
ejnm-305	40	8	in	in	ADP
ejnm-305	40	9	hepatic	hepatic	ADJ
ejnm-305	40	10	lipase	lipase	NOUN
ejnm-305	40	11	activity	activity	NOUN
ejnm-305	40	12	and	and	CCONJ
ejnm-305	40	13	a	a	DET
ejnm-305	40	14	reduction	reduction	NOUN
ejnm-305	40	15	in	in	ADP
ejnm-305	40	16	lipoprotein	lipoprotein	ADJ
ejnm-305	40	17	lipase	lipase	NOUN
ejnm-305	40	18	activity	activity	NOUN
ejnm-305	40	19	[	[	X
ejnm-305	40	20	5	5	NUM
ejnm-305	40	21	]	]	PUNCT
ejnm-305	40	22	.	.	PUNCT
ejnm-305	41	1	another	another	DET
ejnm-305	41	2	study	study	NOUN
ejnm-305	41	3	's	's	PART
ejnm-305	41	4	conclusion	conclusion	NOUN
ejnm-305	41	5	likewise	likewise	ADV
ejnm-305	41	6	confirmed	confirm	VERB
ejnm-305	41	7	a	a	DET
ejnm-305	41	8	consistent	consistent	ADJ
ejnm-305	41	9	positive	positive	ADJ
ejnm-305	41	10	correlation	correlation	NOUN
ejnm-305	41	11	between	between	ADP
ejnm-305	41	12	high	high	ADJ
ejnm-305	41	13	levels	level	NOUN
ejnm-305	41	14	of	of	ADP
ejnm-305	41	15	maternal	maternal	ADJ
ejnm-305	41	16	tg	tg	PROPN
ejnm-305	41	17	and	and	CCONJ
ejnm-305	41	18	the	the	DET
ejnm-305	41	19	likelihood	likelihood	NOUN
ejnm-305	41	20	of	of	ADP
ejnm-305	41	21	pre	pre	ADJ
ejnm-305	41	22	-	-	NOUN
ejnm-305	41	23	eclampsia	eclampsia	NOUN
ejnm-305	42	1	[	[	X
ejnm-305	42	2	6	6	NUM
ejnm-305	42	3	,	,	PUNCT
ejnm-305	42	4	7	7	NUM
ejnm-305	42	5	]	]	PUNCT
ejnm-305	42	6	.	.	PUNCT
ejnm-305	43	1	conversely	conversely	ADV
ejnm-305	43	2	,	,	PUNCT
ejnm-305	43	3	hyperlipidemia	hyperlipidemia	NOUN
ejnm-305	43	4	is	be	AUX
ejnm-305	43	5	considered	consider	VERB
ejnm-305	43	6	a	a	DET
ejnm-305	43	7	natural	natural	ADJ
ejnm-305	43	8	occurrence	occurrence	NOUN
ejnm-305	43	9	during	during	ADP
ejnm-305	43	10	pregnancy	pregnancy	NOUN
ejnm-305	43	11	.	.	PUNCT
ejnm-305	44	1	multiple	multiple	ADJ
ejnm-305	44	2	studies	study	NOUN
ejnm-305	44	3	have	have	AUX
ejnm-305	44	4	noticed	notice	VERB
ejnm-305	44	5	a	a	DET
ejnm-305	44	6	significant	significant	ADJ
ejnm-305	44	7	increase	increase	NOUN
ejnm-305	44	8	of	of	ADP
ejnm-305	44	9	50	50	NUM
ejnm-305	44	10	to	to	PART
ejnm-305	44	11	60	60	NUM
ejnm-305	44	12	%	%	NOUN
ejnm-305	44	13	in	in	ADP
ejnm-305	44	14	cholesterol	cholesterol	NOUN
ejnm-305	44	15	levels	level	NOUN
ejnm-305	44	16	and	and	CCONJ
ejnm-305	44	17	a	a	DET
ejnm-305	44	18	substantial	substantial	ADJ
ejnm-305	44	19	increase	increase	NOUN
ejnm-305	44	20	of	of	ADP
ejnm-305	44	21	100	100	NUM
ejnm-305	44	22	to	to	PART
ejnm-305	44	23	200	200	NUM
ejnm-305	44	24	%	%	NOUN
ejnm-305	44	25	in	in	ADP
ejnm-305	44	26	tg	tg	PROPN
ejnm-305	44	27	levels	level	NOUN
ejnm-305	44	28	during	during	ADP
ejnm-305	44	29	uncomplicated	uncomplicated	ADJ
ejnm-305	44	30	pregnancy	pregnancy	NOUN
ejnm-305	44	31	[	[	X
ejnm-305	44	32	8	8	NUM
ejnm-305	44	33	]	]	PUNCT
ejnm-305	44	34	.	.	PUNCT
ejnm-305	45	1	furthermore	furthermore	ADV
ejnm-305	45	2	,	,	PUNCT
ejnm-305	45	3	there	there	PRON
ejnm-305	45	4	appears	appear	VERB
ejnm-305	45	5	to	to	PART
ejnm-305	45	6	be	be	AUX
ejnm-305	45	7	a	a	DET
ejnm-305	45	8	correlation	correlation	NOUN
ejnm-305	45	9	between	between	ADP
ejnm-305	45	10	various	various	ADJ
ejnm-305	45	11	pregnancy	pregnancy	NOUN
ejnm-305	45	12	problems	problem	NOUN
ejnm-305	45	13	and	and	CCONJ
ejnm-305	45	14	the	the	DET
ejnm-305	45	15	presence	presence	NOUN
ejnm-305	45	16	of	of	ADP
ejnm-305	45	17	extra	extra	ADJ
ejnm-305	45	18	lipid	lipid	NOUN
ejnm-305	45	19	abnormalities	abnormality	NOUN
ejnm-305	45	20	and	and	CCONJ
ejnm-305	45	21	impaired	impair	VERB
ejnm-305	45	22	renal	renal	ADJ
ejnm-305	45	23	function	function	NOUN
ejnm-305	45	24	[	[	X
ejnm-305	45	25	9	9	NUM
ejnm-305	45	26	]	]	PUNCT
ejnm-305	45	27	.	.	PUNCT
ejnm-305	46	1	additionally	additionally	ADV
ejnm-305	46	2	,	,	PUNCT
ejnm-305	46	3	more	more	ADJ
ejnm-305	46	4	than	than	ADP
ejnm-305	46	5	half	half	NOUN
ejnm-305	46	6	of	of	ADP
ejnm-305	46	7	renal	renal	ADJ
ejnm-305	46	8	function	function	NOUN
ejnm-305	46	9	can	can	AUX
ejnm-305	46	10	be	be	AUX
ejnm-305	46	11	lost	lose	VERB
ejnm-305	46	12	before	before	ADP
ejnm-305	46	13	the	the	DET
ejnm-305	46	14	level	level	NOUN
ejnm-305	46	15	of	of	ADP
ejnm-305	46	16	blood	blood	NOUN
ejnm-305	46	17	creatinine	creatinine	NOUN
ejnm-305	46	18	exceeds	exceed	VERB
ejnm-305	46	19	120	120	NUM
ejnm-305	46	20	µmol	µmol	NOUN
ejnm-305	46	21	/	/	SYM
ejnm-305	46	22	l	l	NOUN
ejnm-305	47	1	[	[	X
ejnm-305	47	2	10	10	NUM
ejnm-305	47	3	]	]	PUNCT
ejnm-305	47	4	.	.	PUNCT
ejnm-305	48	1	pregnant	pregnant	ADJ
ejnm-305	48	2	women	woman	NOUN
ejnm-305	48	3	with	with	ADP
ejnm-305	48	4	serum	serum	NOUN
ejnm-305	48	5	creatinine	creatinine	NOUN
ejnm-305	48	6	levels	level	NOUN
ejnm-305	48	7	exceeding	exceed	VERB
ejnm-305	48	8	124	124	NUM
ejnm-305	48	9	µmol	µmol	NOUN
ejnm-305	48	10	/	/	SYM
ejnm-305	48	11	l	l	NOUN
ejnm-305	48	12	are	be	AUX
ejnm-305	48	13	at	at	ADP
ejnm-305	48	14	a	a	DET
ejnm-305	48	15	higher	high	ADJ
ejnm-305	48	16	risk	risk	NOUN
ejnm-305	48	17	of	of	ADP
ejnm-305	48	18	experiencing	experience	VERB
ejnm-305	48	19	a	a	DET
ejnm-305	48	20	faster	fast	ADJ
ejnm-305	48	21	deterioration	deterioration	NOUN
ejnm-305	48	22	in	in	ADP
ejnm-305	48	23	kidney	kidney	NOUN
ejnm-305	48	24	function	function	NOUN
ejnm-305	48	25	and	and	CCONJ
ejnm-305	48	26	having	have	VERB
ejnm-305	48	27	a	a	DET
ejnm-305	48	28	worse	bad	ADJ
ejnm-305	48	29	pregnancy	pregnancy	NOUN
ejnm-305	48	30	outcome	outcome	NOUN
ejnm-305	48	31	.	.	PUNCT
ejnm-305	49	1	when	when	SCONJ
ejnm-305	49	2	managing	manage	VERB
ejnm-305	49	3	pregnant	pregnant	ADJ
ejnm-305	49	4	women	woman	NOUN
ejnm-305	49	5	with	with	ADP
ejnm-305	49	6	chronic	chronic	ADJ
ejnm-305	49	7	kidney	kidney	NOUN
ejnm-305	49	8	disease	disease	NOUN
ejnm-305	49	9	,	,	PUNCT
ejnm-305	49	10	it	it	PRON
ejnm-305	49	11	is	be	AUX
ejnm-305	49	12	important	important	ADJ
ejnm-305	49	13	to	to	PART
ejnm-305	49	14	consider	consider	VERB
ejnm-305	49	15	various	various	ADJ
ejnm-305	49	16	aspects	aspect	NOUN
ejnm-305	49	17	to	to	PART
ejnm-305	49	18	reduce	reduce	VERB
ejnm-305	49	19	the	the	DET
ejnm-305	49	20	negative	negative	ADJ
ejnm-305	49	21	impact	impact	NOUN
ejnm-305	49	22	of	of	ADP
ejnm-305	49	23	pregnancy	pregnancy	NOUN
ejnm-305	49	24	on	on	ADP
ejnm-305	49	25	the	the	DET
ejnm-305	49	26	mother	mother	NOUN
ejnm-305	49	27	's	's	PART
ejnm-305	49	28	kidney	kidney	NOUN
ejnm-305	49	29	function	function	NOUN
ejnm-305	49	30	and	and	CCONJ
ejnm-305	49	31	the	the	DET
ejnm-305	49	32	resulting	result	VERB
ejnm-305	49	33	repercussions	repercussion	NOUN
ejnm-305	49	34	on	on	ADP
ejnm-305	49	35	the	the	DET
ejnm-305	49	36	fetus	fetus	NOUN
ejnm-305	49	37	.	.	PUNCT
ejnm-305	50	1	in	in	ADP
ejnm-305	50	2	addition	addition	NOUN
ejnm-305	50	3	,	,	PUNCT
ejnm-305	50	4	it	it	PRON
ejnm-305	50	5	is	be	AUX
ejnm-305	50	6	noteworthy	noteworthy	ADJ
ejnm-305	50	7	that	that	SCONJ
ejnm-305	50	8	a	a	DET
ejnm-305	50	9	significant	significant	ADJ
ejnm-305	50	10	number	number	NOUN
ejnm-305	50	11	of	of	ADP
ejnm-305	50	12	individuals	individual	NOUN
ejnm-305	50	13	suffering	suffer	VERB
ejnm-305	50	14	from	from	ADP
ejnm-305	50	15	kidney	kidney	NOUN
ejnm-305	50	16	disease	disease	NOUN
ejnm-305	50	17	and	and	CCONJ
ejnm-305	50	18	experiencing	experience	VERB
ejnm-305	50	19	very	very	ADV
ejnm-305	50	20	minor	minor	ADJ
ejnm-305	50	21	impairment	impairment	NOUN
ejnm-305	50	22	exhibit	exhibit	NOUN
ejnm-305	50	23	an	an	DET
ejnm-305	50	24	unexpected	unexpected	ADJ
ejnm-305	50	25	rise	rise	NOUN
ejnm-305	50	26	in	in	ADP
ejnm-305	50	27	glomerular	glomerular	ADJ
ejnm-305	50	28	filtration	filtration	NOUN
ejnm-305	50	29	rate	rate	NOUN
ejnm-305	50	30	(	(	PUNCT
ejnm-305	50	31	gfr	gfr	NOUN
ejnm-305	50	32	)	)	PUNCT
ejnm-305	50	33	during	during	ADP
ejnm-305	50	34	pregnancy	pregnancy	NOUN
ejnm-305	50	35	[	[	X
ejnm-305	50	36	11	11	NUM
ejnm-305	50	37	]	]	PUNCT
ejnm-305	50	38	.	.	PUNCT
ejnm-305	51	1	prior	prior	ADJ
ejnm-305	51	2	research	research	NOUN
ejnm-305	51	3	has	have	AUX
ejnm-305	51	4	indicated	indicate	VERB
ejnm-305	51	5	a	a	DET
ejnm-305	51	6	potential	potential	ADJ
ejnm-305	51	7	link	link	NOUN
ejnm-305	51	8	between	between	ADP
ejnm-305	51	9	lipid	lipid	NOUN
ejnm-305	51	10	metabolism	metabolism	NOUN
ejnm-305	51	11	and	and	CCONJ
ejnm-305	51	12	renal	renal	ADJ
ejnm-305	51	13	function	function	NOUN
ejnm-305	51	14	during	during	ADP
ejnm-305	51	15	pregnancy	pregnancy	NOUN
ejnm-305	51	16	.	.	PUNCT
ejnm-305	52	1	prior	prior	ADJ
ejnm-305	52	2	research	research	NOUN
ejnm-305	52	3	has	have	AUX
ejnm-305	52	4	utilized	utilize	VERB
ejnm-305	52	5	serum	serum	NOUN
ejnm-305	52	6	creatinine	creatinine	NOUN
ejnm-305	52	7	as	as	ADP
ejnm-305	52	8	a	a	DET
ejnm-305	52	9	marker	marker	NOUN
ejnm-305	52	10	for	for	ADP
ejnm-305	52	11	impaired	impaired	ADJ
ejnm-305	52	12	rf	rf	NOUN
ejnm-305	52	13	.	.	PUNCT
ejnm-305	53	1	the	the	DET
ejnm-305	53	2	categorization	categorization	NOUN
ejnm-305	53	3	of	of	ADP
ejnm-305	53	4	renal	renal	ADJ
ejnm-305	53	5	impairment	impairment	NOUN
ejnm-305	53	6	was	be	AUX
ejnm-305	53	7	based	base	VERB
ejnm-305	53	8	on	on	ADP
ejnm-305	53	9	the	the	DET
ejnm-305	53	10	following	follow	VERB
ejnm-305	53	11	criteria	criterion	NOUN
ejnm-305	53	12	:	:	PUNCT
ejnm-305	53	13	mild	mild	ADJ
ejnm-305	53	14	,	,	PUNCT
ejnm-305	53	15	moderate	moderate	ADJ
ejnm-305	53	16	,	,	PUNCT
ejnm-305	53	17	or	or	CCONJ
ejnm-305	53	18	severe	severe	ADJ
ejnm-305	54	1	[	[	X
ejnm-305	54	2	12	12	NUM
ejnm-305	54	3	,	,	PUNCT
ejnm-305	54	4	13	13	NUM
ejnm-305	54	5	]	]	PUNCT
ejnm-305	54	6	.	.	PUNCT
ejnm-305	55	1	finding	find	VERB
ejnm-305	55	2	the	the	DET
ejnm-305	55	3	correlation	correlation	NOUN
ejnm-305	55	4	of	of	ADP
ejnm-305	55	5	lipid	lipid	NOUN
ejnm-305	55	6	profile	profile	NOUN
ejnm-305	55	7	with	with	ADP
ejnm-305	55	8	duration	duration	NOUN
ejnm-305	55	9	of	of	ADP
ejnm-305	55	10	pregnancy	pregnancy	NOUN
ejnm-305	55	11	,	,	PUNCT
ejnm-305	55	12	particularly	particularly	ADV
ejnm-305	55	13	in	in	ADP
ejnm-305	55	14	those	those	DET
ejnm-305	55	15	women	woman	NOUN
ejnm-305	55	16	who	who	PRON
ejnm-305	55	17	have	have	VERB
ejnm-305	55	18	the	the	DET
ejnm-305	55	19	associated	associated	ADJ
ejnm-305	55	20	kidney	kidney	NOUN
ejnm-305	55	21	problems	problem	NOUN
ejnm-305	55	22	,	,	PUNCT
ejnm-305	55	23	could	could	AUX
ejnm-305	55	24	help	help	VERB
ejnm-305	55	25	pregnancy	pregnancy	NOUN
ejnm-305	55	26	outcome	outcome	NOUN
ejnm-305	55	27	,	,	PUNCT
ejnm-305	55	28	mother	mother	NOUN
ejnm-305	55	29	’s	’s	PART
ejnm-305	55	30	health	health	NOUN
ejnm-305	55	31	,	,	PUNCT
ejnm-305	55	32	and	and	CCONJ
ejnm-305	55	33	21	21	NUM
ejnm-305	55	34	copyright	copyright	NOUN
ejnm-305	55	35	©	©	PROPN
ejnm-305	55	36	2025	2025	NUM
ejnm-305	55	37	the	the	DET
ejnm-305	55	38	author(s	author(s	NOUN
ejnm-305	55	39	)	)	PUNCT
ejnm-305	55	40	.	.	PUNCT
ejnm-305	56	1	this	this	PRON
ejnm-305	56	2	is	be	AUX
ejnm-305	56	3	an	an	DET
ejnm-305	56	4	open	open	ADJ
ejnm-305	56	5	access	access	NOUN
ejnm-305	56	6	article	article	NOUN
ejnm-305	56	7	which	which	PRON
ejnm-305	56	8	licensed	license	VERB
ejnm-305	56	9	under	under	ADP
ejnm-305	56	10	the	the	DET
ejnm-305	56	11	terms	term	NOUN
ejnm-305	56	12	and	and	CCONJ
ejnm-305	56	13	conditions	condition	NOUN
ejnm-305	56	14	of	of	ADP
ejnm-305	56	15	the	the	DET
ejnm-305	56	16	creative	creative	ADJ
ejnm-305	56	17	commons	common	NOUN
ejnm-305	56	18	attribution	attribution	NOUN
ejnm-305	56	19	-	-	PUNCT
ejnm-305	56	20	noncommercial	noncommercial	ADJ
ejnm-305	56	21	-	-	PUNCT
ejnm-305	56	22	sharealike	sharealike	ADJ
ejnm-305	56	23	4.0	4.0	NUM
ejnm-305	56	24	international	international	ADJ
ejnm-305	56	25	license	license	NOUN
ejnm-305	56	26	.	.	PUNCT
ejnm-305	57	1	it	it	PRON
ejnm-305	57	2	permits	permit	VERB
ejnm-305	57	3	no	no	DET
ejnm-305	57	4	additional	additional	ADJ
ejnm-305	57	5	restrictions	restriction	NOUN
ejnm-305	57	6	on	on	ADP
ejnm-305	57	7	use	use	NOUN
ejnm-305	57	8	,	,	PUNCT
ejnm-305	57	9	distribution	distribution	NOUN
ejnm-305	57	10	,	,	PUNCT
ejnm-305	57	11	and	and	CCONJ
ejnm-305	57	12	reproduction	reproduction	NOUN
ejnm-305	57	13	in	in	ADP
ejnm-305	57	14	any	any	DET
ejnm-305	57	15	medium	medium	NOUN
ejnm-305	57	16	provided	provide	VERB
ejnm-305	57	17	the	the	DET
ejnm-305	57	18	original	original	ADJ
ejnm-305	57	19	work	work	NOUN
ejnm-305	57	20	is	be	AUX
ejnm-305	57	21	properly	properly	ADV
ejnm-305	57	22	cited	cite	VERB
ejnm-305	57	23	.	.	PUNCT
ejnm-305	58	1	introduction	introduction	NOUN
ejnm-305	58	2	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-305	59	1	https://doi.org/10.15218/ejnm.2025.03	https://doi.org/10.15218/ejnm.2025.03	PROPN
ejnm-305	59	2	erbil	erbil	PROPN
ejnm-305	59	3	j.	j.	PROPN
ejnm-305	59	4	nurs	nurs	PROPN
ejnm-305	59	5	.	.	PUNCT
ejnm-305	60	1	midwifery	midwifery	ADJ
ejnm-305	60	2	,	,	PUNCT
ejnm-305	60	3	vol	vol	NOUN
ejnm-305	60	4	.	.	PROPN
ejnm-305	60	5	8	8	NUM
ejnm-305	60	6	,	,	PUNCT
ejnm-305	60	7	no	no	INTJ
ejnm-305	60	8	.	.	PUNCT
ejnm-305	61	1	(	(	PUNCT
ejnm-305	61	2	1	1	NUM
ejnm-305	61	3	)	)	PUNCT
ejnm-305	61	4	,	,	PUNCT
ejnm-305	61	5	may	may	AUX
ejnm-305	61	6	2025	2025	NUM
ejnm-305	61	7	original	original	ADJ
ejnm-305	61	8	article	article	NOUN
ejnm-305	61	9	general	general	ADJ
ejnm-305	61	10	hospital	hospital	NOUN
ejnm-305	61	11	.	.	PUNCT
ejnm-305	62	1	the	the	DET
ejnm-305	62	2	serum	serum	NOUN
ejnm-305	62	3	was	be	AUX
ejnm-305	62	4	then	then	ADV
ejnm-305	62	5	separated	separate	VERB
ejnm-305	62	6	from	from	ADP
ejnm-305	62	7	the	the	DET
ejnm-305	62	8	rest	rest	NOUN
ejnm-305	62	9	of	of	ADP
ejnm-305	62	10	the	the	DET
ejnm-305	62	11	blood	blood	NOUN
ejnm-305	62	12	by	by	ADP
ejnm-305	62	13	subjecting	subject	VERB
ejnm-305	62	14	it	it	PRON
ejnm-305	62	15	to	to	ADP
ejnm-305	62	16	centrifugal	centrifugal	ADJ
ejnm-305	62	17	force	force	NOUN
ejnm-305	62	18	at	at	ADP
ejnm-305	62	19	a	a	DET
ejnm-305	62	20	speed	speed	NOUN
ejnm-305	62	21	of	of	ADP
ejnm-305	62	22	3000	3000	NUM
ejnm-305	62	23	rpm	rpm	NOUN
ejnm-305	62	24	for	for	ADP
ejnm-305	62	25	3	3	NUM
ejnm-305	62	26	minutes	minute	NOUN
ejnm-305	62	27	and	and	CCONJ
ejnm-305	62	28	repeating	repeat	VERB
ejnm-305	62	29	it	it	PRON
ejnm-305	62	30	three	three	NUM
ejnm-305	62	31	times	time	NOUN
ejnm-305	62	32	.	.	PUNCT
ejnm-305	63	1	gather	gather	VERB
ejnm-305	63	2	specimens	specimen	NOUN
ejnm-305	63	3	of	of	ADP
ejnm-305	63	4	females	female	NOUN
ejnm-305	63	5	,	,	PUNCT
ejnm-305	63	6	encompassing	encompass	VERB
ejnm-305	63	7	both	both	CCONJ
ejnm-305	63	8	expectant	expectant	ADJ
ejnm-305	63	9	and	and	CCONJ
ejnm-305	63	10	non	non	ADJ
ejnm-305	63	11	-	-	ADJ
ejnm-305	63	12	expectant	expectant	ADJ
ejnm-305	63	13	individuals	individual	NOUN
ejnm-305	63	14	,	,	PUNCT
ejnm-305	63	15	from	from	ADP
ejnm-305	63	16	various	various	ADJ
ejnm-305	63	17	age	age	NOUN
ejnm-305	63	18	groups	group	NOUN
ejnm-305	63	19	residing	reside	VERB
ejnm-305	63	20	in	in	ADP
ejnm-305	63	21	urban	urban	ADJ
ejnm-305	63	22	areas	area	NOUN
ejnm-305	63	23	.	.	PUNCT
ejnm-305	64	1	a	a	DET
ejnm-305	64	2	subset	subset	NOUN
ejnm-305	64	3	of	of	ADP
ejnm-305	64	4	female	female	ADJ
ejnm-305	64	5	patients	patient	NOUN
ejnm-305	64	6	has	have	AUX
ejnm-305	64	7	presented	present	VERB
ejnm-305	64	8	with	with	ADP
ejnm-305	64	9	comorbidities	comorbiditie	NOUN
ejnm-305	64	10	including	include	VERB
ejnm-305	64	11	hypertension	hypertension	NOUN
ejnm-305	64	12	,	,	PUNCT
ejnm-305	64	13	thyroid	thyroid	NOUN
ejnm-305	64	14	dysfunction	dysfunction	NOUN
ejnm-305	64	15	,	,	PUNCT
ejnm-305	64	16	diabetes	diabetes	NOUN
ejnm-305	64	17	mellitus	mellitus	NOUN
ejnm-305	64	18	,	,	PUNCT
ejnm-305	64	19	hepatic	hepatic	ADJ
ejnm-305	64	20	disorders	disorder	NOUN
ejnm-305	64	21	,	,	PUNCT
ejnm-305	64	22	and	and	CCONJ
ejnm-305	64	23	renal	renal	ADJ
ejnm-305	64	24	disorders	disorder	NOUN
ejnm-305	64	25	.	.	PUNCT
ejnm-305	65	1	then	then	ADV
ejnm-305	65	2	,	,	PUNCT
ejnm-305	65	3	with	with	ADP
ejnm-305	65	4	the	the	DET
ejnm-305	65	5	assistance	assistance	NOUN
ejnm-305	65	6	of	of	ADP
ejnm-305	65	7	laboratory	laboratory	NOUN
ejnm-305	65	8	expert	expert	NOUN
ejnm-305	65	9	staff	staff	NOUN
ejnm-305	65	10	,	,	PUNCT
ejnm-305	65	11	all	all	DET
ejnm-305	65	12	necessary	necessary	ADJ
ejnm-305	65	13	tests	test	NOUN
ejnm-305	65	14	were	be	AUX
ejnm-305	65	15	performed	perform	VERB
ejnm-305	65	16	in	in	ADP
ejnm-305	65	17	the	the	DET
ejnm-305	65	18	laboratory	laboratory	NOUN
ejnm-305	65	19	department	department	PROPN
ejnm-305	65	20	of	of	ADP
ejnm-305	65	21	darbandikhan	darbandikhan	PROPN
ejnm-305	65	22	shahid	shahid	PROPN
ejnm-305	65	23	tofiq	tofiq	PROPN
ejnm-305	65	24	general	general	ADJ
ejnm-305	65	25	hospital	hospital	PROPN
ejnm-305	65	26	for	for	ADP
ejnm-305	65	27	all	all	DET
ejnm-305	65	28	pregnant	pregnant	ADJ
ejnm-305	65	29	women	woman	NOUN
ejnm-305	65	30	participating	participate	VERB
ejnm-305	65	31	in	in	ADP
ejnm-305	65	32	our	our	PRON
ejnm-305	65	33	research	research	NOUN
ejnm-305	65	34	according	accord	VERB
ejnm-305	65	35	to	to	ADP
ejnm-305	65	36	our	our	PRON
ejnm-305	65	37	study	study	NOUN
ejnm-305	65	38	plan	plan	NOUN
ejnm-305	65	39	.	.	PUNCT
ejnm-305	66	1	serum	serum	NOUN
ejnm-305	66	2	lipid	lipid	PROPN
ejnm-305	66	3	profile	profile	PROPN
ejnm-305	66	4	(	(	PUNCT
ejnm-305	66	5	slp	slp	PROPN
ejnm-305	66	6	)	)	PUNCT
ejnm-305	66	7	the	the	DET
ejnm-305	66	8	enzymatic	enzymatic	ADJ
ejnm-305	66	9	colorimetric	colorimetric	ADJ
ejnm-305	66	10	test	test	NOUN
ejnm-305	66	11	method	method	NOUN
ejnm-305	66	12	for	for	ADP
ejnm-305	66	13	quantifying	quantify	VERB
ejnm-305	66	14	cholesterol	cholesterol	NOUN
ejnm-305	66	15	in	in	ADP
ejnm-305	66	16	human	human	ADJ
ejnm-305	66	17	serum	serum	NOUN
ejnm-305	66	18	is	be	AUX
ejnm-305	66	19	conducted	conduct	VERB
ejnm-305	66	20	using	use	VERB
ejnm-305	66	21	the	the	DET
ejnm-305	66	22	biochemical	biochemical	ADJ
ejnm-305	66	23	analyzer	analyzer	NOUN
ejnm-305	66	24	biolis	biolis	PROPN
ejnm-305	66	25	30i	30i	PROPN
ejnm-305	66	26	apparatus	apparatus	PROPN
ejnm-305	66	27	.	.	PUNCT
ejnm-305	67	1	the	the	DET
ejnm-305	67	2	hydrolysis	hydrolysis	NOUN
ejnm-305	67	3	of	of	ADP
ejnm-305	67	4	cholesterol	cholesterol	NOUN
ejnm-305	67	5	esters	ester	NOUN
ejnm-305	67	6	by	by	ADP
ejnm-305	67	7	cholesterol	cholesterol	NOUN
ejnm-305	67	8	esterase	esterase	NOUN
ejnm-305	67	9	yields	yield	NOUN
ejnm-305	67	10	free	free	ADJ
ejnm-305	67	11	cholesterol	cholesterol	NOUN
ejnm-305	67	12	and	and	CCONJ
ejnm-305	67	13	fatty	fatty	NOUN
ejnm-305	67	14	acids	acid	NOUN
ejnm-305	67	15	.	.	PUNCT
ejnm-305	68	1	cholesterol	cholesterol	NOUN
ejnm-305	68	2	undergoes	undergoe	NOUN
ejnm-305	68	3	oxidation	oxidation	NOUN
ejnm-305	68	4	,	,	PUNCT
ejnm-305	68	5	catalyzing	catalyze	VERB
ejnm-305	68	6	the	the	DET
ejnm-305	68	7	conversion	conversion	NOUN
ejnm-305	68	8	of	of	ADP
ejnm-305	68	9	cholesterol	cholesterol	NOUN
ejnm-305	68	10	to	to	ADP
ejnm-305	68	11	cholest-4	cholest-4	NOUN
ejnm-305	68	12	-	-	PUNCT
ejnm-305	68	13	en-3one	en-3one	NOUN
ejnm-305	68	14	and	and	CCONJ
ejnm-305	68	15	hydrogen	hydrogen	NOUN
ejnm-305	68	16	peroxide	peroxide	NOUN
ejnm-305	68	17	.	.	PUNCT
ejnm-305	69	1	in	in	ADP
ejnm-305	69	2	the	the	DET
ejnm-305	69	3	presence	presence	NOUN
ejnm-305	69	4	of	of	ADP
ejnm-305	69	5	peroxidase	peroxidase	NOUN
ejnm-305	69	6	,	,	PUNCT
ejnm-305	69	7	the	the	DET
ejnm-305	69	8	produced	produce	VERB
ejnm-305	69	9	hydrogen	hydrogen	NOUN
ejnm-305	69	10	peroxide	peroxide	NOUN
ejnm-305	69	11	oxidatively	oxidatively	ADV
ejnm-305	69	12	couples	couple	NOUN
ejnm-305	69	13	with	with	ADP
ejnm-305	69	14	phenol	phenol	NOUN
ejnm-305	69	15	and	and	CCONJ
ejnm-305	69	16	4	4	NUM
ejnm-305	69	17	-	-	PUNCT
ejnm-305	69	18	aminophenazone	aminophenazone	ADJ
ejnm-305	69	19	,	,	PUNCT
ejnm-305	69	20	forming	form	VERB
ejnm-305	69	21	a	a	DET
ejnm-305	69	22	red	red	ADJ
ejnm-305	69	23	quinone	quinone	NOUN
ejnm-305	69	24	-	-	PUNCT
ejnm-305	69	25	imine	imine	NOUN
ejnm-305	69	26	dye	dye	NOUN
ejnm-305	69	27	.	.	PUNCT
ejnm-305	70	1	the	the	DET
ejnm-305	70	2	intensity	intensity	NOUN
ejnm-305	70	3	of	of	ADP
ejnm-305	70	4	the	the	DET
ejnm-305	70	5	dye	dye	NOUN
ejnm-305	70	6	's	's	PART
ejnm-305	70	7	color	color	NOUN
ejnm-305	70	8	is	be	AUX
ejnm-305	70	9	directly	directly	ADV
ejnm-305	70	10	proportional	proportional	ADJ
ejnm-305	70	11	to	to	ADP
ejnm-305	70	12	the	the	DET
ejnm-305	70	13	cholesterol	cholesterol	NOUN
ejnm-305	70	14	concentration	concentration	NOUN
ejnm-305	70	15	,	,	PUNCT
ejnm-305	70	16	measured	measure	VERB
ejnm-305	70	17	at	at	ADP
ejnm-305	70	18	500	500	NUM
ejnm-305	70	19	nm	nm	NOUN
ejnm-305	70	20	.	.	PUNCT
ejnm-305	71	1	t.g	t.g	PROPN
ejnm-305	71	2	.	.	PROPN
ejnm-305	71	3	is	be	AUX
ejnm-305	71	4	enzymatically	enzymatically	ADV
ejnm-305	71	5	measured	measure	VERB
ejnm-305	71	6	in	in	ADP
ejnm-305	71	7	serum	serum	NOUN
ejnm-305	71	8	via	via	ADP
ejnm-305	71	9	a	a	DET
ejnm-305	71	10	series	series	NOUN
ejnm-305	71	11	of	of	ADP
ejnm-305	71	12	coupled	couple	VERB
ejnm-305	71	13	reactions	reaction	NOUN
ejnm-305	71	14	,	,	PUNCT
ejnm-305	71	15	hydrolyzing	hydrolyze	VERB
ejnm-305	71	16	triglycerides	triglyceride	NOUN
ejnm-305	71	17	to	to	PART
ejnm-305	71	18	produce	produce	VERB
ejnm-305	71	19	glycerol	glycerol	NOUN
ejnm-305	71	20	.	.	PUNCT
ejnm-305	72	1	glycerol	glycerol	NOUN
ejnm-305	72	2	is	be	AUX
ejnm-305	72	3	then	then	ADV
ejnm-305	72	4	oxidized	oxidize	VERB
ejnm-305	72	5	by	by	ADP
ejnm-305	72	6	glycerol	glycerol	NOUN
ejnm-305	72	7	oxidase	oxidase	NOUN
ejnm-305	72	8	with	with	ADP
ejnm-305	72	9	hydrogen	hydrogen	NOUN
ejnm-305	72	10	peroxide	peroxide	NOUN
ejnm-305	72	11	,	,	PUNCT
ejnm-305	72	12	a	a	DET
ejnm-305	72	13	reaction	reaction	NOUN
ejnm-305	72	14	product	product	NOUN
ejnm-305	72	15	measured	measure	VERB
ejnm-305	72	16	similarly	similarly	ADV
ejnm-305	72	17	to	to	ADP
ejnm-305	72	18	cholesterol	cholesterol	NOUN
ejnm-305	72	19	absorbance	absorbance	NOUN
ejnm-305	72	20	measured	measure	VERB
ejnm-305	72	21	at	at	ADP
ejnm-305	72	22	500	500	NUM
ejnm-305	72	23	nm	nm	NOUN
ejnm-305	72	24	.	.	PUNCT
ejnm-305	73	1	high	high	ADJ
ejnm-305	73	2	-	-	PUNCT
ejnm-305	73	3	density	density	NOUN
ejnm-305	73	4	lipoprotein	lipoprotein	NOUN
ejnm-305	73	5	is	be	AUX
ejnm-305	73	6	detected	detect	VERB
ejnm-305	73	7	using	use	VERB
ejnm-305	73	8	the	the	DET
ejnm-305	73	9	direct	direct	ADJ
ejnm-305	73	10	method	method	NOUN
ejnm-305	73	11	without	without	ADP
ejnm-305	73	12	specimen	speciman	NOUN
ejnm-305	73	13	pretreatment	pretreatment	NOUN
ejnm-305	73	14	.	.	PUNCT
ejnm-305	74	1	initially	initially	ADV
ejnm-305	74	2	,	,	PUNCT
ejnm-305	74	3	ldl	ldl	PROPN
ejnm-305	74	4	,	,	PUNCT
ejnm-305	74	5	vldl	vldl	NOUN
ejnm-305	74	6	particles	particle	NOUN
ejnm-305	74	7	,	,	PUNCT
ejnm-305	74	8	and	and	CCONJ
ejnm-305	74	9	chylomicrons	chylomicron	NOUN
ejnm-305	74	10	generate	generate	VERB
ejnm-305	74	11	free	free	ADJ
ejnm-305	74	12	cholesterol	cholesterol	NOUN
ejnm-305	74	13	,	,	PUNCT
ejnm-305	74	14	which	which	PRON
ejnm-305	74	15	,	,	PUNCT
ejnm-305	74	16	through	through	ADP
ejnm-305	74	17	an	an	DET
ejnm-305	74	18	enzymatic	enzymatic	ADJ
ejnm-305	74	19	reaction	reaction	NOUN
ejnm-305	74	20	,	,	PUNCT
ejnm-305	74	21	fetal	fetal	ADJ
ejnm-305	74	22	growth	growth	NOUN
ejnm-305	74	23	.	.	PUNCT
ejnm-305	75	1	lipid	lipid	NOUN
ejnm-305	75	2	profiles	profile	NOUN
ejnm-305	75	3	such	such	ADJ
ejnm-305	75	4	as	as	ADP
ejnm-305	75	5	ldl	ldl	NOUN
ejnm-305	75	6	,	,	PUNCT
ejnm-305	75	7	tg	tg	PROPN
ejnm-305	75	8	and	and	CCONJ
ejnm-305	75	9	tc	tc	PRON
ejnm-305	75	10	could	could	AUX
ejnm-305	75	11	be	be	AUX
ejnm-305	75	12	used	use	VERB
ejnm-305	75	13	as	as	ADP
ejnm-305	75	14	indicators	indicator	NOUN
ejnm-305	75	15	to	to	PART
ejnm-305	75	16	assess	assess	VERB
ejnm-305	75	17	a	a	DET
ejnm-305	75	18	healthy	healthy	ADJ
ejnm-305	75	19	pregnancy	pregnancy	NOUN
ejnm-305	75	20	and	and	CCONJ
ejnm-305	75	21	fetal	fetal	ADJ
ejnm-305	75	22	growth	growth	NOUN
ejnm-305	75	23	.	.	PUNCT
ejnm-305	76	1	this	this	DET
ejnm-305	76	2	study	study	NOUN
ejnm-305	76	3	aimed	aim	VERB
ejnm-305	76	4	to	to	PART
ejnm-305	76	5	prospectively	prospectively	ADV
ejnm-305	76	6	examine	examine	VERB
ejnm-305	76	7	the	the	DET
ejnm-305	76	8	blood	blood	NOUN
ejnm-305	76	9	lipid	lipid	NOUN
ejnm-305	76	10	concentration	concentration	NOUN
ejnm-305	76	11	,	,	PUNCT
ejnm-305	76	12	namely	namely	ADV
ejnm-305	76	13	lipoprotein	lipoprotein	ADJ
ejnm-305	76	14	,	,	PUNCT
ejnm-305	76	15	as	as	ADV
ejnm-305	76	16	well	well	ADV
ejnm-305	76	17	as	as	ADP
ejnm-305	76	18	the	the	DET
ejnm-305	76	19	urea	urea	NOUN
ejnm-305	76	20	and	and	CCONJ
ejnm-305	76	21	creatinine	creatinine	NOUN
ejnm-305	76	22	rates	rate	NOUN
ejnm-305	76	23	,	,	PUNCT
ejnm-305	76	24	in	in	ADP
ejnm-305	76	25	pregnant	pregnant	ADJ
ejnm-305	76	26	women	woman	NOUN
ejnm-305	76	27	and	and	CCONJ
ejnm-305	76	28	compare	compare	VERB
ejnm-305	76	29	them	they	PRON
ejnm-305	76	30	with	with	ADP
ejnm-305	76	31	those	those	PRON
ejnm-305	76	32	of	of	ADP
ejnm-305	76	33	non	non	ADJ
ejnm-305	76	34	-	-	ADJ
ejnm-305	76	35	pregnant	pregnant	ADJ
ejnm-305	76	36	women	woman	NOUN
ejnm-305	76	37	.	.	PUNCT
ejnm-305	77	1	this	this	PRON
ejnm-305	77	2	was	be	AUX
ejnm-305	77	3	case	case	NOUN
ejnm-305	77	4	-	-	PUNCT
ejnm-305	77	5	control	control	NOUN
ejnm-305	77	6	study	study	NOUN
ejnm-305	77	7	conducted	conduct	VERB
ejnm-305	77	8	from	from	ADP
ejnm-305	77	9	august	august	PROPN
ejnm-305	77	10	22	22	NUM
ejnm-305	77	11	,	,	PUNCT
ejnm-305	77	12	2022	2022	NUM
ejnm-305	77	13	,	,	PUNCT
ejnm-305	77	14	until	until	ADP
ejnm-305	77	15	december	december	PROPN
ejnm-305	77	16	25	25	NUM
ejnm-305	77	17	,	,	PUNCT
ejnm-305	77	18	2022	2022	NUM
ejnm-305	77	19	.	.	PUNCT
ejnm-305	78	1	fifty	fifty	NUM
ejnm-305	78	2	pregnant	pregnant	ADJ
ejnm-305	78	3	women	woman	NOUN
ejnm-305	78	4	and	and	CCONJ
ejnm-305	78	5	sixty	sixty	NUM
ejnm-305	78	6	-	-	PUNCT
ejnm-305	78	7	four	four	NUM
ejnm-305	78	8	non	non	ADJ
ejnm-305	78	9	-	-	ADJ
ejnm-305	78	10	pregnant	pregnant	ADJ
ejnm-305	78	11	women	woman	NOUN
ejnm-305	78	12	would	would	AUX
ejnm-305	78	13	enroll	enroll	VERB
ejnm-305	78	14	for	for	ADP
ejnm-305	78	15	obstetric	obstetric	ADJ
ejnm-305	78	16	care	care	NOUN
ejnm-305	78	17	at	at	ADP
ejnm-305	78	18	the	the	DET
ejnm-305	78	19	general	general	ADJ
ejnm-305	78	20	health	health	PROPN
ejnm-305	78	21	laboratory	laboratory	NOUN
ejnm-305	78	22	of	of	ADP
ejnm-305	78	23	sulaimanyah	sulaimanyah	PROPN
ejnm-305	78	24	/	/	SYM
ejnm-305	78	25	darbandikhan	darbandikhan	PROPN
ejnm-305	78	26	shahid	shahid	PROPN
ejnm-305	78	27	tofiq	tofiq	VERB
ejnm-305	78	28	general	general	ADJ
ejnm-305	78	29	hospital	hospital	PROPN
ejnm-305	78	30	.	.	PUNCT
ejnm-305	79	1	these	these	DET
ejnm-305	79	2	women	woman	NOUN
ejnm-305	79	3	face	face	VERB
ejnm-305	79	4	various	various	ADJ
ejnm-305	79	5	health	health	NOUN
ejnm-305	79	6	issues	issue	NOUN
ejnm-305	79	7	during	during	ADP
ejnm-305	79	8	pregnancy	pregnancy	NOUN
ejnm-305	79	9	,	,	PUNCT
ejnm-305	79	10	such	such	ADJ
ejnm-305	79	11	as	as	ADP
ejnm-305	79	12	kidney	kidney	NOUN
ejnm-305	79	13	function	function	NOUN
ejnm-305	79	14	disease	disease	NOUN
ejnm-305	79	15	and	and	CCONJ
ejnm-305	79	16	elevated	elevated	ADJ
ejnm-305	79	17	levels	level	NOUN
ejnm-305	79	18	of	of	ADP
ejnm-305	79	19	serum	serum	NOUN
ejnm-305	79	20	lipid	lipid	NOUN
ejnm-305	79	21	profiles	profile	NOUN
ejnm-305	79	22	.	.	PUNCT
ejnm-305	80	1	the	the	DET
ejnm-305	80	2	study	study	NOUN
ejnm-305	80	3	aims	aim	VERB
ejnm-305	80	4	to	to	PART
ejnm-305	80	5	evaluate	evaluate	VERB
ejnm-305	80	6	the	the	DET
ejnm-305	80	7	correlation	correlation	NOUN
ejnm-305	80	8	between	between	ADP
ejnm-305	80	9	blood	blood	NOUN
ejnm-305	80	10	lipid	lipid	NOUN
ejnm-305	80	11	concentrations	concentration	NOUN
ejnm-305	80	12	,	,	PUNCT
ejnm-305	80	13	specifically	specifically	ADV
ejnm-305	80	14	lipoprotein	lipoprotein	ADJ
ejnm-305	80	15	,	,	PUNCT
ejnm-305	80	16	as	as	ADV
ejnm-305	80	17	well	well	ADV
ejnm-305	80	18	as	as	ADP
ejnm-305	80	19	the	the	DET
ejnm-305	80	20	rates	rate	NOUN
ejnm-305	80	21	of	of	ADP
ejnm-305	80	22	urea	urea	NOUN
ejnm-305	80	23	and	and	CCONJ
ejnm-305	80	24	creatinine	creatinine	NOUN
ejnm-305	80	25	in	in	ADP
ejnm-305	80	26	pregnant	pregnant	ADJ
ejnm-305	80	27	and	and	CCONJ
ejnm-305	80	28	non	non	ADJ
ejnm-305	80	29	-	-	ADJ
ejnm-305	80	30	pregnant	pregnant	ADJ
ejnm-305	80	31	individuals	individual	NOUN
ejnm-305	80	32	.	.	PUNCT
ejnm-305	81	1	this	this	DET
ejnm-305	81	2	paper	paper	NOUN
ejnm-305	81	3	would	would	AUX
ejnm-305	81	4	prospectively	prospectively	ADV
ejnm-305	81	5	analyze	analyze	VERB
ejnm-305	81	6	these	these	DET
ejnm-305	81	7	values	value	NOUN
ejnm-305	81	8	.	.	PUNCT
ejnm-305	82	1	also	also	ADV
ejnm-305	82	2	,	,	PUNCT
ejnm-305	82	3	to	to	PART
ejnm-305	82	4	identify	identify	VERB
ejnm-305	82	5	the	the	DET
ejnm-305	82	6	most	most	ADV
ejnm-305	82	7	influential	influential	ADJ
ejnm-305	82	8	factors	factor	NOUN
ejnm-305	82	9	among	among	ADP
ejnm-305	82	10	pregnancy	pregnancy	NOUN
ejnm-305	82	11	duration	duration	NOUN
ejnm-305	82	12	in	in	ADP
ejnm-305	82	13	weeks	week	NOUN
ejnm-305	82	14	,	,	PUNCT
ejnm-305	82	15	age	age	NOUN
ejnm-305	82	16	,	,	PUNCT
ejnm-305	82	17	and	and	CCONJ
ejnm-305	82	18	bmi	bmi	NOUN
ejnm-305	82	19	.	.	PUNCT
ejnm-305	83	1	collection	collection	NOUN
ejnm-305	83	2	of	of	ADP
ejnm-305	83	3	blood	blood	NOUN
ejnm-305	83	4	samples	sample	VERB
ejnm-305	83	5	blood	blood	NOUN
ejnm-305	83	6	samples	sample	NOUN
ejnm-305	83	7	were	be	AUX
ejnm-305	83	8	taken	take	VERB
ejnm-305	83	9	from	from	ADP
ejnm-305	83	10	50	50	NUM
ejnm-305	83	11	pregnant	pregnant	ADJ
ejnm-305	83	12	women	woman	NOUN
ejnm-305	83	13	and	and	CCONJ
ejnm-305	83	14	64	64	NUM
ejnm-305	83	15	nonpregnant	nonpregnant	ADJ
ejnm-305	83	16	women	woman	NOUN
ejnm-305	83	17	in	in	ADP
ejnm-305	83	18	both	both	CCONJ
ejnm-305	83	19	the	the	DET
ejnm-305	83	20	maternity	maternity	NOUN
ejnm-305	83	21	and	and	CCONJ
ejnm-305	83	22	laboratory	laboratory	NOUN
ejnm-305	83	23	departments	department	NOUN
ejnm-305	83	24	of	of	ADP
ejnm-305	83	25	darbandikhan	darbandikhan	PROPN
ejnm-305	83	26	shahid	shahid	PROPN
ejnm-305	83	27	tofiq	tofiq	PROPN
ejnm-305	83	28	general	general	ADJ
ejnm-305	83	29	hospital	hospital	PROPN
ejnm-305	83	30	in	in	ADP
ejnm-305	83	31	northern	northern	ADJ
ejnm-305	83	32	iraq	iraq	PROPN
ejnm-305	83	33	.	.	PUNCT
ejnm-305	84	1	the	the	DET
ejnm-305	84	2	study	study	NOUN
ejnm-305	84	3	received	receive	VERB
ejnm-305	84	4	approval	approval	NOUN
ejnm-305	84	5	from	from	ADP
ejnm-305	84	6	the	the	DET
ejnm-305	84	7	ethics	ethic	NOUN
ejnm-305	84	8	centre	centre	PROPN
ejnm-305	84	9	committee	committee	PROPN
ejnm-305	84	10	at	at	ADP
ejnm-305	84	11	sulaimani	sulaimani	PROPN
ejnm-305	84	12	polytechnic	polytechnic	PROPN
ejnm-305	84	13	university	university	PROPN
ejnm-305	84	14	.	.	PUNCT
ejnm-305	85	1	subsequently	subsequently	ADV
ejnm-305	85	2	,	,	PUNCT
ejnm-305	85	3	written	write	VERB
ejnm-305	85	4	informed	informed	ADJ
ejnm-305	85	5	consent	consent	NOUN
ejnm-305	85	6	was	be	AUX
ejnm-305	85	7	obtained	obtain	VERB
ejnm-305	85	8	from	from	ADP
ejnm-305	85	9	each	each	DET
ejnm-305	85	10	participant	participant	NOUN
ejnm-305	85	11	.	.	PUNCT
ejnm-305	86	1	the	the	DET
ejnm-305	86	2	participants	participant	NOUN
ejnm-305	86	3	were	be	AUX
ejnm-305	86	4	provided	provide	VERB
ejnm-305	86	5	with	with	ADP
ejnm-305	86	6	the	the	DET
ejnm-305	86	7	opportunity	opportunity	NOUN
ejnm-305	86	8	to	to	PART
ejnm-305	86	9	voluntarily	voluntarily	ADV
ejnm-305	86	10	withdraw	withdraw	VERB
ejnm-305	86	11	from	from	ADP
ejnm-305	86	12	the	the	DET
ejnm-305	86	13	research	research	NOUN
ejnm-305	86	14	based	base	VERB
ejnm-305	86	15	on	on	ADP
ejnm-305	86	16	their	their	PRON
ejnm-305	86	17	preferences	preference	NOUN
ejnm-305	86	18	.	.	PUNCT
ejnm-305	87	1	five	five	NUM
ejnm-305	87	2	millilitres	millilitre	NOUN
ejnm-305	87	3	of	of	ADP
ejnm-305	87	4	venus	venus	NOUN
ejnm-305	87	5	blood	blood	NOUN
ejnm-305	87	6	were	be	AUX
ejnm-305	87	7	utilized	utilize	VERB
ejnm-305	87	8	for	for	ADP
ejnm-305	87	9	all	all	DET
ejnm-305	87	10	tests	test	NOUN
ejnm-305	87	11	.	.	PUNCT
ejnm-305	88	1	the	the	DET
ejnm-305	88	2	blood	blood	NOUN
ejnm-305	88	3	was	be	AUX
ejnm-305	88	4	collected	collect	VERB
ejnm-305	88	5	in	in	ADP
ejnm-305	88	6	a	a	DET
ejnm-305	88	7	simple	simple	ADJ
ejnm-305	88	8	polyethylene	polyethylene	NOUN
ejnm-305	88	9	tube	tube	NOUN
ejnm-305	88	10	and	and	CCONJ
ejnm-305	88	11	allowed	allow	VERB
ejnm-305	88	12	to	to	PART
ejnm-305	88	13	coagulate	coagulate	VERB
ejnm-305	88	14	at	at	ADP
ejnm-305	88	15	room	room	NOUN
ejnm-305	88	16	temperature	temperature	NOUN
ejnm-305	88	17	in	in	ADP
ejnm-305	88	18	laboratory	laboratory	PROPN
ejnm-305	88	19	department	department	PROPN
ejnm-305	88	20	of	of	ADP
ejnm-305	88	21	darbandikhan	darbandikhan	PROPN
ejnm-305	88	22	shahid	shahid	PROPN
ejnm-305	88	23	tofiq	tofiq	VERB
ejnm-305	88	24	22	22	NUM
ejnm-305	88	25	copyright	copyright	NOUN
ejnm-305	88	26	©	©	PROPN
ejnm-305	88	27	2025the	2025the	PROPN
ejnm-305	88	28	author(s	author(s	NOUN
ejnm-305	88	29	)	)	PUNCT
ejnm-305	88	30	.	.	PUNCT
ejnm-305	89	1	this	this	PRON
ejnm-305	89	2	is	be	AUX
ejnm-305	89	3	an	an	DET
ejnm-305	89	4	open	open	ADJ
ejnm-305	89	5	access	access	NOUN
ejnm-305	89	6	article	article	NOUN
ejnm-305	89	7	which	which	PRON
ejnm-305	89	8	licensed	license	VERB
ejnm-305	89	9	under	under	ADP
ejnm-305	89	10	the	the	DET
ejnm-305	89	11	terms	term	NOUN
ejnm-305	89	12	and	and	CCONJ
ejnm-305	89	13	conditions	condition	NOUN
ejnm-305	89	14	of	of	ADP
ejnm-305	89	15	the	the	DET
ejnm-305	89	16	creative	creative	ADJ
ejnm-305	89	17	commons	common	NOUN
ejnm-305	89	18	attribution	attribution	NOUN
ejnm-305	89	19	-	-	PUNCT
ejnm-305	89	20	noncommercial	noncommercial	ADJ
ejnm-305	89	21	-	-	PUNCT
ejnm-305	89	22	sharealike	sharealike	ADJ
ejnm-305	89	23	4.0	4.0	NUM
ejnm-305	89	24	international	international	ADJ
ejnm-305	89	25	license	license	NOUN
ejnm-305	89	26	.	.	PUNCT
ejnm-305	90	1	it	it	PRON
ejnm-305	90	2	permits	permit	VERB
ejnm-305	90	3	no	no	DET
ejnm-305	90	4	additional	additional	ADJ
ejnm-305	90	5	restrictions	restriction	NOUN
ejnm-305	90	6	on	on	ADP
ejnm-305	90	7	use	use	NOUN
ejnm-305	90	8	,	,	PUNCT
ejnm-305	90	9	distribution	distribution	NOUN
ejnm-305	90	10	,	,	PUNCT
ejnm-305	90	11	and	and	CCONJ
ejnm-305	90	12	reproduction	reproduction	NOUN
ejnm-305	90	13	in	in	ADP
ejnm-305	90	14	any	any	DET
ejnm-305	90	15	medium	medium	NOUN
ejnm-305	90	16	provided	provide	VERB
ejnm-305	90	17	the	the	DET
ejnm-305	90	18	original	original	ADJ
ejnm-305	90	19	work	work	NOUN
ejnm-305	90	20	is	be	AUX
ejnm-305	90	21	properly	properly	ADV
ejnm-305	90	22	cited	cite	VERB
ejnm-305	90	23	.	.	PUNCT
ejnm-305	91	1	methods	method	NOUN
ejnm-305	91	2	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-305	92	1	https://doi.org/10.15218/ejnm.2025.03	https://doi.org/10.15218/ejnm.2025.03	PROPN
ejnm-305	92	2	erbil	erbil	PROPN
ejnm-305	92	3	j.	j.	PROPN
ejnm-305	92	4	nurs	nurs	PROPN
ejnm-305	92	5	.	.	PUNCT
ejnm-305	93	1	midwifery	midwifery	ADJ
ejnm-305	93	2	,	,	PUNCT
ejnm-305	93	3	vol	vol	NOUN
ejnm-305	93	4	.	.	PROPN
ejnm-305	93	5	8	8	NUM
ejnm-305	93	6	,	,	PUNCT
ejnm-305	93	7	no	no	INTJ
ejnm-305	93	8	.	.	PUNCT
ejnm-305	94	1	(	(	PUNCT
ejnm-305	94	2	1	1	NUM
ejnm-305	94	3	)	)	PUNCT
ejnm-305	94	4	,	,	PUNCT
ejnm-305	94	5	may	may	AUX
ejnm-305	94	6	2025	2025	NUM
ejnm-305	94	7	original	original	ADJ
ejnm-305	94	8	article	article	NOUN
ejnm-305	94	9	produces	produce	VERB
ejnm-305	94	10	hydrogen	hydrogen	NOUN
ejnm-305	94	11	peroxide	peroxide	NOUN
ejnm-305	94	12	.	.	PUNCT
ejnm-305	95	1	the	the	DET
ejnm-305	95	2	generated	generate	VERB
ejnm-305	95	3	peroxide	peroxide	NOUN
ejnm-305	95	4	undergoes	undergo	VERB
ejnm-305	95	5	a	a	DET
ejnm-305	95	6	peroxidase	peroxidase	NOUN
ejnm-305	95	7	reaction	reaction	NOUN
ejnm-305	95	8	with	with	ADP
ejnm-305	95	9	n	n	CCONJ
ejnm-305	95	10	,	,	PUNCT
ejnm-305	95	11	n	n	CCONJ
ejnm-305	95	12	-	-	PUNCT
ejnm-305	95	13	bis(4	bis(4	NOUN
ejnm-305	95	14	-	-	PUNCT
ejnm-305	95	15	sulphobutyl)-mtoluidine	sulphobutyl)-mtoluidine	ADJ
ejnm-305	95	16	-	-	PUNCT
ejnm-305	95	17	disodium	disodium	NOUN
ejnm-305	95	18	(	(	PUNCT
ejnm-305	95	19	dsbmt	dsbmt	NOUN
ejnm-305	95	20	)	)	PUNCT
ejnm-305	95	21	,	,	PUNCT
ejnm-305	95	22	resulting	result	VERB
ejnm-305	95	23	in	in	ADP
ejnm-305	95	24	a	a	DET
ejnm-305	95	25	colorless	colorless	ADJ
ejnm-305	95	26	product	product	NOUN
ejnm-305	95	27	.	.	PUNCT
ejnm-305	96	1	subsequently	subsequently	ADV
ejnm-305	96	2	,	,	PUNCT
ejnm-305	96	3	specific	specific	ADJ
ejnm-305	96	4	detergents	detergent	NOUN
ejnm-305	96	5	solubilize	solubilize	VERB
ejnm-305	96	6	hdl	hdl	PROPN
ejnm-305	96	7	-	-	PUNCT
ejnm-305	96	8	cholesterol	cholesterol	NOUN
ejnm-305	96	9	.	.	PUNCT
ejnm-305	97	1	in	in	ADP
ejnm-305	97	2	conjunction	conjunction	NOUN
ejnm-305	97	3	with	with	ADP
ejnm-305	97	4	the	the	DET
ejnm-305	97	5	action	action	NOUN
ejnm-305	97	6	of	of	ADP
ejnm-305	97	7	cholesterol	cholesterol	NOUN
ejnm-305	97	8	oxidase	oxidase	NOUN
ejnm-305	97	9	(	(	PUNCT
ejnm-305	97	10	co	co	NOUN
ejnm-305	97	11	)	)	PUNCT
ejnm-305	97	12	and	and	CCONJ
ejnm-305	97	13	cholesterol	cholesterol	NOUN
ejnm-305	97	14	esterase	esterase	NOUN
ejnm-305	97	15	(	(	PUNCT
ejnm-305	97	16	ce	ce	PROPN
ejnm-305	97	17	)	)	PUNCT
ejnm-305	97	18	,	,	PUNCT
ejnm-305	97	19	peroxidase	peroxidase	NOUN
ejnm-305	97	20	(	(	PUNCT
ejnm-305	97	21	pod	pod	NOUN
ejnm-305	97	22	)	)	PUNCT
ejnm-305	97	23	and	and	CCONJ
ejnm-305	97	24	4	4	NUM
ejnm-305	97	25	-	-	NUM
ejnm-305	97	26	aminoantipyrine	aminoantipyrine	NOUN
ejnm-305	97	27	(	(	PUNCT
ejnm-305	97	28	4	4	NUM
ejnm-305	97	29	-aap	-aap	PRON
ejnm-305	97	30	)	)	PUNCT
ejnm-305	97	31	develop	develop	VERB
ejnm-305	97	32	a	a	DET
ejnm-305	97	33	colored	colored	ADJ
ejnm-305	97	34	reaction	reaction	NOUN
ejnm-305	97	35	proportionate	proportionate	ADJ
ejnm-305	97	36	to	to	ADP
ejnm-305	97	37	hdl	hdl	NOUN
ejnm-305	97	38	-	-	PUNCT
ejnm-305	97	39	cholesterol	cholesterol	NOUN
ejnm-305	97	40	concentration	concentration	NOUN
ejnm-305	97	41	.	.	PUNCT
ejnm-305	98	1	absorbance	absorbance	NOUN
ejnm-305	98	2	is	be	AUX
ejnm-305	98	3	measured	measure	VERB
ejnm-305	98	4	at	at	ADP
ejnm-305	98	5	600	600	NUM
ejnm-305	98	6	nm	nm	NOUN
ejnm-305	98	7	.	.	PUNCT
ejnm-305	99	1	ldlcholesterol	ldlcholesterol	PROPN
ejnm-305	99	2	is	be	AUX
ejnm-305	99	3	calculated	calculate	VERB
ejnm-305	99	4	from	from	ADP
ejnm-305	99	5	measured	measured	ADJ
ejnm-305	99	6	values	value	NOUN
ejnm-305	99	7	of	of	ADP
ejnm-305	99	8	total	total	ADJ
ejnm-305	99	9	cholesterol	cholesterol	NOUN
ejnm-305	99	10	,	,	PUNCT
ejnm-305	99	11	triglycerides	triglyceride	NOUN
ejnm-305	99	12	,	,	PUNCT
ejnm-305	99	13	and	and	CCONJ
ejnm-305	99	14	hdl	hdl	NOUN
ejnm-305	99	15	-	-	PUNCT
ejnm-305	99	16	cholesterol	cholesterol	NOUN
ejnm-305	99	17	according	accord	VERB
ejnm-305	99	18	to	to	ADP
ejnm-305	99	19	the	the	DET
ejnm-305	99	20	relationship	relationship	NOUN
ejnm-305	99	21	:	:	PUNCT
ejnm-305	100	1	[	[	X
ejnm-305	100	2	ldl	ldl	NOUN
ejnm-305	100	3	-	-	PUNCT
ejnm-305	100	4	cholesterol	cholesterol	NOUN
ejnm-305	100	5	]	]	X
ejnm-305	100	6	=	=	PUNCT
ejnm-305	101	1	[	[	X
ejnm-305	101	2	total	total	ADJ
ejnm-305	101	3	chol	chol	NOUN
ejnm-305	101	4	]	]	X
ejnm-305	102	1	[	[	X
ejnm-305	102	2	hdl	hdl	NOUN
ejnm-305	102	3	-	-	PUNCT
ejnm-305	102	4	chol	chol	NOUN
ejnm-305	102	5	]	]	X
ejnm-305	103	1	[	[	X
ejnm-305	103	2	tg]/5	tg]/5	PROPN
ejnm-305	103	3	,	,	PUNCT
ejnm-305	103	4	where	where	SCONJ
ejnm-305	103	5	[	[	AUX
ejnm-305	103	6	tg]/5	tg]/5	NOUN
ejnm-305	103	7	estimates	estimate	VERB
ejnm-305	103	8	vldl	vldl	NOUN
ejnm-305	103	9	-	-	PUNCT
ejnm-305	103	10	cholesterol	cholesterol	NOUN
ejnm-305	103	11	,	,	PUNCT
ejnm-305	103	12	with	with	SCONJ
ejnm-305	103	13	all	all	DET
ejnm-305	103	14	values	value	NOUN
ejnm-305	103	15	expressed	express	VERB
ejnm-305	103	16	in	in	ADP
ejnm-305	103	17	mg	mg	PROPN
ejnm-305	103	18	/	/	SYM
ejnm-305	103	19	dl	dl	PROPN
ejnm-305	103	20	.	.	PROPN
ejnm-305	103	21	renal	renal	PROPN
ejnm-305	103	22	function	function	PROPN
ejnm-305	103	23	test	test	NOUN
ejnm-305	103	24	(	(	PUNCT
ejnm-305	103	25	rft	rft	NOUN
ejnm-305	103	26	)	)	PUNCT
ejnm-305	103	27	creatinine	creatinine	NOUN
ejnm-305	103	28	is	be	AUX
ejnm-305	103	29	an	an	DET
ejnm-305	103	30	in	in	ADP
ejnm-305	103	31	vitro	vitro	X
ejnm-305	103	32	assay	assay	NOUN
ejnm-305	103	33	used	use	VERB
ejnm-305	103	34	to	to	PART
ejnm-305	103	35	precisely	precisely	ADV
ejnm-305	103	36	measure	measure	VERB
ejnm-305	103	37	the	the	DET
ejnm-305	103	38	concentration	concentration	NOUN
ejnm-305	103	39	of	of	ADP
ejnm-305	103	40	creatinine	creatinine	NOUN
ejnm-305	103	41	in	in	ADP
ejnm-305	103	42	human	human	ADJ
ejnm-305	103	43	serum	serum	NOUN
ejnm-305	103	44	using	use	VERB
ejnm-305	103	45	the	the	DET
ejnm-305	103	46	biochemical	biochemical	ADJ
ejnm-305	103	47	analyzer	analyzer	NOUN
ejnm-305	103	48	biolis	biolis	PROPN
ejnm-305	103	49	30i	30i	PROPN
ejnm-305	103	50	apparatus	apparatus	PROPN
ejnm-305	103	51	.	.	PUNCT
ejnm-305	104	1	this	this	DET
ejnm-305	104	2	enzymatic	enzymatic	ADJ
ejnm-305	104	3	method	method	NOUN
ejnm-305	104	4	relies	rely	VERB
ejnm-305	104	5	on	on	ADP
ejnm-305	104	6	the	the	DET
ejnm-305	104	7	conversion	conversion	NOUN
ejnm-305	104	8	of	of	ADP
ejnm-305	104	9	creatinine	creatinine	NOUN
ejnm-305	104	10	with	with	ADP
ejnm-305	104	11	the	the	DET
ejnm-305	104	12	assistance	assistance	NOUN
ejnm-305	104	13	of	of	ADP
ejnm-305	104	14	creatininase	creatininase	NOUN
ejnm-305	104	15	,	,	PUNCT
ejnm-305	104	16	creatinase	creatinase	NOUN
ejnm-305	104	17	,	,	PUNCT
ejnm-305	104	18	and	and	CCONJ
ejnm-305	104	19	sarcosine	sarcosine	NOUN
ejnm-305	104	20	oxidase	oxidase	NOUN
ejnm-305	104	21	to	to	ADP
ejnm-305	104	22	glycine	glycine	NOUN
ejnm-305	104	23	,	,	PUNCT
ejnm-305	104	24	formaldehyde	formaldehyde	NOUN
ejnm-305	104	25	,	,	PUNCT
ejnm-305	104	26	and	and	CCONJ
ejnm-305	104	27	hydrogen	hydrogen	NOUN
ejnm-305	104	28	peroxide	peroxide	NOUN
ejnm-305	104	29	.	.	PUNCT
ejnm-305	105	1	catalyzed	catalyze	VERB
ejnm-305	105	2	by	by	ADP
ejnm-305	105	3	peroxidase	peroxidase	NOUN
ejnm-305	105	4	,	,	PUNCT
ejnm-305	105	5	the	the	DET
ejnm-305	105	6	liberated	liberated	ADJ
ejnm-305	105	7	hydrogen	hydrogen	NOUN
ejnm-305	105	8	peroxide	peroxide	NOUN
ejnm-305	105	9	reacts	react	NOUN
ejnm-305	105	10	with	with	ADP
ejnm-305	105	11	4aminophenazone	4aminophenazone	NUM
ejnm-305	105	12	and	and	CCONJ
ejnm-305	105	13	htiba	htiba	NOUN
ejnm-305	105	14	to	to	PART
ejnm-305	105	15	form	form	VERB
ejnm-305	105	16	a	a	DET
ejnm-305	105	17	quinone	quinone	NOUN
ejnm-305	105	18	imine	imine	NOUN
ejnm-305	105	19	chromogen	chromogen	NOUN
ejnm-305	105	20	.	.	PUNCT
ejnm-305	106	1	the	the	DET
ejnm-305	106	2	intensity	intensity	NOUN
ejnm-305	106	3	of	of	ADP
ejnm-305	106	4	the	the	DET
ejnm-305	106	5	color	color	NOUN
ejnm-305	106	6	of	of	ADP
ejnm-305	106	7	the	the	DET
ejnm-305	106	8	formed	form	VERB
ejnm-305	106	9	quinone	quinone	NOUN
ejnm-305	106	10	imine	imine	NOUN
ejnm-305	106	11	chromogen	chromogen	NOUN
ejnm-305	106	12	is	be	AUX
ejnm-305	106	13	directly	directly	ADV
ejnm-305	106	14	proportional	proportional	ADJ
ejnm-305	106	15	to	to	ADP
ejnm-305	106	16	the	the	DET
ejnm-305	106	17	creatinine	creatinine	NOUN
ejnm-305	106	18	concentration	concentration	NOUN
ejnm-305	106	19	in	in	ADP
ejnm-305	106	20	the	the	DET
ejnm-305	106	21	reaction	reaction	NOUN
ejnm-305	106	22	mixture	mixture	NOUN
ejnm-305	106	23	.	.	PUNCT
ejnm-305	107	1	this	this	DET
ejnm-305	107	2	coloration	coloration	NOUN
ejnm-305	107	3	,	,	PUNCT
ejnm-305	107	4	indicative	indicative	ADJ
ejnm-305	107	5	of	of	ADP
ejnm-305	107	6	the	the	DET
ejnm-305	107	7	creatinine	creatinine	NOUN
ejnm-305	107	8	concentration	concentration	NOUN
ejnm-305	107	9	in	in	ADP
ejnm-305	107	10	the	the	DET
ejnm-305	107	11	specimen	speciman	NOUN
ejnm-305	107	12	,	,	PUNCT
ejnm-305	107	13	is	be	AUX
ejnm-305	107	14	measured	measure	VERB
ejnm-305	107	15	at	at	ADP
ejnm-305	107	16	550	550	NUM
ejnm-305	107	17	nm	nm	NOUN
ejnm-305	107	18	.	.	PUNCT
ejnm-305	108	1	blood	blood	NOUN
ejnm-305	108	2	urea	urea	NOUN
ejnm-305	108	3	is	be	AUX
ejnm-305	108	4	assessed	assess	VERB
ejnm-305	108	5	by	by	ADP
ejnm-305	108	6	a	a	DET
ejnm-305	108	7	kinetic	kinetic	ADJ
ejnm-305	108	8	method	method	NOUN
ejnm-305	108	9	based	base	VERB
ejnm-305	108	10	on	on	ADP
ejnm-305	108	11	the	the	DET
ejnm-305	108	12	specific	specific	ADJ
ejnm-305	108	13	action	action	NOUN
ejnm-305	108	14	of	of	ADP
ejnm-305	108	15	urease	urease	NOUN
ejnm-305	108	16	,	,	PUNCT
ejnm-305	108	17	which	which	PRON
ejnm-305	108	18	hydrolyzes	hydrolyze	VERB
ejnm-305	108	19	urea	urea	NOUN
ejnm-305	108	20	into	into	ADP
ejnm-305	108	21	ammonium	ammonium	NOUN
ejnm-305	108	22	ions	ion	NOUN
ejnm-305	108	23	and	and	CCONJ
ejnm-305	108	24	carbon	carbon	NOUN
ejnm-305	108	25	dioxide	dioxide	NOUN
ejnm-305	108	26	.	.	PUNCT
ejnm-305	109	1	ammonium	ammonium	NOUN
ejnm-305	109	2	ions	ion	NOUN
ejnm-305	109	3	then	then	ADV
ejnm-305	109	4	react	react	VERB
ejnm-305	109	5	with	with	ADP
ejnm-305	109	6	chloride	chloride	NOUN
ejnm-305	109	7	and	and	CCONJ
ejnm-305	109	8	salicylate	salicylate	NOUN
ejnm-305	109	9	to	to	PART
ejnm-305	109	10	form	form	VERB
ejnm-305	109	11	a	a	DET
ejnm-305	109	12	blue	blue	ADJ
ejnm-305	109	13	-	-	PUNCT
ejnm-305	109	14	green	green	ADJ
ejnm-305	109	15	complex	complex	NOUN
ejnm-305	109	16	.	.	PUNCT
ejnm-305	110	1	this	this	DET
ejnm-305	110	2	coloration	coloration	NOUN
ejnm-305	110	3	,	,	PUNCT
ejnm-305	110	4	proportional	proportional	ADJ
ejnm-305	110	5	to	to	ADP
ejnm-305	110	6	the	the	DET
ejnm-305	110	7	urea	urea	NOUN
ejnm-305	110	8	concentration	concentration	NOUN
ejnm-305	110	9	in	in	ADP
ejnm-305	110	10	the	the	DET
ejnm-305	110	11	specimen	speciman	NOUN
ejnm-305	110	12	,	,	PUNCT
ejnm-305	110	13	is	be	AUX
ejnm-305	110	14	measured	measure	VERB
ejnm-305	110	15	at	at	ADP
ejnm-305	110	16	340	340	NUM
ejnm-305	110	17	nm	nm	NOUN
ejnm-305	110	18	.	.	PUNCT
ejnm-305	111	1	data	datum	NOUN
ejnm-305	111	2	analysis	analysis	NOUN
ejnm-305	111	3	the	the	DET
ejnm-305	111	4	results	result	NOUN
ejnm-305	111	5	of	of	ADP
ejnm-305	111	6	this	this	DET
ejnm-305	111	7	investigation	investigation	NOUN
ejnm-305	111	8	were	be	AUX
ejnm-305	111	9	displayed	display	VERB
ejnm-305	111	10	in	in	ADP
ejnm-305	111	11	a	a	DET
ejnm-305	111	12	table	table	NOUN
ejnm-305	111	13	using	use	VERB
ejnm-305	111	14	the	the	DET
ejnm-305	111	15	statistical	statistical	ADJ
ejnm-305	111	16	software	software	NOUN
ejnm-305	111	17	for	for	ADP
ejnm-305	111	18	social	social	ADJ
ejnm-305	111	19	sciences	science	NOUN
ejnm-305	111	20	(	(	PUNCT
ejnm-305	111	21	spss	spss	PROPN
ejnm-305	111	22	)	)	PUNCT
ejnm-305	111	23	version	version	NOUN
ejnm-305	111	24	22.0	22.0	NUM
ejnm-305	111	25	.	.	PUNCT
ejnm-305	112	1	descriptive	descriptive	ADJ
ejnm-305	112	2	analysis	analysis	NOUN
ejnm-305	112	3	was	be	AUX
ejnm-305	112	4	conducted	conduct	VERB
ejnm-305	112	5	on	on	ADP
ejnm-305	112	6	the	the	DET
ejnm-305	112	7	mean	mean	ADJ
ejnm-305	112	8	and	and	CCONJ
ejnm-305	112	9	standard	standard	ADJ
ejnm-305	112	10	deviation	deviation	NOUN
ejnm-305	112	11	of	of	ADP
ejnm-305	112	12	a	a	DET
ejnm-305	112	13	biochemical	biochemical	ADJ
ejnm-305	112	14	indicator	indicator	NOUN
ejnm-305	112	15	for	for	ADP
ejnm-305	112	16	both	both	CCONJ
ejnm-305	112	17	pregnant	pregnant	ADJ
ejnm-305	112	18	and	and	CCONJ
ejnm-305	112	19	non	non	ADJ
ejnm-305	112	20	-	-	ADJ
ejnm-305	112	21	pregnant	pregnant	ADJ
ejnm-305	112	22	women	woman	NOUN
ejnm-305	112	23	.	.	PUNCT
ejnm-305	113	1	a	a	DET
ejnm-305	113	2	t	t	NOUN
ejnm-305	113	3	-	-	PUNCT
ejnm-305	113	4	test	test	NOUN
ejnm-305	113	5	was	be	AUX
ejnm-305	113	6	then	then	ADV
ejnm-305	113	7	used	use	VERB
ejnm-305	113	8	to	to	PART
ejnm-305	113	9	see	see	VERB
ejnm-305	113	10	if	if	SCONJ
ejnm-305	113	11	there	there	PRON
ejnm-305	113	12	were	be	VERB
ejnm-305	113	13	any	any	DET
ejnm-305	113	14	significant	significant	ADJ
ejnm-305	113	15	differences	difference	NOUN
ejnm-305	113	16	between	between	ADP
ejnm-305	113	17	the	the	DET
ejnm-305	113	18	two	two	NUM
ejnm-305	113	19	groups	group	NOUN
ejnm-305	113	20	.	.	PUNCT
ejnm-305	114	1	pearson	pearson	PROPN
ejnm-305	114	2	correlation	correlation	NOUN
ejnm-305	114	3	has	have	AUX
ejnm-305	114	4	been	be	AUX
ejnm-305	114	5	done	do	VERB
ejnm-305	114	6	to	to	PART
ejnm-305	114	7	figure	figure	VERB
ejnm-305	114	8	out	out	ADP
ejnm-305	114	9	each	each	DET
ejnm-305	114	10	relationship	relationship	NOUN
ejnm-305	114	11	between	between	ADP
ejnm-305	114	12	the	the	DET
ejnm-305	114	13	duration	duration	NOUN
ejnm-305	114	14	of	of	ADP
ejnm-305	114	15	pregnancy	pregnancy	NOUN
ejnm-305	114	16	and	and	CCONJ
ejnm-305	114	17	para	para	NOUN
ejnm-305	114	18	and	and	CCONJ
ejnm-305	114	19	biochemical	biochemical	ADJ
ejnm-305	114	20	indicators	indicator	NOUN
ejnm-305	114	21	in	in	ADP
ejnm-305	114	22	pregnant	pregnant	ADJ
ejnm-305	114	23	and	and	CCONJ
ejnm-305	114	24	nonpregnant	nonpregnant	ADJ
ejnm-305	114	25	women	woman	NOUN
ejnm-305	114	26	differently	differently	ADV
ejnm-305	114	27	.	.	PUNCT
ejnm-305	115	1	a	a	DET
ejnm-305	115	2	multiple	multiple	ADJ
ejnm-305	115	3	linear	linear	ADJ
ejnm-305	115	4	regression	regression	NOUN
ejnm-305	115	5	model	model	NOUN
ejnm-305	115	6	was	be	AUX
ejnm-305	115	7	constructed	construct	VERB
ejnm-305	115	8	to	to	PART
ejnm-305	115	9	identify	identify	VERB
ejnm-305	115	10	the	the	DET
ejnm-305	115	11	characteristics	characteristic	NOUN
ejnm-305	115	12	that	that	PRON
ejnm-305	115	13	are	be	AUX
ejnm-305	115	14	indicative	indicative	ADJ
ejnm-305	115	15	of	of	ADP
ejnm-305	115	16	high	high	ADJ
ejnm-305	115	17	cholesterol	cholesterol	NOUN
ejnm-305	115	18	in	in	ADP
ejnm-305	115	19	pregnant	pregnant	ADJ
ejnm-305	115	20	women	woman	NOUN
ejnm-305	115	21	.	.	PUNCT
ejnm-305	116	1	a	a	DET
ejnm-305	116	2	p	p	NOUN
ejnm-305	116	3	-	-	PUNCT
ejnm-305	116	4	value	value	NOUN
ejnm-305	116	5	of	of	ADP
ejnm-305	116	6	less	less	ADJ
ejnm-305	116	7	than	than	ADP
ejnm-305	116	8	0.05	0.05	NUM
ejnm-305	116	9	was	be	AUX
ejnm-305	116	10	used	use	VERB
ejnm-305	116	11	to	to	PART
ejnm-305	116	12	determine	determine	VERB
ejnm-305	116	13	statistical	statistical	ADJ
ejnm-305	116	14	significance	significance	NOUN
ejnm-305	116	15	.	.	PUNCT
ejnm-305	117	1	and	and	CCONJ
ejnm-305	117	2	egfr	egfr	NOUN
ejnm-305	117	3	has	have	AUX
ejnm-305	117	4	been	be	AUX
ejnm-305	117	5	measured	measure	VERB
ejnm-305	117	6	using	use	VERB
ejnm-305	117	7	the	the	DET
ejnm-305	117	8	following	follow	VERB
ejnm-305	117	9	formula	formula	NOUN
ejnm-305	117	10	:	:	PUNCT
ejnm-305	117	11	egfr	egfr	NOUN
ejnm-305	117	12	=	=	NOUN
ejnm-305	117	13	175	175	NUM
ejnm-305	117	14	×	×	NOUN
ejnm-305	117	15	(	(	PUNCT
ejnm-305	117	16	scr	scr	NOUN
ejnm-305	117	17	)	)	PUNCT
ejnm-305	117	18	^-1.154	^-1.154	NOUN
ejnm-305	117	19	×	×	NOUN
ejnm-305	117	20	(	(	PUNCT
ejnm-305	117	21	age	age	NOUN
ejnm-305	117	22	)	)	PUNCT
ejnm-305	117	23	^-0.203	^-0.203	NUM
ejnm-305	117	24	×	×	PROPN
ejnm-305	117	25	(	(	PUNCT
ejnm-305	117	26	0.742	0.742	NUM
ejnm-305	117	27	)	)	PUNCT
ejnm-305	117	28	.	.	PUNCT
ejnm-305	118	1	exclusion	exclusion	NOUN
ejnm-305	118	2	criteria	criterion	NOUN
ejnm-305	118	3	:	:	PUNCT
ejnm-305	118	4	women	woman	NOUN
ejnm-305	118	5	aged	age	VERB
ejnm-305	118	6	more	more	ADJ
ejnm-305	118	7	than	than	ADP
ejnm-305	118	8	50	50	NUM
ejnm-305	118	9	years	year	NOUN
ejnm-305	118	10	were	be	AUX
ejnm-305	118	11	excluded	exclude	VERB
ejnm-305	118	12	from	from	ADP
ejnm-305	118	13	the	the	DET
ejnm-305	118	14	analysis	analysis	NOUN
ejnm-305	118	15	.	.	PUNCT
ejnm-305	119	1	ethical	ethical	ADJ
ejnm-305	119	2	concerning	concern	VERB
ejnm-305	119	3	this	this	DET
ejnm-305	119	4	study	study	NOUN
ejnm-305	119	5	has	have	AUX
ejnm-305	119	6	been	be	AUX
ejnm-305	119	7	done	do	VERB
ejnm-305	119	8	with	with	ADP
ejnm-305	119	9	the	the	DET
ejnm-305	119	10	general	general	ADJ
ejnm-305	119	11	health	health	NOUN
ejnm-305	119	12	laboratory	laboratory	NOUN
ejnm-305	119	13	of	of	ADP
ejnm-305	119	14	sulaimanyah/	sulaimanyah/	NUM
ejnm-305	119	15	darbandikhan	darbandikhan	PROPN
ejnm-305	119	16	shahid	shahid	PROPN
ejnm-305	119	17	tofiq	tofiq	PROPN
ejnm-305	119	18	general	general	ADJ
ejnm-305	119	19	hospital	hospital	PROPN
ejnm-305	119	20	.	.	PUNCT
ejnm-305	120	1	the	the	DET
ejnm-305	120	2	authorization	authorization	NOUN
ejnm-305	120	3	letter	letter	NOUN
ejnm-305	120	4	was	be	AUX
ejnm-305	120	5	taken	take	VERB
ejnm-305	120	6	from	from	ADP
ejnm-305	120	7	the	the	DET
ejnm-305	120	8	nursing	nursing	NOUN
ejnm-305	120	9	department	department	NOUN
ejnm-305	120	10	,	,	PUNCT
ejnm-305	120	11	darbandikhan	darbandikhan	PROPN
ejnm-305	120	12	technical	technical	PROPN
ejnm-305	120	13	institute	institute	PROPN
ejnm-305	120	14	,	,	PUNCT
ejnm-305	120	15	sulaimani	sulaimani	PROPN
ejnm-305	120	16	polytechnic	polytechnic	ADJ
ejnm-305	120	17	university	university	NOUN
ejnm-305	120	18	.	.	PUNCT
ejnm-305	121	1	all	all	DET
ejnm-305	121	2	patients	patient	NOUN
ejnm-305	121	3	were	be	AUX
ejnm-305	121	4	provided	provide	VERB
ejnm-305	121	5	with	with	ADP
ejnm-305	121	6	a	a	DET
ejnm-305	121	7	clear	clear	ADJ
ejnm-305	121	8	explanation	explanation	NOUN
ejnm-305	121	9	of	of	ADP
ejnm-305	121	10	the	the	DET
ejnm-305	121	11	study	study	NOUN
ejnm-305	121	12	's	's	PART
ejnm-305	121	13	objectives	objective	NOUN
ejnm-305	121	14	,	,	PUNCT
ejnm-305	121	15	and	and	CCONJ
ejnm-305	121	16	consent	consent	NOUN
ejnm-305	121	17	letters	letter	NOUN
ejnm-305	121	18	were	be	AUX
ejnm-305	121	19	obtained	obtain	VERB
ejnm-305	121	20	from	from	ADP
ejnm-305	121	21	all	all	DET
ejnm-305	121	22	participants	participant	NOUN
ejnm-305	121	23	.	.	PUNCT
ejnm-305	122	1	table	table	NOUN
ejnm-305	122	2	1	1	NUM
ejnm-305	122	3	demonstrated	demonstrate	VERB
ejnm-305	122	4	that	that	SCONJ
ejnm-305	122	5	the	the	DET
ejnm-305	122	6	mean	mean	ADJ
ejnm-305	122	7	age	age	NOUN
ejnm-305	122	8	(	(	PUNCT
ejnm-305	122	9	35.54±8.7	35.54±8.7	NUM
ejnm-305	122	10	)	)	PUNCT
ejnm-305	122	11	,	,	PUNCT
ejnm-305	122	12	urea	urea	NOUN
ejnm-305	122	13	(	(	PUNCT
ejnm-305	122	14	23.94±8.08	23.94±8.08	NUM
ejnm-305	122	15	)	)	PUNCT
ejnm-305	122	16	,	,	PUNCT
ejnm-305	122	17	and	and	CCONJ
ejnm-305	122	18	creatinine	creatinine	NOUN
ejnm-305	122	19	(	(	PUNCT
ejnm-305	122	20	0.57±0.128	0.57±0.128	NOUN
ejnm-305	122	21	)	)	PUNCT
ejnm-305	122	22	were	be	AUX
ejnm-305	122	23	significantly	significantly	ADV
ejnm-305	122	24	higher	high	ADJ
ejnm-305	122	25	in	in	ADP
ejnm-305	122	26	non	non	ADJ
ejnm-305	122	27	-	-	ADJ
ejnm-305	122	28	pregnant	pregnant	ADJ
ejnm-305	122	29	women	woman	NOUN
ejnm-305	122	30	compared	compare	VERB
ejnm-305	122	31	with	with	ADP
ejnm-305	122	32	pregnant	pregnant	ADJ
ejnm-305	122	33	women	woman	NOUN
ejnm-305	122	34	.	.	PUNCT
ejnm-305	123	1	while	while	SCONJ
ejnm-305	123	2	the	the	DET
ejnm-305	123	3	mean	mean	NOUN
ejnm-305	123	4	of	of	ADP
ejnm-305	123	5	cholesterol	cholesterol	NOUN
ejnm-305	123	6	(	(	PUNCT
ejnm-305	123	7	182.53±36.94	182.53±36.94	NUM
ejnm-305	123	8	)	)	PUNCT
ejnm-305	123	9	,	,	PUNCT
ejnm-305	123	10	hdl	hdl	X
ejnm-305	123	11	(	(	PUNCT
ejnm-305	123	12	54.28±11.67	54.28±11.67	NUM
ejnm-305	123	13	)	)	PUNCT
ejnm-305	123	14	,	,	PUNCT
ejnm-305	123	15	and	and	CCONJ
ejnm-305	123	16	egfr	egfr	NOUN
ejnm-305	123	17	(	(	PUNCT
ejnm-305	123	18	158.34±44.40	158.34±44.40	NOUN
ejnm-305	123	19	)	)	PUNCT
ejnm-305	123	20	were	be	AUX
ejnm-305	123	21	significantly	significantly	ADV
ejnm-305	123	22	high	high	ADJ
ejnm-305	123	23	among	among	ADP
ejnm-305	123	24	pregnant	pregnant	ADJ
ejnm-305	123	25	women	woman	NOUN
ejnm-305	123	26	(	(	PUNCT
ejnm-305	123	27	p	p	NOUN
ejnm-305	123	28	-	-	PUNCT
ejnm-305	123	29	value<0.05	value<0.05	NOUN
ejnm-305	123	30	)	)	PUNCT
ejnm-305	123	31	.	.	PUNCT
ejnm-305	124	1	23	23	NUM
ejnm-305	124	2	copyright	copyright	NOUN
ejnm-305	124	3	©	©	PROPN
ejnm-305	124	4	2025	2025	NUM
ejnm-305	124	5	the	the	DET
ejnm-305	124	6	author(s	author(s	NOUN
ejnm-305	124	7	)	)	PUNCT
ejnm-305	124	8	.	.	PUNCT
ejnm-305	125	1	this	this	PRON
ejnm-305	125	2	is	be	AUX
ejnm-305	125	3	an	an	DET
ejnm-305	125	4	open	open	ADJ
ejnm-305	125	5	access	access	NOUN
ejnm-305	125	6	article	article	NOUN
ejnm-305	125	7	which	which	PRON
ejnm-305	125	8	licensed	license	VERB
ejnm-305	125	9	under	under	ADP
ejnm-305	125	10	the	the	DET
ejnm-305	125	11	terms	term	NOUN
ejnm-305	125	12	and	and	CCONJ
ejnm-305	125	13	conditions	condition	NOUN
ejnm-305	125	14	of	of	ADP
ejnm-305	125	15	the	the	DET
ejnm-305	125	16	creative	creative	ADJ
ejnm-305	125	17	commons	common	NOUN
ejnm-305	125	18	attribution	attribution	NOUN
ejnm-305	125	19	-	-	PUNCT
ejnm-305	125	20	noncommercial	noncommercial	ADJ
ejnm-305	125	21	-	-	PUNCT
ejnm-305	125	22	sharealike	sharealike	ADJ
ejnm-305	125	23	4.0	4.0	NUM
ejnm-305	125	24	international	international	ADJ
ejnm-305	125	25	license	license	NOUN
ejnm-305	125	26	.	.	PUNCT
ejnm-305	126	1	it	it	PRON
ejnm-305	126	2	permits	permit	VERB
ejnm-305	126	3	no	no	DET
ejnm-305	126	4	additional	additional	ADJ
ejnm-305	126	5	restrictions	restriction	NOUN
ejnm-305	126	6	on	on	ADP
ejnm-305	126	7	use	use	NOUN
ejnm-305	126	8	,	,	PUNCT
ejnm-305	126	9	distribution	distribution	NOUN
ejnm-305	126	10	,	,	PUNCT
ejnm-305	126	11	and	and	CCONJ
ejnm-305	126	12	reproduction	reproduction	NOUN
ejnm-305	126	13	in	in	ADP
ejnm-305	126	14	any	any	DET
ejnm-305	126	15	medium	medium	NOUN
ejnm-305	126	16	provided	provide	VERB
ejnm-305	126	17	the	the	DET
ejnm-305	126	18	original	original	ADJ
ejnm-305	126	19	work	work	NOUN
ejnm-305	126	20	is	be	AUX
ejnm-305	126	21	properly	properly	ADV
ejnm-305	126	22	cited	cite	VERB
ejnm-305	126	23	.	.	PUNCT
ejnm-305	127	1	result	result	PROPN
ejnm-305	127	2	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-305	128	1	https://doi.org/10.15218/ejnm.2025.03	https://doi.org/10.15218/ejnm.2025.03	PROPN
ejnm-305	128	2	erbil	erbil	PROPN
ejnm-305	128	3	j.	j.	PROPN
ejnm-305	128	4	nurs	nurs	PROPN
ejnm-305	128	5	.	.	PUNCT
ejnm-305	129	1	midwifery	midwifery	ADJ
ejnm-305	129	2	,	,	PUNCT
ejnm-305	129	3	vol	vol	NOUN
ejnm-305	129	4	.	.	PROPN
ejnm-305	129	5	8	8	NUM
ejnm-305	129	6	,	,	PUNCT
ejnm-305	129	7	no	no	INTJ
ejnm-305	129	8	.	.	PUNCT
ejnm-305	130	1	(	(	PUNCT
ejnm-305	130	2	1	1	NUM
ejnm-305	130	3	)	)	PUNCT
ejnm-305	130	4	,	,	PUNCT
ejnm-305	130	5	may	may	AUX
ejnm-305	130	6	2025	2025	NUM
ejnm-305	130	7	original	original	ADJ
ejnm-305	130	8	article	article	NOUN
ejnm-305	130	9	24	24	NUM
ejnm-305	130	10	correlation	correlation	NOUN
ejnm-305	130	11	with	with	ADP
ejnm-305	130	12	tsb	tsb	PROPN
ejnm-305	130	13	(	(	PUNCT
ejnm-305	130	14	r	r	NOUN
ejnm-305	130	15	=	=	SYM
ejnm-305	130	16	-0.405	-0.405	PROPN
ejnm-305	130	17	,	,	PUNCT
ejnm-305	130	18	p	p	X
ejnm-305	130	19	<	<	X
ejnm-305	130	20	0.01	0.01	NUM
ejnm-305	130	21	)	)	PUNCT
ejnm-305	130	22	and	and	CCONJ
ejnm-305	130	23	creatinine	creatinine	NOUN
ejnm-305	130	24	(	(	PUNCT
ejnm-305	130	25	r	r	NOUN
ejnm-305	130	26	=	=	SYM
ejnm-305	130	27	-0.967	-0.967	ADJ
ejnm-305	130	28	,	,	PUNCT
ejnm-305	130	29	p	p	NOUN
ejnm-305	130	30	-	-	PUNCT
ejnm-305	130	31	value	value	NOUN
ejnm-305	130	32	<	<	NOUN
ejnm-305	130	33	0.001	0.001	NUM
ejnm-305	130	34	)	)	PUNCT
ejnm-305	130	35	.	.	PUNCT
ejnm-305	131	1	the	the	DET
ejnm-305	131	2	study	study	NOUN
ejnm-305	131	3	also	also	ADV
ejnm-305	131	4	found	find	VERB
ejnm-305	131	5	a	a	DET
ejnm-305	131	6	significant	significant	ADJ
ejnm-305	131	7	moderate	moderate	ADJ
ejnm-305	131	8	correlation	correlation	NOUN
ejnm-305	131	9	of	of	ADP
ejnm-305	131	10	cholesterol	cholesterol	NOUN
ejnm-305	131	11	with	with	ADP
ejnm-305	131	12	tg	tg	PROPN
ejnm-305	131	13	(	(	PUNCT
ejnm-305	131	14	r	r	NOUN
ejnm-305	131	15	=	=	SYM
ejnm-305	131	16	0.399	0.399	NUM
ejnm-305	131	17	,	,	PUNCT
ejnm-305	131	18	p	p	NOUN
ejnm-305	131	19	-	-	PUNCT
ejnm-305	131	20	value	value	NOUN
ejnm-305	131	21	<	<	X
ejnm-305	131	22	0.01	0.01	NUM
ejnm-305	131	23	)	)	PUNCT
ejnm-305	131	24	and	and	CCONJ
ejnm-305	131	25	hdl	hdl	PROPN
ejnm-305	131	26	(	(	PUNCT
ejnm-305	131	27	r	r	NOUN
ejnm-305	131	28	=	=	SYM
ejnm-305	131	29	0.385	0.385	NUM
ejnm-305	131	30	,	,	PUNCT
ejnm-305	131	31	p	p	NOUN
ejnm-305	131	32	-	-	PUNCT
ejnm-305	131	33	value	value	NOUN
ejnm-305	131	34	<	<	X
ejnm-305	131	35	0.01	0.01	NUM
ejnm-305	131	36	)	)	PUNCT
ejnm-305	131	37	,	,	PUNCT
ejnm-305	131	38	and	and	CCONJ
ejnm-305	131	39	serum	serum	NOUN
ejnm-305	131	40	creatinine	creatinine	PROPN
ejnm-305	131	41	had	have	VERB
ejnm-305	131	42	a	a	DET
ejnm-305	131	43	significant	significant	ADJ
ejnm-305	131	44	correlation	correlation	NOUN
ejnm-305	131	45	with	with	ADP
ejnm-305	131	46	the	the	DET
ejnm-305	131	47	tsb	tsb	NOUN
ejnm-305	131	48	(	(	PUNCT
ejnm-305	131	49	r	r	NOUN
ejnm-305	131	50	=	=	SYM
ejnm-305	131	51	0.475	0.475	NUM
ejnm-305	131	52	,	,	PUNCT
ejnm-305	131	53	p	p	NOUN
ejnm-305	131	54	-	-	PUNCT
ejnm-305	131	55	value	value	NOUN
ejnm-305	131	56	<	<	NOUN
ejnm-305	131	57	0.001	0.001	NUM
ejnm-305	131	58	)	)	PUNCT
ejnm-305	131	59	.	.	PUNCT
ejnm-305	132	1	the	the	DET
ejnm-305	132	2	correlation	correlation	NOUN
ejnm-305	132	3	of	of	ADP
ejnm-305	132	4	random	random	ADJ
ejnm-305	132	5	blood	blood	NOUN
ejnm-305	132	6	sugar	sugar	NOUN
ejnm-305	132	7	was	be	AUX
ejnm-305	132	8	close	close	ADJ
ejnm-305	132	9	to	to	ADP
ejnm-305	132	10	being	be	AUX
ejnm-305	132	11	significant	significant	ADJ
ejnm-305	132	12	with	with	ADP
ejnm-305	132	13	the	the	DET
ejnm-305	132	14	tg	tg	PROPN
ejnm-305	132	15	(	(	PUNCT
ejnm-305	132	16	r	r	NOUN
ejnm-305	132	17	=	=	SYM
ejnm-305	132	18	0.285	0.285	NUM
ejnm-305	132	19	,	,	PUNCT
ejnm-305	133	1	p	p	NOUN
ejnm-305	133	2	-	-	PUNCT
ejnm-305	133	3	value	value	NOUN
ejnm-305	133	4	<	<	NOUN
ejnm-305	133	5	0.05	0.05	NUM
ejnm-305	133	6	)	)	PUNCT
ejnm-305	133	7	.	.	PUNCT
ejnm-305	134	1	table	table	NOUN
ejnm-305	134	2	2	2	NUM
ejnm-305	134	3	indicates	indicate	VERB
ejnm-305	134	4	that	that	SCONJ
ejnm-305	134	5	ldl	ldl	NOUN
ejnm-305	134	6	has	have	VERB
ejnm-305	134	7	a	a	DET
ejnm-305	134	8	significant	significant	ADJ
ejnm-305	134	9	positive	positive	ADJ
ejnm-305	134	10	correlation	correlation	NOUN
ejnm-305	134	11	with	with	ADP
ejnm-305	134	12	the	the	DET
ejnm-305	134	13	women‘s	women‘s	PROPN
ejnm-305	134	14	gestation	gestation	NOUN
ejnm-305	134	15	age	age	NOUN
ejnm-305	134	16	(	(	PUNCT
ejnm-305	134	17	r	r	NOUN
ejnm-305	134	18	=	=	SYM
ejnm-305	134	19	0.354	0.354	NUM
ejnm-305	134	20	,	,	PUNCT
ejnm-305	135	1	p	p	NOUN
ejnm-305	135	2	-	-	PUNCT
ejnm-305	135	3	value	value	NOUN
ejnm-305	135	4	<	<	X
ejnm-305	135	5	0.01	0.01	NUM
ejnm-305	135	6	)	)	PUNCT
ejnm-305	135	7	,	,	PUNCT
ejnm-305	135	8	cholesterol	cholesterol	NOUN
ejnm-305	135	9	(	(	PUNCT
ejnm-305	135	10	r	r	NOUN
ejnm-305	135	11	=	=	SYM
ejnm-305	135	12	0.802	0.802	NUM
ejnm-305	135	13	,	,	PUNCT
ejnm-305	135	14	p	p	NOUN
ejnm-305	135	15	-	-	PUNCT
ejnm-305	135	16	value	value	NOUN
ejnm-305	135	17	<	<	NOUN
ejnm-305	135	18	0.001	0.001	NUM
ejnm-305	135	19	)	)	PUNCT
ejnm-305	135	20	,	,	PUNCT
ejnm-305	135	21	tg	tg	PROPN
ejnm-305	135	22	(	(	PUNCT
ejnm-305	135	23	r	r	NOUN
ejnm-305	135	24	=	=	SYM
ejnm-305	135	25	315	315	NUM
ejnm-305	135	26	,	,	PUNCT
ejnm-305	135	27	p	p	NOUN
ejnm-305	135	28	-	-	PUNCT
ejnm-305	135	29	value	value	NOUN
ejnm-305	135	30	<	<	NOUN
ejnm-305	135	31	0.05	0.05	NUM
ejnm-305	135	32	.	.	PUNCT
ejnm-305	135	33	)	)	PUNCT
ejnm-305	135	34	,	,	PUNCT
ejnm-305	135	35	and	and	CCONJ
ejnm-305	135	36	hdl	hdl	PROPN
ejnm-305	135	37	(	(	PUNCT
ejnm-305	135	38	r	r	NOUN
ejnm-305	135	39	=	=	SYM
ejnm-305	135	40	0.454	0.454	NUM
ejnm-305	135	41	,	,	PUNCT
ejnm-305	135	42	p	p	NOUN
ejnm-305	135	43	-	-	PUNCT
ejnm-305	135	44	value	value	NOUN
ejnm-305	135	45	<	<	X
ejnm-305	135	46	0.001	0.001	NUM
ejnm-305	135	47	)	)	PUNCT
ejnm-305	135	48	,	,	PUNCT
ejnm-305	135	49	and	and	CCONJ
ejnm-305	135	50	a	a	DET
ejnm-305	135	51	strong	strong	ADJ
ejnm-305	135	52	negative	negative	ADJ
ejnm-305	135	53	correlation	correlation	NOUN
ejnm-305	135	54	with	with	ADP
ejnm-305	135	55	tsb	tsb	PROPN
ejnm-305	135	56	(	(	PUNCT
ejnm-305	135	57	r	r	NOUN
ejnm-305	135	58	=	=	PUNCT
ejnm-305	135	59	-0.431	-0.431	NOUN
ejnm-305	135	60	,	,	PUNCT
ejnm-305	135	61	p	p	NOUN
ejnm-305	135	62	-	-	PUNCT
ejnm-305	135	63	value	value	NOUN
ejnm-305	135	64	=	=	NOUN
ejnm-305	135	65	0.002	0.002	NUM
ejnm-305	135	66	)	)	PUNCT
ejnm-305	135	67	and	and	CCONJ
ejnm-305	135	68	creatinine	creatinine	NOUN
ejnm-305	135	69	(	(	PUNCT
ejnm-305	135	70	r	r	NOUN
ejnm-305	135	71	=	=	SYM
ejnm-305	135	72	-0.413	-0.413	PROPN
ejnm-305	135	73	,	,	PUNCT
ejnm-305	135	74	p	p	NOUN
ejnm-305	135	75	-	-	PUNCT
ejnm-305	135	76	value	value	NOUN
ejnm-305	135	77	<	<	X
ejnm-305	135	78	0.01	0.01	NUM
ejnm-305	135	79	)	)	PUNCT
ejnm-305	135	80	.	.	PUNCT
ejnm-305	136	1	similarly	similarly	ADV
ejnm-305	136	2	,	,	PUNCT
ejnm-305	136	3	the	the	DET
ejnm-305	136	4	study	study	NOUN
ejnm-305	136	5	found	find	VERB
ejnm-305	136	6	a	a	DET
ejnm-305	136	7	strong	strong	ADJ
ejnm-305	136	8	correlation	correlation	NOUN
ejnm-305	136	9	of	of	ADP
ejnm-305	136	10	egfr	egfr	NOUN
ejnm-305	136	11	with	with	ADP
ejnm-305	136	12	cholesterol	cholesterol	NOUN
ejnm-305	136	13	(	(	PUNCT
ejnm-305	136	14	r	r	NOUN
ejnm-305	136	15	=	=	NOUN
ejnm-305	136	16	0.305	0.305	NUM
ejnm-305	136	17	,	,	PUNCT
ejnm-305	136	18	p	p	NOUN
ejnm-305	136	19	-	-	PUNCT
ejnm-305	136	20	value	value	NOUN
ejnm-305	136	21	<	<	NOUN
ejnm-305	136	22	0.05	0.05	NUM
ejnm-305	136	23	)	)	PUNCT
ejnm-305	136	24	and	and	CCONJ
ejnm-305	136	25	ldl	ldl	NOUN
ejnm-305	136	26	(	(	PUNCT
ejnm-305	136	27	r	r	NOUN
ejnm-305	136	28	=	=	NOUN
ejnm-305	136	29	0.449	0.449	NUM
ejnm-305	136	30	,	,	PUNCT
ejnm-305	136	31	p	p	NOUN
ejnm-305	136	32	-value	-value	ADJ
ejnm-305	136	33	<	<	NOUN
ejnm-305	136	34	0.001	0.001	NUM
ejnm-305	136	35	)	)	PUNCT
ejnm-305	136	36	and	and	CCONJ
ejnm-305	136	37	a	a	DET
ejnm-305	136	38	strong	strong	ADJ
ejnm-305	136	39	negative	negative	ADJ
ejnm-305	136	40	copyright	copyright	NOUN
ejnm-305	136	41	©	©	PROPN
ejnm-305	136	42	2025	2025	NUM
ejnm-305	136	43	the	the	DET
ejnm-305	136	44	author(s	author(s	NOUN
ejnm-305	136	45	)	)	PUNCT
ejnm-305	136	46	.	.	PUNCT
ejnm-305	137	1	this	this	PRON
ejnm-305	137	2	is	be	AUX
ejnm-305	137	3	an	an	DET
ejnm-305	137	4	open	open	ADJ
ejnm-305	137	5	access	access	NOUN
ejnm-305	137	6	article	article	NOUN
ejnm-305	137	7	which	which	PRON
ejnm-305	137	8	licensed	license	VERB
ejnm-305	137	9	under	under	ADP
ejnm-305	137	10	the	the	DET
ejnm-305	137	11	terms	term	NOUN
ejnm-305	137	12	and	and	CCONJ
ejnm-305	137	13	conditions	condition	NOUN
ejnm-305	137	14	of	of	ADP
ejnm-305	137	15	the	the	DET
ejnm-305	137	16	creative	creative	ADJ
ejnm-305	137	17	commons	common	NOUN
ejnm-305	137	18	attribution	attribution	NOUN
ejnm-305	137	19	-	-	PUNCT
ejnm-305	137	20	noncommercial	noncommercial	ADJ
ejnm-305	137	21	-	-	PUNCT
ejnm-305	137	22	sharealike	sharealike	ADJ
ejnm-305	137	23	4.0	4.0	NUM
ejnm-305	137	24	international	international	ADJ
ejnm-305	137	25	license	license	NOUN
ejnm-305	137	26	.	.	PUNCT
ejnm-305	138	1	it	it	PRON
ejnm-305	138	2	permits	permit	VERB
ejnm-305	138	3	no	no	DET
ejnm-305	138	4	additional	additional	ADJ
ejnm-305	138	5	restrictions	restriction	NOUN
ejnm-305	138	6	on	on	ADP
ejnm-305	138	7	use	use	NOUN
ejnm-305	138	8	,	,	PUNCT
ejnm-305	138	9	distribution	distribution	NOUN
ejnm-305	138	10	,	,	PUNCT
ejnm-305	138	11	and	and	CCONJ
ejnm-305	138	12	reproduction	reproduction	NOUN
ejnm-305	138	13	in	in	ADP
ejnm-305	138	14	any	any	DET
ejnm-305	138	15	medium	medium	NOUN
ejnm-305	138	16	provided	provide	VERB
ejnm-305	138	17	the	the	DET
ejnm-305	138	18	original	original	ADJ
ejnm-305	138	19	work	work	NOUN
ejnm-305	138	20	is	be	AUX
ejnm-305	138	21	properly	properly	ADV
ejnm-305	138	22	cited	cite	VERB
ejnm-305	138	23	.	.	PUNCT
ejnm-305	139	1	table	table	NOUN
ejnm-305	139	2	1	1	NUM
ejnm-305	139	3	:	:	PUNCT
ejnm-305	139	4	mean	mean	ADV
ejnm-305	139	5	of	of	ADP
ejnm-305	139	6	biochemical	biochemical	ADJ
ejnm-305	139	7	indicators	indicator	NOUN
ejnm-305	139	8	in	in	ADP
ejnm-305	139	9	pregnant	pregnant	ADJ
ejnm-305	139	10	and	and	CCONJ
ejnm-305	139	11	non	non	ADJ
ejnm-305	139	12	-	-	ADJ
ejnm-305	139	13	pregnant	pregnant	ADJ
ejnm-305	139	14	women	woman	NOUN
ejnm-305	139	15	variables	variable	VERB
ejnm-305	139	16	non	non	ADJ
ejnm-305	139	17	-	-	ADJ
ejnm-305	139	18	pregnant	pregnant	ADJ
ejnm-305	139	19	women	woman	NOUN
ejnm-305	139	20	meant	mean	VERB
ejnm-305	139	21	and	and	CCONJ
ejnm-305	139	22	standard	standard	ADJ
ejnm-305	139	23	deviation	deviation	NOUN
ejnm-305	139	24	(	(	PUNCT
ejnm-305	139	25	n=44	n=44	NOUN
ejnm-305	139	26	)	)	PUNCT
ejnm-305	139	27	pregnant	pregnant	ADJ
ejnm-305	139	28	women	woman	NOUN
ejnm-305	139	29	mean	mean	VERB
ejnm-305	139	30	and	and	CCONJ
ejnm-305	139	31	standard	standard	ADJ
ejnm-305	139	32	deviation	deviation	NOUN
ejnm-305	139	33	(	(	PUNCT
ejnm-305	139	34	n=	n=	ADJ
ejnm-305	139	35	49	49	NUM
ejnm-305	139	36	)	)	PUNCT
ejnm-305	139	37	p	p	X
ejnm-305	139	38	-	-	PUNCT
ejnm-305	139	39	value	value	NOUN
ejnm-305	139	40	age	age	NOUN
ejnm-305	139	41	35.54±8.7	35.54±8.7	NUM
ejnm-305	139	42	29.24±	29.24±	NUM
ejnm-305	139	43	6.2	6.2	NUM
ejnm-305	139	44	<	<	SYM
ejnm-305	139	45	0.001	0.001	NUM
ejnm-305	139	46	tsb	tsb	NOUN
ejnm-305	139	47	0.66±0.22	0.66±0.22	NOUN
ejnm-305	139	48	0.59±0.21	0.59±0.21	NOUN
ejnm-305	139	49	0.148	0.148	NUM
ejnm-305	139	50	diabetes	diabetes	NOUN
ejnm-305	139	51	108.79±30.32	108.79±30.32	NUM
ejnm-305	139	52	110.81±31.93	110.81±31.93	NUM
ejnm-305	139	53	0.756	0.756	NUM
ejnm-305	139	54	urea	urea	NOUN
ejnm-305	139	55	23.94±8.08	23.94±8.08	NUM
ejnm-305	139	56	18.34±5.90	18.34±5.90	NUM
ejnm-305	139	57	<	<	X
ejnm-305	139	58	0.001	0.001	NUM
ejnm-305	139	59	creatinine	creatinine	NOUN
ejnm-305	139	60	0.57±0.128	0.57±0.128	ADP
ejnm-305	139	61	0.50±0.139	0.50±0.139	ADJ
ejnm-305	139	62	0.011	0.011	NUM
ejnm-305	139	63	cholesterol	cholesterol	NOUN
ejnm-305	139	64	162.29±34.81	162.29±34.81	PROPN
ejnm-305	139	65	182.53±36.94	182.53±36.94	PROPN
ejnm-305	139	66	0.008	0.008	NUM
ejnm-305	139	67	tg	tg	PROPN
ejnm-305	139	68	171.13±69.76	171.13±69.76	NUM
ejnm-305	139	69	194.46±45.32	194.46±45.32	NUM
ejnm-305	139	70	0.057	0.057	NUM
ejnm-305	139	71	hdl	hdl	PROPN
ejnm-305	139	72	49.25±8.97	49.25±8.97	PROPN
ejnm-305	139	73	54.28±11.67	54.28±11.67	PROPN
ejnm-305	139	74	0.023	0.023	NUM
ejnm-305	139	75	ldl	ldl	NOUN
ejnm-305	139	76	96.45±26.25	96.45±26.25	NOUN
ejnm-305	139	77	102.14±30.93	102.14±30.93	NUM
ejnm-305	139	78	0.344	0.344	NUM
ejnm-305	139	79	egfr	egfr	NOUN
ejnm-305	139	80	127.48±32.33	127.48±32.33	NUM
ejnm-305	139	81	158.34±44.40	158.34±44.40	NUM
ejnm-305	139	82	<	<	X
ejnm-305	139	83	0.001	0.001	NUM
ejnm-305	139	84	table	table	NOUN
ejnm-305	139	85	2	2	NUM
ejnm-305	139	86	:	:	PUNCT
ejnm-305	139	87	correlation	correlation	NOUN
ejnm-305	139	88	of	of	ADP
ejnm-305	139	89	biochemical	biochemical	ADJ
ejnm-305	139	90	indicators	indicator	NOUN
ejnm-305	139	91	and	and	CCONJ
ejnm-305	139	92	gestational	gestational	ADJ
ejnm-305	139	93	age	age	NOUN
ejnm-305	139	94	in	in	ADP
ejnm-305	139	95	pregnant	pregnant	ADJ
ejnm-305	139	96	women	woman	NOUN
ejnm-305	139	97	control	control	VERB
ejnm-305	139	98	variables	variable	NOUN
ejnm-305	139	99	age	age	NOUN
ejnm-305	139	100	&	&	CCONJ
ejnm-305	139	101	para	para	PROPN
ejnm-305	139	102	age	age	NOUN
ejnm-305	139	103	of	of	ADP
ejnm-305	139	104	pregnancy	pregnancy	NOUN
ejnm-305	139	105	in	in	ADP
ejnm-305	139	106	weeks	week	NOUN
ejnm-305	139	107	tsb	tsb	ADJ
ejnm-305	139	108	diabetes	diabetes	NOUN
ejnm-305	139	109	urea	urea	NOUN
ejnm-305	139	110	creatinine	creatinine	NOUN
ejnm-305	139	111	cholesterol	cholesterol	NOUN
ejnm-305	139	112	tg	tg	PROPN
ejnm-305	139	113	hdl	hdl	PROPN
ejnm-305	139	114	ldl	ldl	PROPN
ejnm-305	139	115	tsb	tsb	VERB
ejnm-305	139	116	-0.045	-0.045	PUNCT
ejnm-305	139	117	p	p	NOUN
ejnm-305	139	118	-	-	PUNCT
ejnm-305	139	119	value	value	NOUN
ejnm-305	139	120	0.762	0.762	NUM
ejnm-305	139	121	diabetes	diabetes	NOUN
ejnm-305	140	1	0.237	0.237	NUM
ejnm-305	140	2	0.180	0.180	NUM
ejnm-305	140	3	p	p	ADJ
ejnm-305	140	4	-	-	PUNCT
ejnm-305	140	5	value	value	NOUN
ejnm-305	140	6	0.105	0.105	NUM
ejnm-305	140	7	0.221	0.221	NUM
ejnm-305	140	8	urea	urea	NOUN
ejnm-305	140	9	-0.043	-0.043	NOUN
ejnm-305	140	10	-0.031	-0.031	NOUN
ejnm-305	140	11	-0.084	-0.084	PUNCT
ejnm-305	140	12	p	p	X
ejnm-305	140	13	-	-	PUNCT
ejnm-305	140	14	value	value	NOUN
ejnm-305	140	15	0.771	0.771	NUM
ejnm-305	140	16	0.836	0.836	NUM
ejnm-305	140	17	0.569	0.569	NUM
ejnm-305	140	18	creatinine	creatinine	NOUN
ejnm-305	140	19	-0.242	-0.242	PUNCT
ejnm-305	140	20	0.475	0.475	NUM
ejnm-305	140	21	-0.155	-0.155	SYM
ejnm-305	140	22	0.196	0.196	NUM
ejnm-305	140	23	p	p	NOUN
ejnm-305	140	24	-	-	PUNCT
ejnm-305	140	25	value	value	NOUN
ejnm-305	140	26	0.097	0.097	NUM
ejnm-305	140	27	0.001	0.001	NUM
ejnm-305	140	28	0.293	0.293	NUM
ejnm-305	140	29	0.182	0.182	NUM
ejnm-305	140	30	total	total	ADJ
ejnm-305	140	31	cholesterol	cholesterol	NOUN
ejnm-305	140	32	0.279	0.279	NUM
ejnm-305	140	33	-0.254	-0.254	NUM
ejnm-305	140	34	0.217	0.217	NUM
ejnm-305	140	35	-0.040	-0.040	NUM
ejnm-305	140	36	-0.265	-0.265	PUNCT
ejnm-305	140	37	.	.	PUNCT
ejnm-305	141	1	p	p	X
ejnm-305	141	2	-	-	PUNCT
ejnm-305	141	3	value	value	NOUN
ejnm-305	141	4	0.055	0.055	NUM
ejnm-305	141	5	0.081	0.081	NUM
ejnm-305	141	6	0.138	0.138	NUM
ejnm-305	141	7	0.789	0.789	NUM
ejnm-305	141	8	0.069	0.069	NUM
ejnm-305	141	9	.	.	PUNCT
ejnm-305	142	1	tg	tg	PRON
ejnm-305	142	2	0.173	0.173	NUM
ejnm-305	142	3	-0.052	-0.052	NUM
ejnm-305	142	4	0.284	0.284	NUM
ejnm-305	142	5	-0.235	-0.235	PUNCT
ejnm-305	142	6	-0.020	-0.020	VERB
ejnm-305	142	7	0.399	0.399	NUM
ejnm-305	142	8	p	p	ADJ
ejnm-305	142	9	-	-	PUNCT
ejnm-305	142	10	value	value	NOUN
ejnm-305	142	11	0.239	0.239	NUM
ejnm-305	142	12	0.728	0.728	NUM
ejnm-305	142	13	0.050	0.050	NUM
ejnm-305	142	14	0.107	0.107	NUM
ejnm-305	142	15	0.894	0.894	NUM
ejnm-305	142	16	0.005	0.005	NUM
ejnm-305	142	17	.	.	PUNCT
ejnm-305	143	1	hdl	hdl	PROPN
ejnm-305	143	2	0.239	0.239	NUM
ejnm-305	143	3	-0.250	-0.250	NUM
ejnm-305	143	4	-0.095	-0.095	NUM
ejnm-305	143	5	0.186	0.186	NUM
ejnm-305	143	6	-0.186	-0.186	NUM
ejnm-305	143	7	0.385	0.385	NUM
ejnm-305	143	8	-0.072	-0.072	NOUN
ejnm-305	143	9	.	.	PUNCT
ejnm-305	144	1	p	p	X
ejnm-305	144	2	-	-	PUNCT
ejnm-305	144	3	value	value	NOUN
ejnm-305	144	4	0.102	0.102	NUM
ejnm-305	144	5	0.086	0.086	NUM
ejnm-305	144	6	0.523	0.523	NUM
ejnm-305	144	7	0.206	0.206	NUM
ejnm-305	144	8	0.206	0.206	NUM
ejnm-305	144	9	0.007	0.007	NUM
ejnm-305	144	10	0.626	0.626	NUM
ejnm-305	144	11	.	.	PUNCT
ejnm-305	145	1	ldl	ldl	VERB
ejnm-305	145	2	0.354	0.354	NUM
ejnm-305	145	3	-0.431	-0.431	NUM
ejnm-305	145	4	0.123	0.123	NUM
ejnm-305	145	5	-0.251	-0.251	NUM
ejnm-305	146	1	-0.413	-0.413	ADP
ejnm-305	146	2	0.802	0.802	NUM
ejnm-305	146	3	0.315	0.315	NUM
ejnm-305	146	4	0.454	0.454	NUM
ejnm-305	146	5	p	p	ADJ
ejnm-305	146	6	-	-	PUNCT
ejnm-305	146	7	value	value	NOUN
ejnm-305	146	8	0.014	0.014	NUM
ejnm-305	146	9	0.002	0.002	NUM
ejnm-305	146	10	0.406	0.406	NUM
ejnm-305	146	11	0.085	0.085	NUM
ejnm-305	146	12	0.004	0.004	NUM
ejnm-305	146	13	0.000	0.000	NUM
ejnm-305	146	14	0.029	0.029	NUM
ejnm-305	146	15	0.001	0.001	NUM
ejnm-305	146	16	.	.	PUNCT
ejnm-305	147	1	egfr	egfr	PROPN
ejnm-305	147	2	0.216	0.216	NUM
ejnm-305	147	3	-0.405	-0.405	SYM
ejnm-305	147	4	0.138	0.138	NUM
ejnm-305	147	5	-0.257	-0.257	NOUN
ejnm-305	147	6	-0.967	-0.967	ADJ
ejnm-305	147	7	0.305	0.305	NUM
ejnm-305	147	8	0.003	0.003	NUM
ejnm-305	147	9	0.166	0.166	NUM
ejnm-305	147	10	0.449	0.449	NUM
ejnm-305	147	11	p	p	NOUN
ejnm-305	147	12	-	-	PUNCT
ejnm-305	147	13	value	value	NOUN
ejnm-305	147	14	0.140	0.140	NUM
ejnm-305	147	15	0.004	0.004	NUM
ejnm-305	147	16	0.350	0.350	NUM
ejnm-305	147	17	0.078	0.078	NUM
ejnm-305	147	18	<	<	X
ejnm-305	147	19	0.001	0.001	NUM
ejnm-305	147	20	0.035	0.035	NUM
ejnm-305	147	21	0.981	0.981	NUM
ejnm-305	147	22	0.261	0.261	NUM
ejnm-305	147	23	<	<	SYM
ejnm-305	147	24	0.001	0.001	NUM
ejnm-305	147	25	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PRON
ejnm-305	147	26	https://doi.org/10.15218/ejnm.2025.03	https://doi.org/10.15218/ejnm.2025.03	PROPN
ejnm-305	147	27	erbil	erbil	PROPN
ejnm-305	147	28	j.	j.	PROPN
ejnm-305	147	29	nurs	nurs	PROPN
ejnm-305	147	30	.	.	PUNCT
ejnm-305	148	1	midwifery	midwifery	ADJ
ejnm-305	148	2	,	,	PUNCT
ejnm-305	148	3	vol	vol	NOUN
ejnm-305	148	4	.	.	PROPN
ejnm-305	148	5	8	8	NUM
ejnm-305	148	6	,	,	PUNCT
ejnm-305	148	7	no	no	INTJ
ejnm-305	148	8	.	.	PUNCT
ejnm-305	149	1	(	(	PUNCT
ejnm-305	149	2	1	1	NUM
ejnm-305	149	3	)	)	PUNCT
ejnm-305	149	4	,	,	PUNCT
ejnm-305	149	5	may	may	AUX
ejnm-305	149	6	2025	2025	NUM
ejnm-305	149	7	original	original	ADJ
ejnm-305	149	8	article	article	NOUN
ejnm-305	149	9	serum	serum	NOUN
ejnm-305	149	10	creatinine	creatinine	PROPN
ejnm-305	149	11	also	also	ADV
ejnm-305	149	12	has	have	VERB
ejnm-305	149	13	a	a	DET
ejnm-305	149	14	significant	significant	ADJ
ejnm-305	149	15	positive	positive	ADJ
ejnm-305	149	16	correlation	correlation	NOUN
ejnm-305	149	17	with	with	ADP
ejnm-305	149	18	urea	urea	NOUN
ejnm-305	149	19	level	level	NOUN
ejnm-305	149	20	(	(	PUNCT
ejnm-305	149	21	r	r	NOUN
ejnm-305	149	22	=	=	SYM
ejnm-305	149	23	0.300	0.300	NUM
ejnm-305	149	24	,	,	PUNCT
ejnm-305	149	25	p	p	NOUN
ejnm-305	149	26	-	-	PUNCT
ejnm-305	149	27	value	value	NOUN
ejnm-305	149	28	<	<	NOUN
ejnm-305	149	29	0.05	0.05	NUM
ejnm-305	149	30	)	)	PUNCT
ejnm-305	149	31	and	and	CCONJ
ejnm-305	149	32	a	a	DET
ejnm-305	149	33	negative	negative	ADJ
ejnm-305	149	34	correlation	correlation	NOUN
ejnm-305	149	35	with	with	ADP
ejnm-305	149	36	random	random	ADJ
ejnm-305	149	37	blood	blood	NOUN
ejnm-305	149	38	sugar	sugar	NOUN
ejnm-305	149	39	(	(	PUNCT
ejnm-305	149	40	r	r	NOUN
ejnm-305	149	41	=	=	SYM
ejnm-305	149	42	-0.394	-0.394	NOUN
ejnm-305	149	43	,	,	PUNCT
ejnm-305	149	44	pvalue	pvalue	VERB
ejnm-305	149	45	<	<	NOUN
ejnm-305	149	46	0.001	0.001	NUM
ejnm-305	149	47	)	)	PUNCT
ejnm-305	149	48	.	.	PUNCT
ejnm-305	150	1	cholesterol	cholesterol	NOUN
ejnm-305	150	2	also	also	ADV
ejnm-305	150	3	has	have	VERB
ejnm-305	150	4	a	a	DET
ejnm-305	150	5	significant	significant	ADJ
ejnm-305	150	6	moderate	moderate	ADJ
ejnm-305	150	7	correlation	correlation	NOUN
ejnm-305	150	8	with	with	ADP
ejnm-305	150	9	tg	tg	PROPN
ejnm-305	150	10	(	(	PUNCT
ejnm-305	150	11	r	r	NOUN
ejnm-305	150	12	=	=	SYM
ejnm-305	150	13	0.364	0.364	NUM
ejnm-305	150	14	,	,	PUNCT
ejnm-305	150	15	p	p	NOUN
ejnm-305	150	16	-	-	PUNCT
ejnm-305	150	17	value	value	NOUN
ejnm-305	150	18	<	<	X
ejnm-305	150	19	0.01	0.01	NUM
ejnm-305	150	20	)	)	PUNCT
ejnm-305	150	21	.	.	PUNCT
ejnm-305	151	1	creatinine	creatinine	NOUN
ejnm-305	151	2	,	,	PUNCT
ejnm-305	151	3	age	age	NOUN
ejnm-305	151	4	,	,	PUNCT
ejnm-305	151	5	hdl	hdl	PROPN
ejnm-305	151	6	,	,	PUNCT
ejnm-305	151	7	and	and	CCONJ
ejnm-305	151	8	egfr	egfr	X
ejnm-305	151	9	.	.	PUNCT
ejnm-305	152	1	the	the	DET
ejnm-305	152	2	regression	regression	NOUN
ejnm-305	152	3	model	model	NOUN
ejnm-305	152	4	has	have	AUX
ejnm-305	152	5	shown	show	VERB
ejnm-305	152	6	a	a	DET
ejnm-305	152	7	significant	significant	ADJ
ejnm-305	152	8	coefficient	coefficient	NOUN
ejnm-305	152	9	of	of	ADP
ejnm-305	152	10	ldl	ldl	NOUN
ejnm-305	152	11	and	and	CCONJ
ejnm-305	152	12	urea	urea	NOUN
ejnm-305	152	13	with	with	ADP
ejnm-305	152	14	cholesterol	cholesterol	NOUN
ejnm-305	152	15	.	.	PUNCT
ejnm-305	153	1	the	the	DET
ejnm-305	153	2	model	model	NOUN
ejnm-305	153	3	shows	show	VERB
ejnm-305	153	4	that	that	SCONJ
ejnm-305	153	5	urea	urea	NOUN
ejnm-305	153	6	and	and	CCONJ
ejnm-305	153	7	ldl	ldl	NOUN
ejnm-305	153	8	indicate	indicate	VERB
ejnm-305	153	9	1.398	1.398	NUM
ejnm-305	153	10	%	%	NOUN
ejnm-305	153	11	and	and	CCONJ
ejnm-305	153	12	0.913	0.913	NUM
ejnm-305	153	13	%	%	NOUN
ejnm-305	153	14	variances	variance	NOUN
ejnm-305	153	15	in	in	ADP
ejnm-305	153	16	cholesterol	cholesterol	NOUN
ejnm-305	153	17	levels	level	NOUN
ejnm-305	153	18	,	,	PUNCT
ejnm-305	153	19	respectively	respectively	ADV
ejnm-305	153	20	.	.	PUNCT
ejnm-305	154	1	25	25	NUM
ejnm-305	154	2	table	table	NOUN
ejnm-305	154	3	3	3	NUM
ejnm-305	154	4	shows	show	VERB
ejnm-305	154	5	the	the	DET
ejnm-305	154	6	correlation	correlation	NOUN
ejnm-305	154	7	coefficient	coefficient	NOUN
ejnm-305	154	8	among	among	ADP
ejnm-305	154	9	biochemical	biochemical	ADJ
ejnm-305	154	10	indicators	indicator	NOUN
ejnm-305	154	11	and	and	CCONJ
ejnm-305	154	12	gestational	gestational	ADJ
ejnm-305	154	13	age	age	NOUN
ejnm-305	154	14	of	of	ADP
ejnm-305	154	15	pregnancy	pregnancy	NOUN
ejnm-305	154	16	.	.	PUNCT
ejnm-305	155	1	the	the	DET
ejnm-305	155	2	study	study	NOUN
ejnm-305	155	3	has	have	AUX
ejnm-305	155	4	shown	show	VERB
ejnm-305	155	5	a	a	DET
ejnm-305	155	6	moderate	moderate	ADJ
ejnm-305	155	7	positive	positive	ADJ
ejnm-305	155	8	correlation	correlation	NOUN
ejnm-305	155	9	of	of	ADP
ejnm-305	155	10	egfr	egfr	NOUN
ejnm-305	155	11	with	with	ADP
ejnm-305	155	12	random	random	ADJ
ejnm-305	155	13	blood	blood	NOUN
ejnm-305	155	14	sugar	sugar	NOUN
ejnm-305	155	15	(	(	PUNCT
ejnm-305	155	16	r	r	NOUN
ejnm-305	155	17	=	=	SYM
ejnm-305	155	18	0.434	0.434	NUM
ejnm-305	155	19	,	,	PUNCT
ejnm-305	155	20	p	p	NOUN
ejnm-305	155	21	-	-	PUNCT
ejnm-305	155	22	value	value	NOUN
ejnm-305	155	23	<	<	NOUN
ejnm-305	155	24	0.001	0.001	NUM
ejnm-305	155	25	)	)	PUNCT
ejnm-305	155	26	and	and	CCONJ
ejnm-305	155	27	a	a	DET
ejnm-305	155	28	negative	negative	ADJ
ejnm-305	155	29	strong	strong	ADJ
ejnm-305	155	30	to	to	ADP
ejnm-305	155	31	moderate	moderate	ADJ
ejnm-305	155	32	correlation	correlation	NOUN
ejnm-305	155	33	with	with	ADP
ejnm-305	155	34	urea	urea	NOUN
ejnm-305	155	35	(	(	PUNCT
ejnm-305	155	36	r	r	NOUN
ejnm-305	155	37	=	=	NOUN
ejnm-305	155	38	0.365	0.365	NUM
ejnm-305	155	39	,	,	PUNCT
ejnm-305	155	40	p	p	NOUN
ejnm-305	155	41	-	-	PUNCT
ejnm-305	155	42	value	value	NOUN
ejnm-305	155	43	<	<	X
ejnm-305	155	44	0.01	0.01	NUM
ejnm-305	155	45	)	)	PUNCT
ejnm-305	155	46	and	and	CCONJ
ejnm-305	155	47	creatinine	creatinine	NOUN
ejnm-305	155	48	(	(	PUNCT
ejnm-305	155	49	r	r	NOUN
ejnm-305	155	50	=	=	SYM
ejnm-305	155	51	0.916	0.916	NUM
ejnm-305	155	52	,	,	PUNCT
ejnm-305	155	53	p	p	NOUN
ejnm-305	155	54	-	-	PUNCT
ejnm-305	155	55	value	value	NOUN
ejnm-305	155	56	<	<	NOUN
ejnm-305	155	57	0.001	0.001	NUM
ejnm-305	155	58	)	)	PUNCT
ejnm-305	155	59	.	.	PUNCT
ejnm-305	156	1	table	table	NOUN
ejnm-305	156	2	4	4	NUM
ejnm-305	156	3	demonstrate	demonstrate	VERB
ejnm-305	156	4	a	a	DET
ejnm-305	156	5	linear	linear	ADJ
ejnm-305	156	6	regression	regression	NOUN
ejnm-305	156	7	model	model	NOUN
ejnm-305	156	8	of	of	ADP
ejnm-305	156	9	multiple	multiple	ADJ
ejnm-305	156	10	variables	variable	NOUN
ejnm-305	156	11	with	with	ADP
ejnm-305	156	12	the	the	DET
ejnm-305	156	13	cholesterol	cholesterol	NOUN
ejnm-305	156	14	level	level	NOUN
ejnm-305	156	15	in	in	ADP
ejnm-305	156	16	pregnant	pregnant	ADJ
ejnm-305	156	17	women	woman	NOUN
ejnm-305	156	18	.	.	PUNCT
ejnm-305	157	1	the	the	DET
ejnm-305	157	2	linear	linear	PROPN
ejnm-305	157	3	regression	regression	NOUN
ejnm-305	157	4	model	model	NOUN
ejnm-305	157	5	has	have	AUX
ejnm-305	157	6	explored	explore	VERB
ejnm-305	157	7	a	a	DET
ejnm-305	157	8	70	70	NUM
ejnm-305	157	9	%	%	NOUN
ejnm-305	157	10	variance	variance	NOUN
ejnm-305	157	11	in	in	ADP
ejnm-305	157	12	cholesterol	cholesterol	NOUN
ejnm-305	157	13	level	level	NOUN
ejnm-305	157	14	,	,	PUNCT
ejnm-305	157	15	significantly	significantly	ADV
ejnm-305	157	16	explained	explain	VERB
ejnm-305	157	17	by	by	ADP
ejnm-305	157	18	para	para	PROPN
ejnm-305	157	19	,	,	PUNCT
ejnm-305	157	20	ldl	ldl	NOUN
ejnm-305	157	21	,	,	PUNCT
ejnm-305	157	22	diabetes	diabetes	NOUN
ejnm-305	157	23	,	,	PUNCT
ejnm-305	157	24	bmi	bmi	PROPN
ejnm-305	157	25	,	,	PUNCT
ejnm-305	157	26	urea	urea	NOUN
ejnm-305	157	27	,	,	PUNCT
ejnm-305	157	28	and	and	CCONJ
ejnm-305	157	29	age	age	NOUN
ejnm-305	157	30	of	of	ADP
ejnm-305	157	31	pregnancy	pregnancy	NOUN
ejnm-305	157	32	in	in	ADP
ejnm-305	157	33	weeks	week	NOUN
ejnm-305	157	34	,	,	PUNCT
ejnm-305	157	35	tg	tg	PRON
ejnm-305	157	36	,	,	PUNCT
ejnm-305	157	37	copyright	copyright	NOUN
ejnm-305	157	38	©	©	PROPN
ejnm-305	157	39	2025	2025	NUM
ejnm-305	157	40	the	the	DET
ejnm-305	157	41	author(s	author(s	NOUN
ejnm-305	157	42	)	)	PUNCT
ejnm-305	157	43	.	.	PUNCT
ejnm-305	158	1	this	this	PRON
ejnm-305	158	2	is	be	AUX
ejnm-305	158	3	an	an	DET
ejnm-305	158	4	open	open	ADJ
ejnm-305	158	5	access	access	NOUN
ejnm-305	158	6	article	article	NOUN
ejnm-305	158	7	which	which	PRON
ejnm-305	158	8	licensed	license	VERB
ejnm-305	158	9	under	under	ADP
ejnm-305	158	10	the	the	DET
ejnm-305	158	11	terms	term	NOUN
ejnm-305	158	12	and	and	CCONJ
ejnm-305	158	13	conditions	condition	NOUN
ejnm-305	158	14	of	of	ADP
ejnm-305	158	15	the	the	DET
ejnm-305	158	16	creative	creative	ADJ
ejnm-305	158	17	commons	common	NOUN
ejnm-305	158	18	attribution	attribution	NOUN
ejnm-305	158	19	-	-	PUNCT
ejnm-305	158	20	noncommercial	noncommercial	ADJ
ejnm-305	158	21	-	-	PUNCT
ejnm-305	158	22	sharealike	sharealike	ADJ
ejnm-305	158	23	4.0	4.0	NUM
ejnm-305	158	24	international	international	ADJ
ejnm-305	158	25	license	license	NOUN
ejnm-305	158	26	.	.	PUNCT
ejnm-305	159	1	it	it	PRON
ejnm-305	159	2	permits	permit	VERB
ejnm-305	159	3	no	no	DET
ejnm-305	159	4	additional	additional	ADJ
ejnm-305	159	5	restrictions	restriction	NOUN
ejnm-305	159	6	on	on	ADP
ejnm-305	159	7	use	use	NOUN
ejnm-305	159	8	,	,	PUNCT
ejnm-305	159	9	distribution	distribution	NOUN
ejnm-305	159	10	,	,	PUNCT
ejnm-305	159	11	and	and	CCONJ
ejnm-305	159	12	reproduction	reproduction	NOUN
ejnm-305	159	13	in	in	ADP
ejnm-305	159	14	any	any	DET
ejnm-305	159	15	medium	medium	NOUN
ejnm-305	159	16	provided	provide	VERB
ejnm-305	159	17	the	the	DET
ejnm-305	159	18	original	original	ADJ
ejnm-305	159	19	work	work	NOUN
ejnm-305	159	20	is	be	AUX
ejnm-305	159	21	properly	properly	ADV
ejnm-305	159	22	cited	cite	VERB
ejnm-305	159	23	.	.	PUNCT
ejnm-305	160	1	table	table	NOUN
ejnm-305	160	2	3	3	NUM
ejnm-305	160	3	:	:	PUNCT
ejnm-305	160	4	correlation	correlation	NOUN
ejnm-305	160	5	of	of	ADP
ejnm-305	160	6	biochemical	biochemical	ADJ
ejnm-305	160	7	indicators	indicator	NOUN
ejnm-305	160	8	and	and	CCONJ
ejnm-305	160	9	gestational	gestational	ADJ
ejnm-305	160	10	age	age	NOUN
ejnm-305	160	11	in	in	ADP
ejnm-305	160	12	non	non	ADJ
ejnm-305	160	13	-	-	ADJ
ejnm-305	160	14	pregnant	pregnant	ADJ
ejnm-305	160	15	women	woman	NOUN
ejnm-305	160	16	.	.	PUNCT
ejnm-305	161	1	control	control	NOUN
ejnm-305	161	2	for	for	ADP
ejnm-305	161	3	age	age	NOUN
ejnm-305	161	4	.	.	PUNCT
ejnm-305	162	1	non	non	ADJ
ejnm-305	162	2	-	-	ADJ
ejnm-305	162	3	pregnancy	pregnancy	ADJ
ejnm-305	162	4	women	woman	NOUN
ejnm-305	162	5	diabetes	diabetes	VERB
ejnm-305	162	6	urea	urea	NOUN
ejnm-305	162	7	creatinine	creatinine	NOUN
ejnm-305	162	8	cholesterol	cholesterol	NOUN
ejnm-305	162	9	tg	tg	PROPN
ejnm-305	162	10	hdl	hdl	PROPN
ejnm-305	162	11	ldl	ldl	PROPN
ejnm-305	162	12	egfr	egfr	ADV
ejnm-305	162	13	tsb	tsb	VERB
ejnm-305	162	14	0.073	0.073	NUM
ejnm-305	162	15	0.066	0.066	NUM
ejnm-305	162	16	-0.115	-0.115	PUNCT
ejnm-305	162	17	-0.083	-0.083	PUNCT
ejnm-305	162	18	-0.001	-0.001	NOUN
ejnm-305	162	19	-0.183	-0.183	PUNCT
ejnm-305	162	20	-0.077	-0.077	PROPN
ejnm-305	162	21	0.177	0.177	NUM
ejnm-305	162	22	p	p	NOUN
ejnm-305	162	23	-	-	PUNCT
ejnm-305	162	24	value	value	NOUN
ejnm-305	162	25	0.570	0.570	NUM
ejnm-305	162	26	0.609	0.609	NUM
ejnm-305	162	27	0.370	0.370	NUM
ejnm-305	162	28	0.518	0.518	NUM
ejnm-305	162	29	0.994	0.994	NUM
ejnm-305	162	30	0.151	0.151	NUM
ejnm-305	162	31	0.551	0.551	NUM
ejnm-305	162	32	0.165	0.165	NUM
ejnm-305	162	33	diabetes	diabetes	NOUN
ejnm-305	162	34	-0.145	-0.145	NOUN
ejnm-305	162	35	-0.394	-0.394	NOUN
ejnm-305	162	36	-0.105	-0.105	NOUN
ejnm-305	162	37	0.022	0.022	NUM
ejnm-305	162	38	-0.132	-0.132	NUM
ejnm-305	162	39	-0.034	-0.034	NOUN
ejnm-305	162	40	0.434	0.434	NUM
ejnm-305	162	41	p	p	NOUN
ejnm-305	162	42	-	-	PUNCT
ejnm-305	162	43	value	value	NOUN
ejnm-305	162	44	0.256	0.256	NUM
ejnm-305	162	45	0.001	0.001	NUM
ejnm-305	162	46	0.414	0.414	NUM
ejnm-305	162	47	0.862	0.862	NUM
ejnm-305	162	48	0.304	0.304	NUM
ejnm-305	162	49	0.792	0.792	NUM
ejnm-305	162	50	0.000	0.000	NUM
ejnm-305	162	51	urea	urea	NOUN
ejnm-305	162	52	0.300	0.300	NUM
ejnm-305	162	53	0.069	0.069	NUM
ejnm-305	162	54	-0.086	-0.086	NUM
ejnm-305	162	55	-0.050	-0.050	PROPN
ejnm-305	162	56	0.107	0.107	NUM
ejnm-305	162	57	-0.365	-0.365	PUNCT
ejnm-305	162	58	p	p	NOUN
ejnm-305	162	59	-	-	PUNCT
ejnm-305	162	60	value	value	NOUN
ejnm-305	162	61	0.017	0.017	NUM
ejnm-305	162	62	0.592	0.592	NUM
ejnm-305	162	63	0.503	0.503	NUM
ejnm-305	162	64	0.695	0.695	NUM
ejnm-305	162	65	0.402	0.402	NUM
ejnm-305	162	66	0.003	0.003	NUM
ejnm-305	162	67	creatinine	creatinine	NOUN
ejnm-305	162	68	-0.076	-0.076	NOUN
ejnm-305	162	69	-0.065	-0.065	NUM
ejnm-305	162	70	-0.121	-0.121	X
ejnm-305	162	71	-0.167	-0.167	NOUN
ejnm-305	162	72	-0.916	-0.916	PRON
ejnm-305	162	73	p	p	NOUN
ejnm-305	162	74	-	-	PUNCT
ejnm-305	162	75	value	value	NOUN
ejnm-305	162	76	0.554	0.554	NUM
ejnm-305	162	77	0.610	0.610	NUM
ejnm-305	162	78	0.345	0.345	NUM
ejnm-305	162	79	0.190	0.190	NUM
ejnm-305	162	80	0.000	0.000	NUM
ejnm-305	162	81	cholesterol	cholesterol	NOUN
ejnm-305	162	82	0.364	0.364	NUM
ejnm-305	162	83	0.180	0.180	NUM
ejnm-305	162	84	0.715	0.715	NUM
ejnm-305	162	85	0.062	0.062	NUM
ejnm-305	162	86	p	p	NOUN
ejnm-305	162	87	-	-	PUNCT
ejnm-305	162	88	value	value	NOUN
ejnm-305	162	89	0.003	0.003	NUM
ejnm-305	162	90	0.158	0.158	NUM
ejnm-305	162	91	0.000	0.000	NUM
ejnm-305	162	92	0.627	0.627	NUM
ejnm-305	162	93	tg	tg	INTJ
ejnm-305	162	94	-0.251	-0.251	NUM
ejnm-305	162	95	0.126	0.126	NUM
ejnm-305	162	96	0.008	0.008	NUM
ejnm-305	162	97	p	p	ADJ
ejnm-305	162	98	-	-	PUNCT
ejnm-305	162	99	value	value	NOUN
ejnm-305	162	100	0.047	0.047	NUM
ejnm-305	162	101	0.324	0.324	NUM
ejnm-305	162	102	0.952	0.952	NUM
ejnm-305	162	103	hdl	hdl	PROPN
ejnm-305	162	104	0.053	0.053	NUM
ejnm-305	162	105	0.118	0.118	NUM
ejnm-305	163	1	p	p	NOUN
ejnm-305	163	2	-	-	PUNCT
ejnm-305	163	3	value	value	NOUN
ejnm-305	163	4	0.679	0.679	NUM
ejnm-305	163	5	0.355	0.355	NUM
ejnm-305	163	6	ldl	ldl	VERB
ejnm-305	163	7	0.132	0.132	NUM
ejnm-305	163	8	p	p	NOUN
ejnm-305	163	9	-	-	PUNCT
ejnm-305	163	10	value	value	NOUN
ejnm-305	163	11	0.302	0.302	NUM
ejnm-305	163	12	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-305	163	13	https://doi.org/10.15218/ejnm.2025.03	https://doi.org/10.15218/ejnm.2025.03	PROPN
ejnm-305	163	14	erbil	erbil	PROPN
ejnm-305	163	15	j.	j.	PROPN
ejnm-305	163	16	nurs	nurs	PROPN
ejnm-305	163	17	.	.	PUNCT
ejnm-305	164	1	midwifery	midwifery	ADJ
ejnm-305	164	2	,	,	PUNCT
ejnm-305	164	3	vol	vol	NOUN
ejnm-305	164	4	.	.	PROPN
ejnm-305	164	5	8	8	NUM
ejnm-305	164	6	,	,	PUNCT
ejnm-305	164	7	no	no	INTJ
ejnm-305	164	8	.	.	PUNCT
ejnm-305	165	1	(	(	PUNCT
ejnm-305	165	2	1	1	NUM
ejnm-305	165	3	)	)	PUNCT
ejnm-305	165	4	,	,	PUNCT
ejnm-305	165	5	may	may	AUX
ejnm-305	165	6	2025	2025	NUM
ejnm-305	165	7	original	original	ADJ
ejnm-305	165	8	article	article	NOUN
ejnm-305	165	9	correlation	correlation	NOUN
ejnm-305	165	10	with	with	ADP
ejnm-305	165	11	protein	protein	NOUN
ejnm-305	165	12	excretion	excretion	NOUN
ejnm-305	165	13	products	product	NOUN
ejnm-305	165	14	such	such	ADJ
ejnm-305	165	15	as	as	ADP
ejnm-305	165	16	tsb	tsb	NOUN
ejnm-305	165	17	and	and	CCONJ
ejnm-305	165	18	creatinine	creatinine	NOUN
ejnm-305	165	19	.	.	PUNCT
ejnm-305	166	1	gestational	gestational	ADJ
ejnm-305	166	2	age	age	NOUN
ejnm-305	166	3	has	have	AUX
ejnm-305	166	4	more	more	ADV
ejnm-305	166	5	indicated	indicate	VERB
ejnm-305	166	6	the	the	DET
ejnm-305	166	7	lipid	lipid	NOUN
ejnm-305	166	8	profile	profile	NOUN
ejnm-305	166	9	.	.	PUNCT
ejnm-305	167	1	this	this	DET
ejnm-305	167	2	finding	finding	NOUN
ejnm-305	167	3	has	have	AUX
ejnm-305	167	4	been	be	AUX
ejnm-305	167	5	proven	prove	VERB
ejnm-305	167	6	by	by	ADP
ejnm-305	167	7	many	many	ADJ
ejnm-305	167	8	other	other	ADJ
ejnm-305	167	9	studies	study	NOUN
ejnm-305	167	10	.	.	PUNCT
ejnm-305	168	1	tc	tc	X
ejnm-305	168	2	,	,	PUNCT
ejnm-305	168	3	tg	tg	PROPN
ejnm-305	168	4	,	,	PUNCT
ejnm-305	168	5	and	and	CCONJ
ejnm-305	168	6	ldl	ldl	NOUN
ejnm-305	168	7	have	have	AUX
ejnm-305	168	8	been	be	AUX
ejnm-305	168	9	increasing	increase	VERB
ejnm-305	168	10	with	with	ADP
ejnm-305	168	11	gestational	gestational	ADJ
ejnm-305	168	12	age	age	NOUN
ejnm-305	169	1	[	[	X
ejnm-305	169	2	16	16	NUM
ejnm-305	169	3	,	,	PUNCT
ejnm-305	169	4	17	17	NUM
ejnm-305	169	5	]	]	PUNCT
ejnm-305	169	6	.	.	PUNCT
ejnm-305	170	1	a	a	DET
ejnm-305	170	2	study	study	NOUN
ejnm-305	170	3	has	have	AUX
ejnm-305	170	4	confirmed	confirm	VERB
ejnm-305	170	5	that	that	SCONJ
ejnm-305	170	6	there	there	PRON
ejnm-305	170	7	is	be	VERB
ejnm-305	170	8	an	an	DET
ejnm-305	170	9	association	association	NOUN
ejnm-305	170	10	between	between	ADP
ejnm-305	170	11	lipid	lipid	NOUN
ejnm-305	170	12	profile	profile	NOUN
ejnm-305	170	13	and	and	CCONJ
ejnm-305	170	14	uric	uric	ADJ
ejnm-305	170	15	acid	acid	NOUN
ejnm-305	170	16	in	in	ADP
ejnm-305	170	17	preeclampsia	preeclampsia	NOUN
ejnm-305	170	18	and	and	CCONJ
ejnm-305	170	19	dyslipidemia	dyslipidemia	VERB
ejnm-305	170	20	and	and	CCONJ
ejnm-305	170	21	raised	raise	VERB
ejnm-305	170	22	uric	uric	ADJ
ejnm-305	170	23	acid	acid	NOUN
ejnm-305	170	24	levels	level	NOUN
ejnm-305	170	25	are	be	AUX
ejnm-305	170	26	symptoms	symptom	NOUN
ejnm-305	170	27	of	of	ADP
ejnm-305	170	28	preeclampsia	preeclampsia	NOUN
ejnm-305	170	29	in	in	ADP
ejnm-305	170	30	nullipara	nullipara	ADJ
ejnm-305	170	31	pregnant	pregnant	ADJ
ejnm-305	170	32	women	woman	NOUN
ejnm-305	170	33	in	in	ADP
ejnm-305	170	34	their	their	PRON
ejnm-305	170	35	third	third	ADJ
ejnm-305	170	36	trimester	trimester	NOUN
ejnm-305	171	1	[	[	X
ejnm-305	171	2	18	18	NUM
ejnm-305	171	3	]	]	PUNCT
ejnm-305	171	4	.	.	PUNCT
ejnm-305	172	1	this	this	DET
ejnm-305	172	2	study	study	NOUN
ejnm-305	172	3	could	could	AUX
ejnm-305	172	4	not	not	PART
ejnm-305	172	5	find	find	VERB
ejnm-305	172	6	a	a	DET
ejnm-305	172	7	significant	significant	ADJ
ejnm-305	172	8	association	association	NOUN
ejnm-305	172	9	between	between	ADP
ejnm-305	172	10	urea	urea	NOUN
ejnm-305	172	11	and	and	CCONJ
ejnm-305	172	12	lipid	lipid	NOUN
ejnm-305	172	13	profiles	profile	NOUN
ejnm-305	172	14	in	in	ADP
ejnm-305	172	15	pregnant	pregnant	ADJ
ejnm-305	172	16	women	woman	NOUN
ejnm-305	172	17	.	.	PUNCT
ejnm-305	173	1	among	among	ADP
ejnm-305	173	2	pregnant	pregnant	ADJ
ejnm-305	173	3	women	woman	NOUN
ejnm-305	173	4	,	,	PUNCT
ejnm-305	173	5	the	the	DET
ejnm-305	173	6	current	current	ADJ
ejnm-305	173	7	study	study	NOUN
ejnm-305	173	8	has	have	AUX
ejnm-305	173	9	indicated	indicate	VERB
ejnm-305	173	10	that	that	SCONJ
ejnm-305	173	11	ldl	ldl	NOUN
ejnm-305	173	12	has	have	VERB
ejnm-305	173	13	a	a	DET
ejnm-305	173	14	significant	significant	ADJ
ejnm-305	173	15	positive	positive	ADJ
ejnm-305	173	16	correlation	correlation	NOUN
ejnm-305	173	17	with	with	ADP
ejnm-305	173	18	the	the	DET
ejnm-305	173	19	woman	woman	NOUN
ejnm-305	173	20	’s	’s	PART
ejnm-305	173	21	gestation	gestation	NOUN
ejnm-305	173	22	period	period	NOUN
ejnm-305	173	23	,	,	PUNCT
ejnm-305	173	24	cholesterol	cholesterol	NOUN
ejnm-305	173	25	,	,	PUNCT
ejnm-305	173	26	tg	tg	PROPN
ejnm-305	173	27	,	,	PUNCT
ejnm-305	173	28	and	and	CCONJ
ejnm-305	173	29	hdl	hdl	PROPN
ejnm-305	173	30	,	,	PUNCT
ejnm-305	173	31	and	and	CCONJ
ejnm-305	173	32	a	a	DET
ejnm-305	173	33	strong	strong	ADJ
ejnm-305	173	34	negative	negative	ADJ
ejnm-305	173	35	correlation	correlation	NOUN
ejnm-305	173	36	with	with	ADP
ejnm-305	173	37	tsb	tsb	NOUN
ejnm-305	173	38	,	,	PUNCT
ejnm-305	173	39	and	and	CCONJ
ejnm-305	173	40	creatinine	creatinine	NOUN
ejnm-305	173	41	.	.	PUNCT
ejnm-305	174	1	the	the	DET
ejnm-305	174	2	study	study	NOUN
ejnm-305	174	3	also	also	ADV
ejnm-305	174	4	found	find	VERB
ejnm-305	174	5	a	a	DET
ejnm-305	174	6	significant	significant	ADJ
ejnm-305	174	7	moderate	moderate	ADJ
ejnm-305	174	8	correlation	correlation	NOUN
ejnm-305	174	9	between	between	ADP
ejnm-305	174	10	cholesterol	cholesterol	NOUN
ejnm-305	174	11	and	and	CCONJ
ejnm-305	174	12	tg	tg	PROPN
ejnm-305	174	13	and	and	CCONJ
ejnm-305	174	14	hdl	hdl	PROPN
ejnm-305	174	15	,	,	PUNCT
ejnm-305	174	16	and	and	CCONJ
ejnm-305	174	17	serum	serum	NOUN
ejnm-305	174	18	creatinine	creatinine	NOUN
ejnm-305	174	19	had	have	VERB
ejnm-305	174	20	a	a	DET
ejnm-305	174	21	significant	significant	ADJ
ejnm-305	174	22	the	the	DET
ejnm-305	174	23	objective	objective	NOUN
ejnm-305	174	24	of	of	ADP
ejnm-305	174	25	this	this	DET
ejnm-305	174	26	study	study	NOUN
ejnm-305	174	27	was	be	AUX
ejnm-305	174	28	to	to	PART
ejnm-305	174	29	determine	determine	VERB
ejnm-305	174	30	the	the	DET
ejnm-305	174	31	metabolic	metabolic	NOUN
ejnm-305	174	32	differences	difference	NOUN
ejnm-305	174	33	in	in	ADP
ejnm-305	174	34	lipid	lipid	NOUN
ejnm-305	174	35	profile	profile	NOUN
ejnm-305	174	36	and	and	CCONJ
ejnm-305	174	37	kidney	kidney	NOUN
ejnm-305	174	38	function	function	NOUN
ejnm-305	174	39	between	between	ADP
ejnm-305	174	40	pregnant	pregnant	ADJ
ejnm-305	174	41	and	and	CCONJ
ejnm-305	174	42	non	non	ADJ
ejnm-305	174	43	-	-	ADJ
ejnm-305	174	44	pregnant	pregnant	ADJ
ejnm-305	174	45	individuals	individual	NOUN
ejnm-305	174	46	.	.	PUNCT
ejnm-305	175	1	pregnancy	pregnancy	NOUN
ejnm-305	175	2	status	status	NOUN
ejnm-305	175	3	was	be	AUX
ejnm-305	175	4	known	know	VERB
ejnm-305	175	5	by	by	ADP
ejnm-305	175	6	a	a	DET
ejnm-305	175	7	high	high	ADJ
ejnm-305	175	8	level	level	NOUN
ejnm-305	175	9	of	of	ADP
ejnm-305	175	10	lipid	lipid	NOUN
ejnm-305	175	11	profile	profile	NOUN
ejnm-305	175	12	and	and	CCONJ
ejnm-305	175	13	a	a	DET
ejnm-305	175	14	decreased	decreased	ADJ
ejnm-305	175	15	level	level	NOUN
ejnm-305	175	16	of	of	ADP
ejnm-305	175	17	urea	urea	NOUN
ejnm-305	175	18	and	and	CCONJ
ejnm-305	175	19	creatinine	creatinine	NOUN
ejnm-305	175	20	.	.	PUNCT
ejnm-305	176	1	the	the	DET
ejnm-305	176	2	latest	late	ADJ
ejnm-305	176	3	research	research	NOUN
ejnm-305	176	4	has	have	AUX
ejnm-305	176	5	shown	show	VERB
ejnm-305	176	6	that	that	SCONJ
ejnm-305	176	7	the	the	DET
ejnm-305	176	8	mean	mean	ADJ
ejnm-305	176	9	urea	urea	NOUN
ejnm-305	176	10	and	and	CCONJ
ejnm-305	176	11	creatinine	creatinine	NOUN
ejnm-305	176	12	levels	level	NOUN
ejnm-305	176	13	were	be	AUX
ejnm-305	176	14	significantly	significantly	ADV
ejnm-305	176	15	decreased	decrease	VERB
ejnm-305	176	16	in	in	ADP
ejnm-305	176	17	pregnant	pregnant	ADJ
ejnm-305	176	18	women	woman	NOUN
ejnm-305	176	19	,	,	PUNCT
ejnm-305	176	20	whereas	whereas	SCONJ
ejnm-305	176	21	the	the	DET
ejnm-305	176	22	average	average	ADJ
ejnm-305	176	23	levels	level	NOUN
ejnm-305	176	24	of	of	ADP
ejnm-305	176	25	cholesterol	cholesterol	NOUN
ejnm-305	176	26	,	,	PUNCT
ejnm-305	176	27	hdl	hdl	PROPN
ejnm-305	176	28	,	,	PUNCT
ejnm-305	176	29	and	and	CCONJ
ejnm-305	176	30	egfr	egfr	NOUN
ejnm-305	176	31	were	be	AUX
ejnm-305	176	32	observed	observe	VERB
ejnm-305	176	33	to	to	PART
ejnm-305	176	34	be	be	AUX
ejnm-305	176	35	significantly	significantly	ADV
ejnm-305	176	36	high	high	ADJ
ejnm-305	176	37	.	.	PUNCT
ejnm-305	177	1	another	another	DET
ejnm-305	177	2	study	study	NOUN
ejnm-305	177	3	has	have	AUX
ejnm-305	177	4	confirmed	confirm	VERB
ejnm-305	177	5	that	that	SCONJ
ejnm-305	177	6	tc	tc	NOUN
ejnm-305	177	7	,	,	PUNCT
ejnm-305	177	8	tg	tg	PROPN
ejnm-305	177	9	,	,	PUNCT
ejnm-305	177	10	ldl	ldl	NOUN
ejnm-305	177	11	-	-	PUNCT
ejnm-305	177	12	c	c	PROPN
ejnm-305	177	13	,	,	PUNCT
ejnm-305	177	14	hdl	hdl	PROPN
ejnm-305	177	15	-	-	PUNCT
ejnm-305	177	16	c	c	PROPN
ejnm-305	177	17	,	,	PUNCT
ejnm-305	177	18	and	and	CCONJ
ejnm-305	177	19	egfr	egfr	VERB
ejnm-305	177	20	all	all	DET
ejnm-305	177	21	increase	increase	VERB
ejnm-305	177	22	significantly	significantly	ADV
ejnm-305	177	23	during	during	ADP
ejnm-305	177	24	pregnancy	pregnancy	NOUN
ejnm-305	177	25	.	.	PUNCT
ejnm-305	178	1	pregnant	pregnant	ADJ
ejnm-305	178	2	women	woman	NOUN
ejnm-305	178	3	exhibited	exhibit	VERB
ejnm-305	178	4	decreased	decrease	VERB
ejnm-305	178	5	levels	level	NOUN
ejnm-305	178	6	of	of	ADP
ejnm-305	178	7	urea	urea	NOUN
ejnm-305	178	8	,	,	PUNCT
ejnm-305	178	9	creatinine	creatinine	NOUN
ejnm-305	178	10	,	,	PUNCT
ejnm-305	178	11	and	and	CCONJ
ejnm-305	178	12	uric	uric	ADJ
ejnm-305	178	13	acid	acid	NOUN
ejnm-305	178	14	.	.	PUNCT
ejnm-305	179	1	[	[	X
ejnm-305	179	2	14	14	NUM
ejnm-305	179	3	,	,	PUNCT
ejnm-305	179	4	15	15	NUM
ejnm-305	179	5	]	]	PUNCT
ejnm-305	179	6	.	.	PUNCT
ejnm-305	180	1	lower	low	ADJ
ejnm-305	180	2	levels	level	NOUN
ejnm-305	180	3	of	of	ADP
ejnm-305	180	4	urea	urea	NOUN
ejnm-305	180	5	,	,	PUNCT
ejnm-305	180	6	creatinine	creatinine	NOUN
ejnm-305	180	7	,	,	PUNCT
ejnm-305	180	8	and	and	CCONJ
ejnm-305	180	9	uric	uric	ADJ
ejnm-305	180	10	acid	acid	NOUN
ejnm-305	180	11	in	in	ADP
ejnm-305	180	12	pregnancy	pregnancy	NOUN
ejnm-305	180	13	are	be	AUX
ejnm-305	180	14	mostly	mostly	ADV
ejnm-305	180	15	related	relate	VERB
ejnm-305	180	16	to	to	ADP
ejnm-305	180	17	high	high	ADJ
ejnm-305	180	18	renal	renal	ADJ
ejnm-305	180	19	blood	blood	NOUN
ejnm-305	180	20	flow	flow	NOUN
ejnm-305	180	21	and	and	CCONJ
ejnm-305	180	22	gfr	gfr	NOUN
ejnm-305	180	23	in	in	ADP
ejnm-305	180	24	pregnant	pregnant	ADJ
ejnm-305	180	25	women	woman	NOUN
ejnm-305	180	26	[	[	X
ejnm-305	180	27	15	15	NUM
ejnm-305	180	28	]	]	PUNCT
ejnm-305	180	29	.	.	PUNCT
ejnm-305	181	1	compared	compare	VERB
ejnm-305	181	2	to	to	ADP
ejnm-305	181	3	non	non	ADJ
ejnm-305	181	4	-	-	ADJ
ejnm-305	181	5	pregnant	pregnant	ADJ
ejnm-305	181	6	status	status	NOUN
ejnm-305	181	7	,	,	PUNCT
ejnm-305	181	8	in	in	ADP
ejnm-305	181	9	pregnancy	pregnancy	NOUN
ejnm-305	181	10	status	status	NOUN
ejnm-305	181	11	,	,	PUNCT
ejnm-305	181	12	the	the	DET
ejnm-305	181	13	metabolism	metabolism	NOUN
ejnm-305	181	14	of	of	ADP
ejnm-305	181	15	biochemical	biochemical	ADJ
ejnm-305	181	16	profiles	profile	NOUN
ejnm-305	181	17	such	such	ADJ
ejnm-305	181	18	as	as	ADP
ejnm-305	181	19	ldl	ldl	NOUN
ejnm-305	181	20	and	and	CCONJ
ejnm-305	181	21	tc	tc	NOUN
ejnm-305	181	22	has	have	VERB
ejnm-305	181	23	a	a	DET
ejnm-305	181	24	high	high	ADJ
ejnm-305	181	25	26	26	NUM
ejnm-305	181	26	copyright	copyright	NOUN
ejnm-305	181	27	©	©	PROPN
ejnm-305	181	28	2025	2025	NUM
ejnm-305	181	29	the	the	DET
ejnm-305	181	30	author(s	author(s	NOUN
ejnm-305	181	31	)	)	PUNCT
ejnm-305	181	32	.	.	PUNCT
ejnm-305	182	1	this	this	PRON
ejnm-305	182	2	is	be	AUX
ejnm-305	182	3	an	an	DET
ejnm-305	182	4	open	open	ADJ
ejnm-305	182	5	access	access	NOUN
ejnm-305	182	6	article	article	NOUN
ejnm-305	182	7	which	which	PRON
ejnm-305	182	8	licensed	license	VERB
ejnm-305	182	9	under	under	ADP
ejnm-305	182	10	the	the	DET
ejnm-305	182	11	terms	term	NOUN
ejnm-305	182	12	and	and	CCONJ
ejnm-305	182	13	conditions	condition	NOUN
ejnm-305	182	14	of	of	ADP
ejnm-305	182	15	the	the	DET
ejnm-305	182	16	creative	creative	ADJ
ejnm-305	182	17	commons	common	NOUN
ejnm-305	182	18	attribution	attribution	NOUN
ejnm-305	182	19	-	-	PUNCT
ejnm-305	182	20	noncommercial	noncommercial	ADJ
ejnm-305	182	21	-	-	PUNCT
ejnm-305	182	22	sharealike	sharealike	ADJ
ejnm-305	182	23	4.0	4.0	NUM
ejnm-305	182	24	international	international	ADJ
ejnm-305	182	25	license	license	NOUN
ejnm-305	182	26	.	.	PUNCT
ejnm-305	183	1	it	it	PRON
ejnm-305	183	2	permits	permit	VERB
ejnm-305	183	3	no	no	DET
ejnm-305	183	4	additional	additional	ADJ
ejnm-305	183	5	restrictions	restriction	NOUN
ejnm-305	183	6	on	on	ADP
ejnm-305	183	7	use	use	NOUN
ejnm-305	183	8	,	,	PUNCT
ejnm-305	183	9	distribution	distribution	NOUN
ejnm-305	183	10	,	,	PUNCT
ejnm-305	183	11	and	and	CCONJ
ejnm-305	183	12	reproduction	reproduction	NOUN
ejnm-305	183	13	in	in	ADP
ejnm-305	183	14	any	any	DET
ejnm-305	183	15	medium	medium	NOUN
ejnm-305	183	16	provided	provide	VERB
ejnm-305	183	17	the	the	DET
ejnm-305	183	18	original	original	ADJ
ejnm-305	183	19	work	work	NOUN
ejnm-305	183	20	is	be	AUX
ejnm-305	183	21	properly	properly	ADV
ejnm-305	183	22	cited	cite	VERB
ejnm-305	183	23	.	.	PUNCT
ejnm-305	184	1	table	table	NOUN
ejnm-305	184	2	4	4	NUM
ejnm-305	184	3	:	:	PUNCT
ejnm-305	184	4	coefficient	coefficient	NOUN
ejnm-305	184	5	linear	linear	PROPN
ejnm-305	184	6	regression	regression	NOUN
ejnm-305	184	7	of	of	ADP
ejnm-305	184	8	cholesterol	cholesterol	NOUN
ejnm-305	184	9	predictor	predictor	NOUN
ejnm-305	184	10	variables	variable	NOUN
ejnm-305	184	11	unstandardized	unstandardized	ADJ
ejnm-305	184	12	coefficients	coefficient	NOUN
ejnm-305	184	13	standardized	standardized	ADJ
ejnm-305	184	14	coefficients	coefficient	NOUN
ejnm-305	184	15	t	t	NOUN
ejnm-305	184	16	-	-	PUNCT
ejnm-305	184	17	value	value	NOUN
ejnm-305	184	18	p	p	NOUN
ejnm-305	184	19	-	-	PUNCT
ejnm-305	184	20	value	value	NOUN
ejnm-305	184	21	95.0	95.0	NUM
ejnm-305	184	22	%	%	NOUN
ejnm-305	184	23	confidence	confidence	NOUN
ejnm-305	184	24	interval	interval	NOUN
ejnm-305	184	25	for	for	ADP
ejnm-305	184	26	b	b	PROPN
ejnm-305	184	27	b	b	PROPN
ejnm-305	184	28	std	std	PROPN
ejnm-305	184	29	.	.	NOUN
ejnm-305	184	30	error	error	NOUN
ejnm-305	184	31	beta	beta	NOUN
ejnm-305	184	32	lower	lower	ADV
ejnm-305	184	33	bound	bind	VERB
ejnm-305	184	34	upper	upper	ADJ
ejnm-305	184	35	bound	bound	ADJ
ejnm-305	184	36	(	(	PUNCT
ejnm-305	184	37	constant	constant	ADJ
ejnm-305	184	38	)	)	PUNCT
ejnm-305	184	39	-125.245	-125.245	PROPN
ejnm-305	184	40	107.770	107.770	NUM
ejnm-305	184	41	-1.162	-1.162	X
ejnm-305	184	42	0.252	0.252	NUM
ejnm-305	184	43	-343.415	-343.415	NUM
ejnm-305	184	44	92.924	92.924	NUM
ejnm-305	184	45	tg	tg	PROPN
ejnm-305	184	46	0.163	0.163	NUM
ejnm-305	184	47	0.084	0.084	NUM
ejnm-305	184	48	0.202	0.202	NUM
ejnm-305	184	49	1.954	1.954	NUM
ejnm-305	184	50	0.058	0.058	NUM
ejnm-305	184	51	-0.006	-0.006	X
ejnm-305	184	52	0.332	0.332	NUM
ejnm-305	184	53	hdl	hdl	PROPN
ejnm-305	184	54	0.138	0.138	NUM
ejnm-305	184	55	0.336	0.336	NUM
ejnm-305	184	56	0.043	0.043	NUM
ejnm-305	184	57	0.409	0.409	NUM
ejnm-305	184	58	0.685	0.685	NUM
ejnm-305	184	59	-0.543	-0.543	NOUN
ejnm-305	184	60	0.818	0.818	NUM
ejnm-305	184	61	ldl	ldl	NOUN
ejnm-305	184	62	0.913	0.913	NUM
ejnm-305	184	63	0.148	0.148	NUM
ejnm-305	184	64	0.764	0.764	NUM
ejnm-305	184	65	6.178	6.178	NUM
ejnm-305	184	66	0.000	0.000	NUM
ejnm-305	184	67	0.614	0.614	NUM
ejnm-305	184	68	1.212	1.212	NUM
ejnm-305	184	69	diabetes	diabetes	NOUN
ejnm-305	184	70	0.130	0.130	NUM
ejnm-305	184	71	0.108	0.108	NUM
ejnm-305	184	72	0.113	0.113	NUM
ejnm-305	184	73	1.211	1.211	NUM
ejnm-305	184	74	0.233	0.233	NUM
ejnm-305	184	75	-0.087	-0.087	NOUN
ejnm-305	184	76	0.348	0.348	NUM
ejnm-305	184	77	urea	urea	VERB
ejnm-305	184	78	1.398	1.398	NUM
ejnm-305	184	79	0.615	0.615	NUM
ejnm-305	184	80	0.223	0.223	NUM
ejnm-305	184	81	2.276	2.276	NUM
ejnm-305	184	82	0.029	0.029	NUM
ejnm-305	184	83	0.154	0.154	NUM
ejnm-305	184	84	2.642	2.642	NUM
ejnm-305	184	85	creatinine	creatinine	NOUN
ejnm-305	184	86	124.263	124.263	NUM
ejnm-305	184	87	92.882	92.882	NUM
ejnm-305	184	88	0.470	0.470	NUM
ejnm-305	184	89	1.338	1.338	NUM
ejnm-305	184	90	0.189	0.189	NUM
ejnm-305	184	91	-63.766	-63.766	NUM
ejnm-305	184	92	312.293	312.293	NUM
ejnm-305	184	93	egfr	egfr	VERB
ejnm-305	184	94	0.377	0.377	NUM
ejnm-305	184	95	0.300	0.300	NUM
ejnm-305	184	96	0.452	0.452	NUM
ejnm-305	184	97	1.257	1.257	NUM
ejnm-305	184	98	0.216	0.216	NUM
ejnm-305	184	99	-0.230	-0.230	NUM
ejnm-305	184	100	0.985	0.985	NUM
ejnm-305	184	101	age	age	NOUN
ejnm-305	184	102	0.414	0.414	NUM
ejnm-305	184	103	0.576	0.576	NUM
ejnm-305	184	104	0.080	0.080	NUM
ejnm-305	184	105	0.719	0.719	NUM
ejnm-305	184	106	0.477	0.477	NUM
ejnm-305	184	107	-0.752	-0.752	NUM
ejnm-305	184	108	1.580	1.580	NUM
ejnm-305	184	109	gestational	gestational	ADJ
ejnm-305	184	110	period	period	NOUN
ejnm-305	184	111	in	in	ADP
ejnm-305	184	112	weeks	week	NOUN
ejnm-305	184	113	-0.124	-0.124	PROPN
ejnm-305	184	114	0.306	0.306	NUM
ejnm-305	184	115	-0.038	-0.038	PUNCT
ejnm-305	184	116	-0.405	-0.405	PUNCT
ejnm-305	184	117	0.688	0.688	NUM
ejnm-305	184	118	-0.744	-0.744	NUM
ejnm-305	184	119	0.496	0.496	NUM
ejnm-305	184	120	bmi	bmi	VERB
ejnm-305	184	121	0.217	0.217	NUM
ejnm-305	184	122	0.614	0.614	NUM
ejnm-305	184	123	0.031	0.031	NUM
ejnm-305	184	124	0.353	0.353	NUM
ejnm-305	184	125	0.726	0.726	NUM
ejnm-305	184	126	-1.027	-1.027	NUM
ejnm-305	184	127	1.460	1.460	NUM
ejnm-305	184	128	para	para	NOUN
ejnm-305	184	129	-1.298	-1.298	PUNCT
ejnm-305	184	130	3.203	3.203	NUM
ejnm-305	184	131	-0.042	-0.042	NUM
ejnm-305	184	132	-0.405	-0.405	NUM
ejnm-305	184	133	0.688	0.688	NUM
ejnm-305	184	134	-7.783	-7.783	NUM
ejnm-305	184	135	5.187	5.187	NUM
ejnm-305	184	136	discussion	discussion	NOUN
ejnm-305	184	137	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-305	185	1	https://doi.org/10.15218/ejnm.2025.03	https://doi.org/10.15218/ejnm.2025.03	PROPN
ejnm-305	185	2	erbil	erbil	PROPN
ejnm-305	185	3	j.	j.	PROPN
ejnm-305	185	4	nurs	nurs	PROPN
ejnm-305	185	5	.	.	PUNCT
ejnm-305	186	1	midwifery	midwifery	ADJ
ejnm-305	186	2	,	,	PUNCT
ejnm-305	186	3	vol	vol	NOUN
ejnm-305	186	4	.	.	PROPN
ejnm-305	186	5	8	8	NUM
ejnm-305	186	6	,	,	PUNCT
ejnm-305	186	7	no	no	INTJ
ejnm-305	186	8	.	.	PUNCT
ejnm-305	187	1	(	(	PUNCT
ejnm-305	187	2	1	1	NUM
ejnm-305	187	3	)	)	PUNCT
ejnm-305	187	4	,	,	PUNCT
ejnm-305	187	5	may	may	AUX
ejnm-305	187	6	2025	2025	NUM
ejnm-305	187	7	original	original	ADJ
ejnm-305	187	8	article	article	NOUN
ejnm-305	187	9	variables	variable	VERB
ejnm-305	187	10	.	.	PUNCT
ejnm-305	188	1	the	the	DET
ejnm-305	188	2	linear	linear	PROPN
ejnm-305	188	3	regression	regression	NOUN
ejnm-305	188	4	model	model	NOUN
ejnm-305	188	5	has	have	AUX
ejnm-305	188	6	explored	explore	VERB
ejnm-305	188	7	a	a	DET
ejnm-305	188	8	70	70	NUM
ejnm-305	188	9	%	%	NOUN
ejnm-305	188	10	variance	variance	NOUN
ejnm-305	188	11	in	in	ADP
ejnm-305	188	12	cholesterol	cholesterol	NOUN
ejnm-305	188	13	level	level	NOUN
ejnm-305	188	14	,	,	PUNCT
ejnm-305	188	15	which	which	PRON
ejnm-305	188	16	is	be	AUX
ejnm-305	188	17	significantly	significantly	ADV
ejnm-305	188	18	explained	explain	VERB
ejnm-305	188	19	by	by	ADP
ejnm-305	188	20	para	para	PROPN
ejnm-305	188	21	,	,	PUNCT
ejnm-305	188	22	ldl	ldl	NOUN
ejnm-305	188	23	,	,	PUNCT
ejnm-305	188	24	diabetes	diabetes	NOUN
ejnm-305	188	25	,	,	PUNCT
ejnm-305	188	26	bmi	bmi	PROPN
ejnm-305	188	27	,	,	PUNCT
ejnm-305	188	28	urea	urea	NOUN
ejnm-305	188	29	,	,	PUNCT
ejnm-305	188	30	age	age	NOUN
ejnm-305	188	31	of	of	ADP
ejnm-305	188	32	pregnancy	pregnancy	NOUN
ejnm-305	188	33	in	in	ADP
ejnm-305	188	34	weeks	week	NOUN
ejnm-305	188	35	,	,	PUNCT
ejnm-305	188	36	tg	tg	PROPN
ejnm-305	188	37	,	,	PUNCT
ejnm-305	188	38	creatinine	creatinine	NOUN
ejnm-305	188	39	,	,	PUNCT
ejnm-305	188	40	age	age	NOUN
ejnm-305	188	41	,	,	PUNCT
ejnm-305	188	42	hdl	hdl	PROPN
ejnm-305	188	43	,	,	PUNCT
ejnm-305	188	44	and	and	CCONJ
ejnm-305	188	45	egfr	egfr	X
ejnm-305	188	46	.	.	PUNCT
ejnm-305	189	1	the	the	DET
ejnm-305	189	2	regression	regression	NOUN
ejnm-305	189	3	model	model	NOUN
ejnm-305	189	4	has	have	AUX
ejnm-305	189	5	shown	show	VERB
ejnm-305	189	6	a	a	DET
ejnm-305	189	7	significant	significant	ADJ
ejnm-305	189	8	coefficient	coefficient	NOUN
ejnm-305	189	9	of	of	ADP
ejnm-305	189	10	ldl	ldl	NOUN
ejnm-305	189	11	and	and	CCONJ
ejnm-305	189	12	urea	urea	NOUN
ejnm-305	189	13	with	with	ADP
ejnm-305	189	14	cholesterol	cholesterol	NOUN
ejnm-305	189	15	[	[	X
ejnm-305	189	16	24	24	NUM
ejnm-305	189	17	]	]	PUNCT
ejnm-305	189	18	.	.	PUNCT
ejnm-305	190	1	the	the	DET
ejnm-305	190	2	model	model	NOUN
ejnm-305	190	3	has	have	AUX
ejnm-305	190	4	shown	show	VERB
ejnm-305	190	5	that	that	PRON
ejnm-305	190	6	urea	urea	NOUN
ejnm-305	190	7	and	and	CCONJ
ejnm-305	190	8	ldl	ldl	NOUN
ejnm-305	190	9	indicate	indicate	VERB
ejnm-305	190	10	a	a	DET
ejnm-305	190	11	1.398	1.398	NUM
ejnm-305	190	12	%	%	NOUN
ejnm-305	190	13	and	and	CCONJ
ejnm-305	190	14	0.913	0.913	NUM
ejnm-305	190	15	%	%	NOUN
ejnm-305	190	16	variance	variance	NOUN
ejnm-305	190	17	in	in	ADP
ejnm-305	190	18	cholesterol	cholesterol	NOUN
ejnm-305	190	19	levels	level	NOUN
ejnm-305	190	20	,	,	PUNCT
ejnm-305	190	21	respectively	respectively	ADV
ejnm-305	190	22	.	.	PUNCT
ejnm-305	191	1	a	a	DET
ejnm-305	191	2	lipid	lipid	NOUN
ejnm-305	191	3	profile	profile	NOUN
ejnm-305	191	4	can	can	AUX
ejnm-305	191	5	help	help	VERB
ejnm-305	191	6	predict	predict	VERB
ejnm-305	191	7	the	the	DET
ejnm-305	191	8	risk	risk	NOUN
ejnm-305	191	9	of	of	ADP
ejnm-305	191	10	gestational	gestational	ADJ
ejnm-305	191	11	diabetes	diabete	NOUN
ejnm-305	191	12	[	[	X
ejnm-305	191	13	25	25	NUM
ejnm-305	191	14	,	,	PUNCT
ejnm-305	191	15	26	26	NUM
ejnm-305	191	16	]	]	PUNCT
ejnm-305	191	17	,	,	PUNCT
ejnm-305	191	18	while	while	SCONJ
ejnm-305	191	19	the	the	DET
ejnm-305	191	20	current	current	ADJ
ejnm-305	191	21	study	study	NOUN
ejnm-305	191	22	could	could	AUX
ejnm-305	191	23	not	not	PART
ejnm-305	191	24	find	find	VERB
ejnm-305	191	25	a	a	DET
ejnm-305	191	26	significant	significant	ADJ
ejnm-305	191	27	correlation	correlation	NOUN
ejnm-305	191	28	between	between	ADP
ejnm-305	191	29	lipid	lipid	NOUN
ejnm-305	191	30	profile	profile	NOUN
ejnm-305	191	31	and	and	CCONJ
ejnm-305	191	32	random	random	ADJ
ejnm-305	191	33	blood	blood	NOUN
ejnm-305	191	34	sugar	sugar	NOUN
ejnm-305	191	35	[	[	X
ejnm-305	191	36	27	27	NUM
ejnm-305	191	37	]	]	PUNCT
ejnm-305	191	38	.	.	PUNCT
ejnm-305	192	1	to	to	PART
ejnm-305	192	2	sum	sum	VERB
ejnm-305	192	3	up	up	ADP
ejnm-305	192	4	,	,	PUNCT
ejnm-305	192	5	this	this	DET
ejnm-305	192	6	study	study	NOUN
ejnm-305	192	7	highlights	highlight	VERB
ejnm-305	192	8	notable	notable	ADJ
ejnm-305	192	9	metabolic	metabolic	NOUN
ejnm-305	192	10	disparities	disparity	NOUN
ejnm-305	192	11	between	between	ADP
ejnm-305	192	12	pregnant	pregnant	ADJ
ejnm-305	192	13	and	and	CCONJ
ejnm-305	192	14	non	non	ADJ
ejnm-305	192	15	-	-	ADJ
ejnm-305	192	16	pregnant	pregnant	ADJ
ejnm-305	192	17	women	woman	NOUN
ejnm-305	192	18	,	,	PUNCT
ejnm-305	192	19	namely	namely	ADV
ejnm-305	192	20	in	in	ADP
ejnm-305	192	21	terms	term	NOUN
ejnm-305	192	22	of	of	ADP
ejnm-305	192	23	lipid	lipid	NOUN
ejnm-305	192	24	profiles	profile	NOUN
ejnm-305	192	25	and	and	CCONJ
ejnm-305	192	26	kidney	kidney	NOUN
ejnm-305	192	27	function	function	NOUN
ejnm-305	192	28	.	.	PUNCT
ejnm-305	193	1	in	in	ADP
ejnm-305	193	2	pregnant	pregnant	ADJ
ejnm-305	193	3	women	woman	NOUN
ejnm-305	193	4	,	,	PUNCT
ejnm-305	193	5	ldl	ldl	NOUN
ejnm-305	193	6	shows	show	VERB
ejnm-305	193	7	significant	significant	ADJ
ejnm-305	193	8	positive	positive	ADJ
ejnm-305	193	9	correlations	correlation	NOUN
ejnm-305	193	10	with	with	ADP
ejnm-305	193	11	gestation	gestation	NOUN
ejnm-305	193	12	age	age	NOUN
ejnm-305	193	13	,	,	PUNCT
ejnm-305	193	14	cholesterol	cholesterol	NOUN
ejnm-305	193	15	,	,	PUNCT
ejnm-305	193	16	tg	tg	PROPN
ejnm-305	193	17	,	,	PUNCT
ejnm-305	193	18	and	and	CCONJ
ejnm-305	193	19	hdl	hdl	PROPN
ejnm-305	193	20	,	,	PUNCT
ejnm-305	193	21	alongside	alongside	ADP
ejnm-305	193	22	strong	strong	ADJ
ejnm-305	193	23	negative	negative	ADJ
ejnm-305	193	24	correlations	correlation	NOUN
ejnm-305	193	25	with	with	ADP
ejnm-305	193	26	tsb	tsb	NOUN
ejnm-305	193	27	and	and	CCONJ
ejnm-305	193	28	creatinine	creatinine	NOUN
ejnm-305	193	29	.	.	PUNCT
ejnm-305	194	1	moreover	moreover	ADV
ejnm-305	194	2	,	,	PUNCT
ejnm-305	194	3	egfr	egfr	NOUN
ejnm-305	194	4	demonstrates	demonstrate	VERB
ejnm-305	194	5	strong	strong	ADJ
ejnm-305	194	6	positive	positive	ADJ
ejnm-305	194	7	associations	association	NOUN
ejnm-305	194	8	with	with	ADP
ejnm-305	194	9	cholesterol	cholesterol	NOUN
ejnm-305	194	10	and	and	CCONJ
ejnm-305	194	11	ldl	ldl	NOUN
ejnm-305	194	12	and	and	CCONJ
ejnm-305	194	13	negative	negative	ADJ
ejnm-305	194	14	correlations	correlation	NOUN
ejnm-305	194	15	with	with	ADP
ejnm-305	194	16	tsb	tsb	NOUN
ejnm-305	194	17	and	and	CCONJ
ejnm-305	194	18	creatinine	creatinine	NOUN
ejnm-305	194	19	,	,	PUNCT
ejnm-305	194	20	while	while	SCONJ
ejnm-305	194	21	moderate	moderate	ADJ
ejnm-305	194	22	correlations	correlation	NOUN
ejnm-305	194	23	exist	exist	VERB
ejnm-305	194	24	between	between	ADP
ejnm-305	194	25	cholesterol	cholesterol	NOUN
ejnm-305	194	26	and	and	CCONJ
ejnm-305	194	27	tg	tg	PROPN
ejnm-305	194	28	as	as	ADV
ejnm-305	194	29	well	well	ADV
ejnm-305	194	30	as	as	ADP
ejnm-305	194	31	hdl	hdl	PROPN
ejnm-305	194	32	.	.	PROPN
ejnm-305	194	33	serum	serum	PROPN
ejnm-305	194	34	creatinine	creatinine	PROPN
ejnm-305	194	35	also	also	ADV
ejnm-305	194	36	exhibits	exhibit	VERB
ejnm-305	194	37	a	a	DET
ejnm-305	194	38	significant	significant	ADJ
ejnm-305	194	39	correlation	correlation	NOUN
ejnm-305	194	40	with	with	ADP
ejnm-305	194	41	tsb	tsb	NOUN
ejnm-305	194	42	.	.	PUNCT
ejnm-305	195	1	conversely	conversely	ADV
ejnm-305	195	2	,	,	PUNCT
ejnm-305	195	3	in	in	ADP
ejnm-305	195	4	non	non	ADJ
ejnm-305	195	5	-	-	ADJ
ejnm-305	195	6	pregnant	pregnant	ADJ
ejnm-305	195	7	individuals	individual	NOUN
ejnm-305	195	8	,	,	PUNCT
ejnm-305	195	9	egfr	egfr	NOUN
ejnm-305	195	10	moderately	moderately	ADV
ejnm-305	195	11	correlates	correlate	VERB
ejnm-305	195	12	with	with	ADP
ejnm-305	195	13	random	random	ADJ
ejnm-305	195	14	blood	blood	NOUN
ejnm-305	195	15	sugar	sugar	NOUN
ejnm-305	195	16	but	but	CCONJ
ejnm-305	195	17	strongly	strongly	ADV
ejnm-305	195	18	negatively	negatively	ADV
ejnm-305	195	19	correlates	correlate	VERB
ejnm-305	195	20	with	with	ADP
ejnm-305	195	21	urea	urea	NOUN
ejnm-305	195	22	and	and	CCONJ
ejnm-305	195	23	creatinine	creatinine	NOUN
ejnm-305	195	24	.	.	PUNCT
ejnm-305	196	1	serum	serum	PROPN
ejnm-305	196	2	creatinine	creatinine	PROPN
ejnm-305	196	3	shows	show	VERB
ejnm-305	196	4	a	a	DET
ejnm-305	196	5	significant	significant	ADJ
ejnm-305	196	6	positive	positive	ADJ
ejnm-305	196	7	correlation	correlation	NOUN
ejnm-305	196	8	with	with	ADP
ejnm-305	196	9	urea	urea	NOUN
ejnm-305	196	10	and	and	CCONJ
ejnm-305	196	11	a	a	DET
ejnm-305	196	12	negative	negative	ADJ
ejnm-305	196	13	correlation	correlation	NOUN
ejnm-305	196	14	with	with	ADP
ejnm-305	196	15	random	random	ADJ
ejnm-305	196	16	blood	blood	NOUN
ejnm-305	196	17	sugar	sugar	NOUN
ejnm-305	196	18	,	,	PUNCT
ejnm-305	196	19	while	while	SCONJ
ejnm-305	196	20	cholesterol	cholesterol	NOUN
ejnm-305	196	21	displays	display	VERB
ejnm-305	196	22	a	a	DET
ejnm-305	196	23	significant	significant	ADJ
ejnm-305	196	24	moderate	moderate	ADJ
ejnm-305	196	25	correlation	correlation	NOUN
ejnm-305	196	26	with	with	ADP
ejnm-305	196	27	tg	tg	PROPN
ejnm-305	196	28	.	.	PUNCT
ejnm-305	197	1	these	these	DET
ejnm-305	197	2	findings	finding	NOUN
ejnm-305	197	3	emphasize	emphasize	VERB
ejnm-305	197	4	the	the	DET
ejnm-305	197	5	complexity	complexity	NOUN
ejnm-305	197	6	of	of	ADP
ejnm-305	197	7	biomarker	biomarker	NOUN
ejnm-305	197	8	interactions	interaction	NOUN
ejnm-305	197	9	and	and	CCONJ
ejnm-305	197	10	their	their	PRON
ejnm-305	197	11	implications	implication	NOUN
ejnm-305	197	12	for	for	ADP
ejnm-305	197	13	health	health	NOUN
ejnm-305	197	14	in	in	ADP
ejnm-305	197	15	diverse	diverse	ADJ
ejnm-305	197	16	physiological	physiological	ADJ
ejnm-305	197	17	contexts	contexts	NOUN
ejnm-305	197	18	.	.	PUNCT
ejnm-305	198	1	correlation	correlation	NOUN
ejnm-305	198	2	with	with	ADP
ejnm-305	198	3	the	the	DET
ejnm-305	198	4	tsb	tsb	PROPN
ejnm-305	198	5	.	.	PUNCT
ejnm-305	199	1	other	other	ADJ
ejnm-305	199	2	studies	study	NOUN
ejnm-305	199	3	have	have	AUX
ejnm-305	199	4	found	find	VERB
ejnm-305	199	5	that	that	SCONJ
ejnm-305	199	6	serum	serum	NOUN
ejnm-305	199	7	levels	level	NOUN
ejnm-305	199	8	of	of	ADP
ejnm-305	199	9	uric	uric	ADJ
ejnm-305	199	10	acid	acid	NOUN
ejnm-305	199	11	,	,	PUNCT
ejnm-305	199	12	creatinine	creatinine	NOUN
ejnm-305	199	13	,	,	PUNCT
ejnm-305	199	14	and	and	CCONJ
ejnm-305	199	15	blood	blood	NOUN
ejnm-305	199	16	urea	urea	NOUN
ejnm-305	199	17	indicate	indicate	VERB
ejnm-305	199	18	the	the	DET
ejnm-305	199	19	pre	pre	ADJ
ejnm-305	199	20	-eclamptic	-eclamptic	ADJ
ejnm-305	199	21	status	status	NOUN
ejnm-305	199	22	of	of	ADP
ejnm-305	199	23	pregnant	pregnant	ADJ
ejnm-305	199	24	women	woman	NOUN
ejnm-305	199	25	[	[	X
ejnm-305	199	26	19	19	NUM
ejnm-305	199	27	]	]	PUNCT
ejnm-305	199	28	.	.	PUNCT
ejnm-305	200	1	in	in	ADP
ejnm-305	200	2	this	this	DET
ejnm-305	200	3	study	study	NOUN
ejnm-305	200	4	,	,	PUNCT
ejnm-305	200	5	urea	urea	NOUN
ejnm-305	200	6	and	and	CCONJ
ejnm-305	200	7	creatinine	creatinine	NOUN
ejnm-305	200	8	were	be	AUX
ejnm-305	200	9	significantly	significantly	ADV
ejnm-305	200	10	decreased	decrease	VERB
ejnm-305	200	11	in	in	ADP
ejnm-305	200	12	pregnant	pregnant	ADJ
ejnm-305	200	13	women	woman	NOUN
ejnm-305	200	14	[	[	X
ejnm-305	200	15	20	20	NUM
ejnm-305	200	16	]	]	PUNCT
ejnm-305	200	17	,	,	PUNCT
ejnm-305	200	18	and	and	CCONJ
ejnm-305	200	19	creatinine	creatinine	NOUN
ejnm-305	200	20	and	and	CCONJ
ejnm-305	200	21	tsb	tsb	PROPN
ejnm-305	200	22	were	be	AUX
ejnm-305	200	23	negatively	negatively	ADV
ejnm-305	200	24	correlated	correlate	VERB
ejnm-305	200	25	with	with	ADP
ejnm-305	200	26	ldl	ldl	NOUN
ejnm-305	200	27	[	[	X
ejnm-305	200	28	21	21	NUM
ejnm-305	200	29	]	]	PUNCT
ejnm-305	200	30	.	.	PUNCT
ejnm-305	201	1	among	among	ADP
ejnm-305	201	2	non	non	ADJ
ejnm-305	201	3	-pregnant	-pregnant	ADJ
ejnm-305	201	4	women	woman	NOUN
ejnm-305	201	5	,	,	PUNCT
ejnm-305	201	6	tsb	tsb	PROPN
ejnm-305	201	7	and	and	CCONJ
ejnm-305	201	8	serum	serum	PROPN
ejnm-305	201	9	creatinine	creatinine	NOUN
ejnm-305	201	10	did	do	AUX
ejnm-305	201	11	not	not	PART
ejnm-305	201	12	have	have	VERB
ejnm-305	201	13	a	a	DET
ejnm-305	201	14	significant	significant	ADJ
ejnm-305	201	15	correlation	correlation	NOUN
ejnm-305	201	16	with	with	ADP
ejnm-305	201	17	ldl	ldl	NOUN
ejnm-305	201	18	[	[	X
ejnm-305	201	19	22	22	NUM
ejnm-305	201	20	]	]	PUNCT
ejnm-305	201	21	.	.	PUNCT
ejnm-305	202	1	decreased	decrease	VERB
ejnm-305	202	2	levels	level	NOUN
ejnm-305	202	3	of	of	ADP
ejnm-305	202	4	tsb	tsb	PROPN
ejnm-305	202	5	and	and	CCONJ
ejnm-305	202	6	serum	serum	NOUN
ejnm-305	202	7	creatinine	creatinine	NOUN
ejnm-305	202	8	in	in	ADP
ejnm-305	202	9	pregnant	pregnant	ADJ
ejnm-305	202	10	women	woman	NOUN
ejnm-305	202	11	are	be	AUX
ejnm-305	202	12	related	relate	VERB
ejnm-305	202	13	to	to	ADP
ejnm-305	202	14	kidney	kidney	NOUN
ejnm-305	202	15	function	function	NOUN
ejnm-305	202	16	during	during	ADP
ejnm-305	202	17	pregnancy	pregnancy	NOUN
ejnm-305	202	18	,	,	PUNCT
ejnm-305	202	19	which	which	PRON
ejnm-305	202	20	leads	lead	VERB
ejnm-305	202	21	to	to	ADP
ejnm-305	202	22	an	an	DET
ejnm-305	202	23	increase	increase	NOUN
ejnm-305	202	24	in	in	ADP
ejnm-305	202	25	egfr	egfr	NOUN
ejnm-305	202	26	and	and	CCONJ
ejnm-305	202	27	the	the	DET
ejnm-305	202	28	excretion	excretion	NOUN
ejnm-305	202	29	of	of	ADP
ejnm-305	202	30	proteins	protein	NOUN
ejnm-305	202	31	such	such	ADJ
ejnm-305	202	32	as	as	ADP
ejnm-305	202	33	creatinine	creatinine	NOUN
ejnm-305	202	34	and	and	CCONJ
ejnm-305	202	35	tsb	tsb	NOUN
ejnm-305	202	36	.	.	PUNCT
ejnm-305	203	1	in	in	ADP
ejnm-305	203	2	addition	addition	NOUN
ejnm-305	203	3	,	,	PUNCT
ejnm-305	203	4	during	during	ADP
ejnm-305	203	5	pregnancy	pregnancy	NOUN
ejnm-305	203	6	,	,	PUNCT
ejnm-305	203	7	physiological	physiological	ADJ
ejnm-305	203	8	adaptations	adaptation	NOUN
ejnm-305	203	9	occur	occur	VERB
ejnm-305	203	10	to	to	PART
ejnm-305	203	11	support	support	VERB
ejnm-305	203	12	fetal	fetal	ADJ
ejnm-305	203	13	growth	growth	NOUN
ejnm-305	203	14	and	and	CCONJ
ejnm-305	203	15	development	development	NOUN
ejnm-305	203	16	;	;	PUNCT
ejnm-305	203	17	these	these	DET
ejnm-305	203	18	adaptations	adaptation	NOUN
ejnm-305	203	19	can	can	AUX
ejnm-305	203	20	affect	affect	VERB
ejnm-305	203	21	renal	renal	ADJ
ejnm-305	203	22	function	function	NOUN
ejnm-305	203	23	and	and	CCONJ
ejnm-305	203	24	lipid	lipid	NOUN
ejnm-305	203	25	metabolism	metabolism	NOUN
ejnm-305	203	26	,	,	PUNCT
ejnm-305	203	27	leading	lead	VERB
ejnm-305	203	28	to	to	ADP
ejnm-305	203	29	changes	change	NOUN
ejnm-305	203	30	in	in	ADP
ejnm-305	203	31	the	the	DET
ejnm-305	203	32	correlation	correlation	NOUN
ejnm-305	203	33	between	between	ADP
ejnm-305	203	34	egfr	egfr	NOUN
ejnm-305	203	35	and	and	CCONJ
ejnm-305	203	36	cholesterol	cholesterol	NOUN
ejnm-305	203	37	/	/	SYM
ejnm-305	203	38	ldl	ldl	NOUN
ejnm-305	204	1	[	[	X
ejnm-305	204	2	23].similarly	23].similarly	PROPN
ejnm-305	204	3	,	,	PUNCT
ejnm-305	204	4	the	the	DET
ejnm-305	204	5	study	study	NOUN
ejnm-305	204	6	found	find	VERB
ejnm-305	204	7	a	a	DET
ejnm-305	204	8	strong	strong	ADJ
ejnm-305	204	9	positive	positive	ADJ
ejnm-305	204	10	correlation	correlation	NOUN
ejnm-305	204	11	between	between	ADP
ejnm-305	204	12	egfr	egfr	NOUN
ejnm-305	204	13	and	and	CCONJ
ejnm-305	204	14	cholesterol	cholesterol	NOUN
ejnm-305	204	15	and	and	CCONJ
ejnm-305	204	16	ldl	ldl	NOUN
ejnm-305	204	17	,	,	PUNCT
ejnm-305	204	18	but	but	CCONJ
ejnm-305	204	19	this	this	DET
ejnm-305	204	20	correlation	correlation	NOUN
ejnm-305	204	21	was	be	AUX
ejnm-305	204	22	not	not	PART
ejnm-305	204	23	significant	significant	ADJ
ejnm-305	204	24	among	among	ADP
ejnm-305	204	25	nonpregnant	nonpregnant	ADJ
ejnm-305	204	26	women	woman	NOUN
ejnm-305	204	27	.	.	PUNCT
ejnm-305	205	1	among	among	ADP
ejnm-305	205	2	non	non	ADJ
ejnm-305	205	3	-	-	ADJ
ejnm-305	205	4	pregnant	pregnant	ADJ
ejnm-305	205	5	women	woman	NOUN
ejnm-305	205	6	,	,	PUNCT
ejnm-305	205	7	this	this	DET
ejnm-305	205	8	study	study	NOUN
ejnm-305	205	9	has	have	AUX
ejnm-305	205	10	shown	show	VERB
ejnm-305	205	11	a	a	DET
ejnm-305	205	12	moderately	moderately	ADV
ejnm-305	205	13	positive	positive	ADJ
ejnm-305	205	14	correlation	correlation	NOUN
ejnm-305	205	15	of	of	ADP
ejnm-305	205	16	egfr	egfr	NOUN
ejnm-305	205	17	with	with	ADP
ejnm-305	205	18	random	random	ADJ
ejnm-305	205	19	blood	blood	NOUN
ejnm-305	205	20	sugar	sugar	NOUN
ejnm-305	205	21	and	and	CCONJ
ejnm-305	205	22	a	a	DET
ejnm-305	205	23	strong	strong	ADJ
ejnm-305	205	24	to	to	PART
ejnm-305	205	25	moderately	moderately	ADV
ejnm-305	205	26	negative	negative	ADJ
ejnm-305	205	27	correlation	correlation	NOUN
ejnm-305	205	28	with	with	ADP
ejnm-305	205	29	urea	urea	NOUN
ejnm-305	205	30	.	.	PUNCT
ejnm-305	206	1	this	this	DET
ejnm-305	206	2	correlation	correlation	NOUN
ejnm-305	206	3	was	be	AUX
ejnm-305	206	4	not	not	PART
ejnm-305	206	5	found	find	VERB
ejnm-305	206	6	among	among	ADP
ejnm-305	206	7	pregnant	pregnant	ADJ
ejnm-305	206	8	women	woman	NOUN
ejnm-305	206	9	.	.	PUNCT
ejnm-305	207	1	normally	normally	ADV
ejnm-305	207	2	,	,	PUNCT
ejnm-305	207	3	during	during	ADP
ejnm-305	207	4	pregnancy	pregnancy	NOUN
ejnm-305	207	5	,	,	PUNCT
ejnm-305	207	6	egfr	egfr	NOUN
ejnm-305	207	7	increases	increase	NOUN
ejnm-305	207	8	by	by	ADP
ejnm-305	207	9	50	50	NUM
ejnm-305	207	10	%	%	NOUN
ejnm-305	207	11	,	,	PUNCT
ejnm-305	207	12	which	which	PRON
ejnm-305	207	13	also	also	ADV
ejnm-305	207	14	leads	lead	VERB
ejnm-305	207	15	to	to	ADP
ejnm-305	207	16	a	a	DET
ejnm-305	207	17	substantial	substantial	ADJ
ejnm-305	207	18	decrease	decrease	NOUN
ejnm-305	207	19	in	in	ADP
ejnm-305	207	20	serum	serum	NOUN
ejnm-305	207	21	creatinine	creatinine	NOUN
ejnm-305	207	22	,	,	PUNCT
ejnm-305	207	23	urea	urea	NOUN
ejnm-305	207	24	,	,	PUNCT
ejnm-305	207	25	and	and	CCONJ
ejnm-305	207	26	uric	uric	ADJ
ejnm-305	207	27	acid	acid	NOUN
ejnm-305	207	28	values	value	NOUN
ejnm-305	207	29	[	[	X
ejnm-305	207	30	20	20	NUM
ejnm-305	207	31	]	]	PUNCT
ejnm-305	207	32	.	.	PUNCT
ejnm-305	208	1	overall	overall	ADV
ejnm-305	208	2	,	,	PUNCT
ejnm-305	208	3	the	the	DET
ejnm-305	208	4	combination	combination	NOUN
ejnm-305	208	5	of	of	ADP
ejnm-305	208	6	increased	increase	VERB
ejnm-305	208	7	renal	renal	ADJ
ejnm-305	208	8	blood	blood	NOUN
ejnm-305	208	9	flow	flow	NOUN
ejnm-305	208	10	,	,	PUNCT
ejnm-305	208	11	hormonal	hormonal	ADJ
ejnm-305	208	12	influences	influence	NOUN
ejnm-305	208	13	,	,	PUNCT
ejnm-305	208	14	and	and	CCONJ
ejnm-305	208	15	changes	change	NOUN
ejnm-305	208	16	in	in	ADP
ejnm-305	208	17	lipid	lipid	ADJ
ejnm-305	208	18	metabolism	metabolism	NOUN
ejnm-305	208	19	,	,	PUNCT
ejnm-305	208	20	physiological	physiological	ADJ
ejnm-305	208	21	adaptations	adaptation	NOUN
ejnm-305	208	22	,	,	PUNCT
ejnm-305	208	23	and	and	CCONJ
ejnm-305	208	24	gestational	gestational	ADJ
ejnm-305	208	25	hypertensive	hypertensive	ADJ
ejnm-305	208	26	disorders	disorder	NOUN
ejnm-305	208	27	can	can	AUX
ejnm-305	208	28	lead	lead	VERB
ejnm-305	208	29	to	to	ADP
ejnm-305	208	30	a	a	DET
ejnm-305	208	31	strong	strong	ADJ
ejnm-305	208	32	positive	positive	ADJ
ejnm-305	208	33	correlation	correlation	NOUN
ejnm-305	208	34	between	between	ADP
ejnm-305	208	35	egfr	egfr	NOUN
ejnm-305	208	36	and	and	CCONJ
ejnm-305	208	37	cholesterol/	cholesterol/	PRON
ejnm-305	208	38	ldl	ldl	NOUN
ejnm-305	208	39	during	during	ADP
ejnm-305	208	40	pregnancy	pregnancy	NOUN
ejnm-305	208	41	,	,	PUNCT
ejnm-305	208	42	whereas	whereas	SCONJ
ejnm-305	208	43	this	this	DET
ejnm-305	208	44	correlation	correlation	NOUN
ejnm-305	208	45	may	may	AUX
ejnm-305	208	46	not	not	PART
ejnm-305	208	47	be	be	AUX
ejnm-305	208	48	as	as	ADV
ejnm-305	208	49	significant	significant	ADJ
ejnm-305	208	50	among	among	ADP
ejnm-305	208	51	non	non	ADJ
ejnm-305	208	52	-pregnant	-pregnant	ADJ
ejnm-305	208	53	women	woman	NOUN
ejnm-305	208	54	due	due	ADP
ejnm-305	208	55	to	to	ADP
ejnm-305	208	56	differences	difference	NOUN
ejnm-305	208	57	in	in	ADP
ejnm-305	208	58	hormonal	hormonal	ADJ
ejnm-305	208	59	and	and	CCONJ
ejnm-305	208	60	physiological	physiological	ADJ
ejnm-305	208	61	status	status	NOUN
ejnm-305	208	62	.	.	PUNCT
ejnm-305	209	1	a	a	DET
ejnm-305	209	2	high	high	ADJ
ejnm-305	209	3	cholesterol	cholesterol	NOUN
ejnm-305	209	4	rate	rate	NOUN
ejnm-305	209	5	is	be	AUX
ejnm-305	209	6	indicated	indicate	VERB
ejnm-305	209	7	by	by	ADP
ejnm-305	209	8	several	several	ADJ
ejnm-305	209	9	27	27	NUM
ejnm-305	209	10	copyright	copyright	NOUN
ejnm-305	209	11	©	©	PROPN
ejnm-305	209	12	2025	2025	NUM
ejnm-305	209	13	the	the	DET
ejnm-305	209	14	author(s	author(s	NOUN
ejnm-305	209	15	)	)	PUNCT
ejnm-305	209	16	.	.	PUNCT
ejnm-305	210	1	this	this	PRON
ejnm-305	210	2	is	be	AUX
ejnm-305	210	3	an	an	DET
ejnm-305	210	4	open	open	ADJ
ejnm-305	210	5	access	access	NOUN
ejnm-305	210	6	article	article	NOUN
ejnm-305	210	7	which	which	PRON
ejnm-305	210	8	licensed	license	VERB
ejnm-305	210	9	under	under	ADP
ejnm-305	210	10	the	the	DET
ejnm-305	210	11	terms	term	NOUN
ejnm-305	210	12	and	and	CCONJ
ejnm-305	210	13	conditions	condition	NOUN
ejnm-305	210	14	of	of	ADP
ejnm-305	210	15	the	the	DET
ejnm-305	210	16	creative	creative	ADJ
ejnm-305	210	17	commons	common	NOUN
ejnm-305	210	18	attribution	attribution	NOUN
ejnm-305	210	19	-	-	PUNCT
ejnm-305	210	20	noncommercial	noncommercial	ADJ
ejnm-305	210	21	-	-	PUNCT
ejnm-305	210	22	sharealike	sharealike	ADJ
ejnm-305	210	23	4.0	4.0	NUM
ejnm-305	210	24	international	international	ADJ
ejnm-305	210	25	license	license	NOUN
ejnm-305	210	26	.	.	PUNCT
ejnm-305	211	1	it	it	PRON
ejnm-305	211	2	permits	permit	VERB
ejnm-305	211	3	no	no	DET
ejnm-305	211	4	additional	additional	ADJ
ejnm-305	211	5	restrictions	restriction	NOUN
ejnm-305	211	6	on	on	ADP
ejnm-305	211	7	use	use	NOUN
ejnm-305	211	8	,	,	PUNCT
ejnm-305	211	9	distribution	distribution	NOUN
ejnm-305	211	10	,	,	PUNCT
ejnm-305	211	11	and	and	CCONJ
ejnm-305	211	12	reproduction	reproduction	NOUN
ejnm-305	211	13	in	in	ADP
ejnm-305	211	14	any	any	DET
ejnm-305	211	15	medium	medium	NOUN
ejnm-305	211	16	provided	provide	VERB
ejnm-305	211	17	the	the	DET
ejnm-305	211	18	original	original	ADJ
ejnm-305	211	19	work	work	NOUN
ejnm-305	211	20	is	be	AUX
ejnm-305	211	21	properly	properly	ADV
ejnm-305	211	22	cited	cite	VERB
ejnm-305	211	23	.	.	PUNCT
ejnm-305	212	1	conclusion	conclusion	NOUN
ejnm-305	212	2	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-305	213	1	https://doi.org/10.15218/ejnm.2025.03	https://doi.org/10.15218/ejnm.2025.03	PROPN
ejnm-305	213	2	erbil	erbil	PROPN
ejnm-305	213	3	j.	j.	PROPN
ejnm-305	213	4	nurs	nurs	PROPN
ejnm-305	213	5	.	.	PUNCT
ejnm-305	214	1	midwifery	midwifery	ADJ
ejnm-305	214	2	,	,	PUNCT
ejnm-305	214	3	vol	vol	NOUN
ejnm-305	214	4	.	.	PROPN
ejnm-305	214	5	8	8	NUM
ejnm-305	214	6	,	,	PUNCT
ejnm-305	214	7	no	no	INTJ
ejnm-305	214	8	.	.	PUNCT
ejnm-305	215	1	(	(	PUNCT
ejnm-305	215	2	1	1	NUM
ejnm-305	215	3	)	)	PUNCT
ejnm-305	215	4	,	,	PUNCT
ejnm-305	215	5	may	may	AUX
ejnm-305	215	6	2025	2025	NUM
ejnm-305	215	7	original	original	ADJ
ejnm-305	215	8	article	article	NOUN
ejnm-305	215	9	[	[	X
ejnm-305	215	10	4	4	NUM
ejnm-305	215	11	]	]	X
ejnm-305	215	12	devi	devi	PROPN
ejnm-305	215	13	,	,	PUNCT
ejnm-305	215	14	s.a	s.a	PROPN
ejnm-305	215	15	.	.	PROPN
ejnm-305	215	16	,	,	PUNCT
ejnm-305	215	17	study	study	NOUN
ejnm-305	215	18	of	of	ADP
ejnm-305	215	19	serum	serum	NOUN
ejnm-305	215	20	lipid	lipid	NOUN
ejnm-305	215	21	profile	profile	NOUN
ejnm-305	215	22	in	in	ADP
ejnm-305	215	23	second	second	ADJ
ejnm-305	215	24	trimester	trimester	NOUN
ejnm-305	215	25	as	as	ADP
ejnm-305	215	26	a	a	DET
ejnm-305	215	27	predictor	predictor	NOUN
ejnm-305	215	28	for	for	ADP
ejnm-305	215	29	pregnancy	pregnancy	NOUN
ejnm-305	215	30	induced	induce	VERB
ejnm-305	215	31	hypertension	hypertension	NOUN
ejnm-305	215	32	in	in	ADP
ejnm-305	215	33	rajarajeswari	rajarajeswari	PROPN
ejnm-305	215	34	medical	medical	PROPN
ejnm-305	215	35	college	college	PROPN
ejnm-305	215	36	and	and	CCONJ
ejnm-305	215	37	hospital	hospital	NOUN
ejnm-305	215	38	.	.	PUNCT
ejnm-305	216	1	2019	2019	NUM
ejnm-305	216	2	,	,	PUNCT
ejnm-305	216	3	master	master	NOUN
ejnm-305	216	4	thesis	thesis	PROPN
ejnm-305	216	5	rajiv	rajiv	PROPN
ejnm-305	216	6	gandhi	gandhi	PROPN
ejnm-305	216	7	university	university	PROPN
ejnm-305	216	8	of	of	ADP
ejnm-305	216	9	health	health	PROPN
ejnm-305	216	10	sciences	sciences	PROPN
ejnm-305	216	11	(	(	PUNCT
ejnm-305	216	12	india	india	PROPN
ejnm-305	216	13	)	)	PUNCT
ejnm-305	216	14	.	.	PUNCT
ejnm-305	217	1	[	[	X
ejnm-305	217	2	5	5	NUM
ejnm-305	217	3	]	]	X
ejnm-305	217	4	casado	casado	PROPN
ejnm-305	217	5	,	,	PUNCT
ejnm-305	217	6	m.e	m.e	PROPN
ejnm-305	217	7	.	.	PROPN
ejnm-305	217	8	,	,	PUNCT
ejnm-305	217	9	l.	l.	PROPN
ejnm-305	217	10	huerta	huerta	PROPN
ejnm-305	217	11	,	,	PUNCT
ejnm-305	217	12	a.	a.	PROPN
ejnm-305	217	13	marcos	marcos	PROPN
ejnm-305	217	14	-	-	PUNCT
ejnm-305	217	15	díaz	díaz	NOUN
ejnm-305	217	16	,	,	PUNCT
ejnm-305	217	17	a.i	a.i	PROPN
ejnm-305	217	18	.	.	PROPN
ejnm-305	217	19	ortiz	ortiz	PROPN
ejnm-305	217	20	,	,	PUNCT
ejnm-305	217	21	f.b	f.b	PROPN
ejnm-305	217	22	.	.	PROPN
ejnm-305	217	23	kraemer	kraemer	PROPN
ejnm-305	217	24	,	,	PUNCT
ejnm-305	217	25	m.a	m.a	PROPN
ejnm-305	217	26	.	.	PROPN
ejnm-305	217	27	lasunción	lasunción	PROPN
ejnm-305	217	28	,	,	PUNCT
ejnm-305	217	29	et	et	PROPN
ejnm-305	217	30	al	al	PROPN
ejnm-305	217	31	.	.	PROPN
ejnm-305	217	32	,	,	PUNCT
ejnm-305	217	33	hormone	hormone	NOUN
ejnm-305	217	34	-	-	PUNCT
ejnm-305	217	35	sensitive	sensitive	ADJ
ejnm-305	217	36	lipase	lipase	NOUN
ejnm-305	217	37	deficiency	deficiency	NOUN
ejnm-305	217	38	affects	affect	VERB
ejnm-305	217	39	the	the	DET
ejnm-305	217	40	expression	expression	NOUN
ejnm-305	217	41	of	of	ADP
ejnm-305	217	42	sr	sr	PROPN
ejnm-305	217	43	-	-	PUNCT
ejnm-305	217	44	bi	bi	PROPN
ejnm-305	217	45	,	,	PUNCT
ejnm-305	217	46	ldlr	ldlr	ADJ
ejnm-305	217	47	,	,	PUNCT
ejnm-305	217	48	and	and	CCONJ
ejnm-305	217	49	abca1	abca1	NOUN
ejnm-305	217	50	receptors	receptor	NOUN
ejnm-305	217	51	/	/	SYM
ejnm-305	217	52	transporters	transporter	NOUN
ejnm-305	217	53	involved	involve	VERB
ejnm-305	217	54	in	in	ADP
ejnm-305	217	55	cellular	cellular	ADJ
ejnm-305	217	56	cholesterol	cholesterol	NOUN
ejnm-305	217	57	uptake	uptake	NOUN
ejnm-305	217	58	and	and	CCONJ
ejnm-305	217	59	efflux	efflux	VERB
ejnm-305	217	60	and	and	CCONJ
ejnm-305	217	61	disturbs	disturb	VERB
ejnm-305	217	62	fertility	fertility	NOUN
ejnm-305	217	63	in	in	ADP
ejnm-305	217	64	mouse	mouse	NOUN
ejnm-305	217	65	testis	testis	NOUN
ejnm-305	217	66	.	.	PUNCT
ejnm-305	218	1	biochimica	biochimica	PROPN
ejnm-305	218	2	et	et	PROPN
ejnm-305	218	3	biophysica	biophysica	PROPN
ejnm-305	218	4	acta	acta	PROPN
ejnm-305	218	5	(	(	PUNCT
ejnm-305	218	6	bba)-molecular	bba)-molecular	ADJ
ejnm-305	218	7	and	and	CCONJ
ejnm-305	218	8	cell	cell	NOUN
ejnm-305	218	9	biology	biology	NOUN
ejnm-305	218	10	of	of	ADP
ejnm-305	218	11	lipids	lipid	NOUN
ejnm-305	218	12	,	,	PUNCT
ejnm-305	218	13	2021	2021	NUM
ejnm-305	218	14	.	.	PUNCT
ejnm-305	219	1	1866(12	1866(12	NUM
ejnm-305	219	2	):	):	PUNCT
ejnm-305	219	3	p.	p.	NOUN
ejnm-305	219	4	159043.https://	159043.https://	NUM
ejnm-305	219	5	doi.org/10.1016j.bbalip.2021.15904	doi.org/10.1016j.bbalip.2021.15904	VERB
ejnm-305	219	6	.	.	PUNCT
ejnm-305	220	1	[	[	X
ejnm-305	220	2	6	6	NUM
ejnm-305	220	3	]	]	X
ejnm-305	220	4	jiang	jiang	PROPN
ejnm-305	220	5	,	,	PUNCT
ejnm-305	220	6	z.g	z.g	PROPN
ejnm-305	220	7	.	.	PROPN
ejnm-305	220	8	,	,	PUNCT
ejnm-305	220	9	s.c	s.c	PROPN
ejnm-305	220	10	.	.	PROPN
ejnm-305	220	11	robson	robson	PROPN
ejnm-305	220	12	,	,	PUNCT
ejnm-305	220	13	and	and	CCONJ
ejnm-305	220	14	z.	z.	PROPN
ejnm-305	220	15	yao	yao	PROPN
ejnm-305	220	16	,	,	PUNCT
ejnm-305	220	17	lipoprotein	lipoprotein	ADJ
ejnm-305	220	18	metabolism	metabolism	NOUN
ejnm-305	220	19	in	in	ADP
ejnm-305	220	20	nonalcoholic	nonalcoholic	ADJ
ejnm-305	220	21	fatty	fatty	NOUN
ejnm-305	220	22	liver	liver	NOUN
ejnm-305	220	23	disease	disease	NOUN
ejnm-305	220	24	.	.	PUNCT
ejnm-305	221	1	journal	journal	PROPN
ejnm-305	221	2	of	of	ADP
ejnm-305	221	3	biomedical	biomedical	ADJ
ejnm-305	221	4	research	research	NOUN
ejnm-305	221	5	,	,	PUNCT
ejnm-305	221	6	2013	2013	NUM
ejnm-305	221	7	.	.	PUNCT
ejnm-305	222	1	27(1	27(1	NUM
ejnm-305	222	2	):	):	PUNCT
ejnm-305	222	3	p.	p.	NOUN
ejnm-305	222	4	1.https://doi.org/10.755	1.https://doi.org/10.755	NUM
ejnm-305	223	1	2fjbr.27.20120077	2fjbr.27.20120077	PROPN
ejnm-305	224	1	[	[	X
ejnm-305	224	2	7	7	NUM
ejnm-305	224	3	]	]	X
ejnm-305	224	4	huggins	huggins	PROPN
ejnm-305	224	5	,	,	PUNCT
ejnm-305	224	6	c.e	c.e	PROPN
ejnm-305	224	7	.	.	PROPN
ejnm-305	224	8	,	,	PUNCT
ejnm-305	224	9	a.p	a.p	PROPN
ejnm-305	224	10	.	.	PROPN
ejnm-305	224	11	james	james	PROPN
ejnm-305	224	12	,	,	PUNCT
ejnm-305	224	13	m.p	m.p	PROPN
ejnm-305	224	14	.	.	PROPN
ejnm-305	224	15	bonham	bonham	PROPN
ejnm-305	224	16	,	,	PUNCT
ejnm-305	224	17	k.m	k.m	PROPN
ejnm-305	224	18	.	.	PROPN
ejnm-305	224	19	clark	clark	PROPN
ejnm-305	224	20	,	,	PUNCT
ejnm-305	224	21	and	and	CCONJ
ejnm-305	224	22	s.d	s.d	PROPN
ejnm-305	224	23	.	.	PROPN
ejnm-305	224	24	lee	lee	PROPN
ejnm-305	224	25	,	,	PUNCT
ejnm-305	224	26	postprandial	postprandial	ADJ
ejnm-305	224	27	lipemia	lipemia	NOUN
ejnm-305	224	28	and	and	CCONJ
ejnm-305	224	29	the	the	DET
ejnm-305	224	30	relationship	relationship	NOUN
ejnm-305	224	31	to	to	ADP
ejnm-305	224	32	health	health	NOUN
ejnm-305	224	33	,	,	PUNCT
ejnm-305	224	34	in	in	ADP
ejnm-305	224	35	advances	advance	NOUN
ejnm-305	224	36	in	in	ADP
ejnm-305	224	37	dietary	dietary	ADJ
ejnm-305	224	38	lipids	lipid	NOUN
ejnm-305	224	39	and	and	CCONJ
ejnm-305	224	40	human	human	ADJ
ejnm-305	224	41	health	health	NOUN
ejnm-305	224	42	.	.	PUNCT
ejnm-305	225	1	2022	2022	NUM
ejnm-305	225	2	,	,	PUNCT
ejnm-305	225	3	elsevier	elsevier	NOUN
ejnm-305	225	4	.	.	PUNCT
ejnm-305	226	1	p.	p.	NOUN
ejnm-305	226	2	193	193	NUM
ejnm-305	226	3	-	-	SYM
ejnm-305	226	4	209	209	NUM
ejnm-305	226	5	.	.	PUNCT
ejnm-305	227	1	https://	https://	PROPN
ejnm-305	227	2	doi.org/10.1016/b978-0-12-823914-8.00019	doi.org/10.1016/b978-0-12-823914-8.00019	PROPN
ejnm-305	227	3	-7	-7	PUNCT
ejnm-305	228	1	[	[	X
ejnm-305	228	2	8	8	NUM
ejnm-305	228	3	]	]	SYM
ejnm-305	228	4	della	della	ADJ
ejnm-305	228	5	porta	porta	PROPN
ejnm-305	228	6	,	,	PUNCT
ejnm-305	228	7	m.	m.	NOUN
ejnm-305	228	8	,	,	PUNCT
ejnm-305	228	9	fatty	fatty	ADJ
ejnm-305	228	10	acids	acid	NOUN
ejnm-305	228	11	unsaturation	unsaturation	NOUN
ejnm-305	228	12	and	and	CCONJ
ejnm-305	228	13	oxidative	oxidative	ADJ
ejnm-305	228	14	stress	stress	NOUN
ejnm-305	228	15	in	in	ADP
ejnm-305	228	16	membrane	membrane	NOUN
ejnm-305	228	17	function	function	NOUN
ejnm-305	228	18	,	,	PUNCT
ejnm-305	228	19	pregnancy	pregnancy	NOUN
ejnm-305	228	20	,	,	PUNCT
ejnm-305	228	21	and	and	CCONJ
ejnm-305	228	22	metabolic	metabolic	NOUN
ejnm-305	228	23	syndrome	syndrome	NOUN
ejnm-305	228	24	.	.	PUNCT
ejnm-305	229	1	doctoral	doctoral	ADJ
ejnm-305	229	2	thesis	thesis	NOUN
ejnm-305	229	3	2021	2021	NUM
ejnm-305	229	4	.	.	PUNCT
ejnm-305	230	1	[	[	X
ejnm-305	230	2	9	9	NUM
ejnm-305	230	3	]	]	X
ejnm-305	230	4	bonassi	bonassi	NOUN
ejnm-305	230	5	,	,	PUNCT
ejnm-305	230	6	s.	s.	PROPN
ejnm-305	230	7	and	and	CCONJ
ejnm-305	230	8	m.	m.	PROPN
ejnm-305	230	9	fenech	fenech	PROPN
ejnm-305	230	10	,	,	PUNCT
ejnm-305	230	11	micronuclei	micronucleus	NOUN
ejnm-305	230	12	and	and	CCONJ
ejnm-305	230	13	their	their	PRON
ejnm-305	230	14	association	association	NOUN
ejnm-305	230	15	with	with	ADP
ejnm-305	230	16	infertility	infertility	NOUN
ejnm-305	230	17	,	,	PUNCT
ejnm-305	230	18	pregnancy	pregnancy	NOUN
ejnm-305	230	19	complications	complication	NOUN
ejnm-305	230	20	,	,	PUNCT
ejnm-305	230	21	developmental	developmental	ADJ
ejnm-305	230	22	defects	defect	NOUN
ejnm-305	230	23	,	,	PUNCT
ejnm-305	230	24	anaemias	anaemias	PROPN
ejnm-305	230	25	,	,	PUNCT
ejnm-305	230	26	inflammation	inflammation	NOUN
ejnm-305	230	27	,	,	PUNCT
ejnm-305	230	28	diabetes	diabetes	NOUN
ejnm-305	230	29	,	,	PUNCT
ejnm-305	230	30	chronic	chronic	ADJ
ejnm-305	230	31	kidney	kidney	NOUN
ejnm-305	230	32	disease	disease	NOUN
ejnm-305	230	33	,	,	PUNCT
ejnm-305	230	34	obesity	obesity	NOUN
ejnm-305	230	35	,	,	PUNCT
ejnm-305	230	36	cardiovascular	cardiovascular	ADJ
ejnm-305	230	37	disease	disease	NOUN
ejnm-305	230	38	,	,	PUNCT
ejnm-305	230	39	neurodegenerative	neurodegenerative	ADJ
ejnm-305	230	40	diseases	disease	NOUN
ejnm-305	230	41	and	and	CCONJ
ejnm-305	230	42	cancer	cancer	NOUN
ejnm-305	230	43	.	.	PUNCT
ejnm-305	231	1	the	the	DET
ejnm-305	231	2	micronucleus	micronucleus	PROPN
ejnm-305	231	3	assay	assay	VERB
ejnm-305	231	4	in	in	ADP
ejnm-305	231	5	toxicology	toxicology	NOUN
ejnm-305	231	6	chapter	chapter	NOUN
ejnm-305	231	7	.4	.4	NUM
ejnm-305	231	8	2019.https://	2019.https://	NUM
ejnm-305	231	9	doi.org/10.1039/9781788013604-00038	doi.org/10.1039/9781788013604-00038	NOUN
ejnm-305	231	10	[	[	X
ejnm-305	231	11	10	10	NUM
ejnm-305	231	12	]	]	X
ejnm-305	231	13	zhao	zhao	PROPN
ejnm-305	231	14	,	,	PUNCT
ejnm-305	231	15	l.	l.	PROPN
ejnm-305	231	16	,	,	PUNCT
ejnm-305	231	17	s.	s.	PROPN
ejnm-305	231	18	li	li	PROPN
ejnm-305	231	19	,	,	PUNCT
ejnm-305	231	20	and	and	CCONJ
ejnm-305	231	21	y.	y.	PROPN
ejnm-305	231	22	gao	gao	PROPN
ejnm-305	231	23	,	,	PUNCT
ejnm-305	231	24	efficacy	efficacy	NOUN
ejnm-305	231	25	of	of	ADP
ejnm-305	231	26	statins	statins	PROPN
ejnm-305	231	27	on	on	ADP
ejnm-305	231	28	renal	renal	ADJ
ejnm-305	231	29	function	function	NOUN
ejnm-305	231	30	in	in	ADP
ejnm-305	231	31	patients	patient	NOUN
ejnm-305	231	32	with	with	ADP
ejnm-305	231	33	chronic	chronic	ADJ
ejnm-305	231	34	kidney	kidney	NOUN
ejnm-305	231	35	disease	disease	NOUN
ejnm-305	231	36	:	:	PUNCT
ejnm-305	231	37	a	a	DET
ejnm-305	231	38	systematic	systematic	ADJ
ejnm-305	231	39	review	review	NOUN
ejnm-305	231	40	and	and	CCONJ
ejnm-305	231	41	meta	meta	ADJ
ejnm-305	231	42	-	-	PUNCT
ejnm-305	231	43	analysis	analysis	NOUN
ejnm-305	231	44	.	.	PUNCT
ejnm-305	232	1	renal	renal	ADJ
ejnm-305	232	2	failure	failure	NOUN
ejnm-305	232	3	,	,	PUNCT
ejnm-305	232	4	2021	2021	NUM
ejnm-305	232	5	.	.	PUNCT
ejnm-305	233	1	43(1	43(1	NUM
ejnm-305	233	2	):	):	PUNCT
ejnm-305	234	1	p.	p.	NOUN
ejnm-305	234	2	718	718	NUM
ejnm-305	235	1	-728	-728	NOUN
ejnm-305	235	2	.	.	PUNCT
ejnm-305	236	1	https://	https://	PROPN
ejnm-305	236	2	doi.org/10.1080/0886022x.2021.1915799	doi.org/10.1080/0886022x.2021.1915799	PUNCT
ejnm-305	237	1	[	[	X
ejnm-305	237	2	11	11	NUM
ejnm-305	237	3	]	]	SYM
ejnm-305	237	4	turi	turi	PROPN
ejnm-305	237	5	,	,	PUNCT
ejnm-305	237	6	v.-r	v.-r	PROPN
ejnm-305	237	7	.	.	PUNCT
ejnm-305	237	8	,	,	PUNCT
ejnm-305	237	9	c.t	c.t	PROPN
ejnm-305	237	10	.	.	PROPN
ejnm-305	237	11	luca	luca	PROPN
ejnm-305	237	12	,	,	PUNCT
ejnm-305	237	13	d.	d.	PROPN
ejnm-305	237	14	gaita	gaita	PROPN
ejnm-305	237	15	,	,	PUNCT
ejnm-305	237	16	s.	s.	PROPN
ejnm-305	237	17	iurciuc	iurciuc	PROPN
ejnm-305	237	18	,	,	PUNCT
ejnm-305	237	19	i.	i.	PROPN
ejnm-305	237	20	petre	petre	PROPN
ejnm-305	237	21	,	,	PUNCT
ejnm-305	237	22	m.	m.	NOUN
ejnm-305	237	23	iurciuc	iurciuc	PROPN
ejnm-305	237	24	,	,	PUNCT
ejnm-305	237	25	et	et	PROPN
ejnm-305	237	26	al	al	PROPN
ejnm-305	237	27	.	.	PROPN
ejnm-305	237	28	,	,	PUNCT
ejnm-305	237	29	diagnosing	diagnose	VERB
ejnm-305	237	30	arterial	arterial	ADJ
ejnm-305	237	31	stiffness	stiffness	NOUN
ejnm-305	237	32	in	in	ADP
ejnm-305	237	33	pregnancy	pregnancy	NOUN
ejnm-305	237	34	and	and	CCONJ
ejnm-305	237	35	its	its	PRON
ejnm-305	237	36	implications	implication	NOUN
ejnm-305	237	37	in	in	ADP
ejnm-305	237	38	the	the	DET
ejnm-305	237	39	cardio	cardio	NOUN
ejnm-305	237	40	-	-	PUNCT
ejnm-305	237	41	renal	renal	ADJ
ejnm-305	237	42	-	-	PUNCT
ejnm-305	237	43	metabolic	metabolic	NOUN
ejnm-305	237	44	chain	chain	NOUN
ejnm-305	237	45	.	.	PUNCT
ejnm-305	238	1	diagnostics	diagnostic	NOUN
ejnm-305	238	2	,	,	PUNCT
ejnm-305	238	3	2022	2022	NUM
ejnm-305	238	4	.	.	PUNCT
ejnm-305	239	1	12(9	12(9	NUM
ejnm-305	239	2	):	):	PUNCT
ejnm-305	239	3	p.	p.	NOUN
ejnm-305	239	4	2221	2221	NUM
ejnm-305	239	5	.	.	PUNCT
ejnm-305	240	1	https://	https://	NOUN
ejnm-305	240	2	doi.org/10.3390/diagnostics12092221	doi.org/10.3390/diagnostics12092221	VERB
ejnm-305	240	3	conflicts	conflict	NOUN
ejnm-305	240	4	of	of	ADP
ejnm-305	240	5	interest	interest	NOUN
ejnm-305	240	6	:	:	PUNCT
ejnm-305	240	7	the	the	DET
ejnm-305	240	8	authors	author	NOUN
ejnm-305	240	9	declare	declare	VERB
ejnm-305	240	10	that	that	SCONJ
ejnm-305	240	11	they	they	PRON
ejnm-305	240	12	have	have	VERB
ejnm-305	240	13	no	no	DET
ejnm-305	240	14	conflicts	conflict	NOUN
ejnm-305	240	15	of	of	ADP
ejnm-305	240	16	interest	interest	NOUN
ejnm-305	240	17	.	.	PUNCT
ejnm-305	241	1	in	in	ADP
ejnm-305	241	2	this	this	DET
ejnm-305	241	3	manuscript	manuscript	NOUN
ejnm-305	241	4	,	,	PUNCT
ejnm-305	241	5	all	all	DET
ejnm-305	241	6	tables	table	NOUN
ejnm-305	241	7	have	have	AUX
ejnm-305	241	8	been	be	AUX
ejnm-305	241	9	authored	author	VERB
ejnm-305	241	10	by	by	ADP
ejnm-305	241	11	us	we	PRON
ejnm-305	241	12	.	.	PUNCT
ejnm-305	242	1	the	the	DET
ejnm-305	242	2	authors	author	NOUN
ejnm-305	242	3	have	have	AUX
ejnm-305	242	4	signed	sign	VERB
ejnm-305	242	5	a	a	DET
ejnm-305	242	6	welfare	welfare	NOUN
ejnm-305	242	7	statement	statement	NOUN
ejnm-305	242	8	at	at	ADP
ejnm-305	242	9	the	the	DET
ejnm-305	242	10	nursing	nursing	NOUN
ejnm-305	242	11	department	department	NOUN
ejnm-305	242	12	at	at	ADP
ejnm-305	242	13	the	the	DET
ejnm-305	242	14	sulaimani	sulaimani	PROPN
ejnm-305	242	15	polytechnic	polytechnic	PROPN
ejnm-305	242	16	university	university	PROPN
ejnm-305	242	17	.	.	PUNCT
ejnm-305	243	1	the	the	DET
ejnm-305	243	2	authors	author	NOUN
ejnm-305	243	3	signed	sign	VERB
ejnm-305	243	4	the	the	DET
ejnm-305	243	5	ethical	ethical	ADJ
ejnm-305	243	6	consideration	consideration	NOUN
ejnm-305	243	7	’s	’s	PART
ejnm-305	243	8	approval	approval	NOUN
ejnm-305	243	9	.	.	PUNCT
ejnm-305	244	1	ethical	ethical	ADJ
ejnm-305	244	2	clearance	clearance	NOUN
ejnm-305	244	3	:	:	PUNCT
ejnm-305	244	4	our	our	PRON
ejnm-305	244	5	work	work	NOUN
ejnm-305	244	6	has	have	AUX
ejnm-305	244	7	been	be	AUX
ejnm-305	244	8	approved	approve	VERB
ejnm-305	244	9	by	by	ADP
ejnm-305	244	10	the	the	DET
ejnm-305	244	11	scientific	scientific	ADJ
ejnm-305	244	12	and	and	CCONJ
ejnm-305	244	13	ethical	ethical	ADJ
ejnm-305	244	14	committee	committee	NOUN
ejnm-305	244	15	at	at	ADP
ejnm-305	244	16	the	the	DET
ejnm-305	244	17	sulaimani	sulaimani	PROPN
ejnm-305	244	18	polytechnic	polytechnic	PROPN
ejnm-305	244	19	university	university	NOUN
ejnm-305	244	20	.	.	PUNCT
ejnm-305	245	1	all	all	DET
ejnm-305	245	2	authors	author	NOUN
ejnm-305	245	3	of	of	ADP
ejnm-305	245	4	this	this	DET
ejnm-305	245	5	study	study	NOUN
ejnm-305	245	6	participated	participate	VERB
ejnm-305	245	7	equally	equally	ADV
ejnm-305	245	8	in	in	ADP
ejnm-305	245	9	all	all	DET
ejnm-305	245	10	stages	stage	NOUN
ejnm-305	245	11	of	of	ADP
ejnm-305	245	12	the	the	DET
ejnm-305	245	13	writing	writing	NOUN
ejnm-305	245	14	process	process	NOUN
ejnm-305	245	15	;	;	PUNCT
ejnm-305	245	16	they	they	PRON
ejnm-305	245	17	also	also	ADV
ejnm-305	245	18	reviewed	review	VERB
ejnm-305	245	19	and	and	CCONJ
ejnm-305	245	20	approved	approve	VERB
ejnm-305	245	21	the	the	DET
ejnm-305	245	22	submission	submission	NOUN
ejnm-305	245	23	of	of	ADP
ejnm-305	245	24	this	this	DET
ejnm-305	245	25	work	work	NOUN
ejnm-305	245	26	.	.	PUNCT
ejnm-305	246	1	the	the	DET
ejnm-305	246	2	authors	author	NOUN
ejnm-305	246	3	would	would	AUX
ejnm-305	246	4	like	like	VERB
ejnm-305	246	5	to	to	PART
ejnm-305	246	6	thank	thank	VERB
ejnm-305	246	7	the	the	DET
ejnm-305	246	8	sulaimani	sulaimani	PROPN
ejnm-305	246	9	polytechnic	polytechnic	PROPN
ejnm-305	246	10	university	university	PROPN
ejnm-305	246	11	,	,	PUNCT
ejnm-305	246	12	darbandikhan	darbandikhan	PROPN
ejnm-305	246	13	technical	technical	PROPN
ejnm-305	246	14	institute	institute	PROPN
ejnm-305	246	15	,	,	PUNCT
ejnm-305	246	16	nursing	nursing	NOUN
ejnm-305	246	17	department	department	NOUN
ejnm-305	246	18	,	,	PUNCT
ejnm-305	246	19	general	general	ADJ
ejnm-305	246	20	health	health	NOUN
ejnm-305	246	21	laboratory	laboratory	NOUN
ejnm-305	246	22	of	of	ADP
ejnm-305	246	23	sulaimanyah/	sulaimanyah/	NUM
ejnm-305	246	24	darbandikhan	darbandikhan	PROPN
ejnm-305	246	25	shahid	shahid	PROPN
ejnm-305	246	26	tofiq	tofiq	PROPN
ejnm-305	246	27	general	general	ADJ
ejnm-305	246	28	hospital	hospital	NOUN
ejnm-305	246	29	,	,	PUNCT
ejnm-305	246	30	and	and	CCONJ
ejnm-305	246	31	all	all	DET
ejnm-305	246	32	patients	patient	NOUN
ejnm-305	246	33	for	for	ADP
ejnm-305	246	34	their	their	PRON
ejnm-305	246	35	support	support	NOUN
ejnm-305	246	36	and	and	CCONJ
ejnm-305	246	37	collaboration	collaboration	NOUN
ejnm-305	246	38	in	in	ADP
ejnm-305	246	39	providing	provide	VERB
ejnm-305	246	40	data	datum	NOUN
ejnm-305	246	41	for	for	ADP
ejnm-305	246	42	this	this	DET
ejnm-305	246	43	research	research	NOUN
ejnm-305	246	44	.	.	PUNCT
ejnm-305	247	1	[	[	X
ejnm-305	247	2	1	1	NUM
ejnm-305	247	3	]	]	X
ejnm-305	247	4	majhi	majhi	NOUN
ejnm-305	247	5	,	,	PUNCT
ejnm-305	247	6	b.	b.	PROPN
ejnm-305	247	7	,	,	PUNCT
ejnm-305	247	8	role	role	NOUN
ejnm-305	247	9	of	of	ADP
ejnm-305	247	10	lipid	lipid	NOUN
ejnm-305	247	11	profile	profile	NOUN
ejnm-305	247	12	in	in	ADP
ejnm-305	247	13	early	early	ADJ
ejnm-305	247	14	second	second	ADJ
ejnm-305	247	15	trimester	trimester	NOUN
ejnm-305	247	16	for	for	ADP
ejnm-305	247	17	prediction	prediction	NOUN
ejnm-305	247	18	of	of	ADP
ejnm-305	247	19	pre	pre	NOUN
ejnm-305	247	20	-	-	NOUN
ejnm-305	247	21	eclampsia	eclampsia	NOUN
ejnm-305	247	22	.	.	PUNCT
ejnm-305	248	1	international	international	ADJ
ejnm-305	248	2	journal	journal	PROPN
ejnm-305	248	3	of	of	ADP
ejnm-305	248	4	reproduction	reproduction	NOUN
ejnm-305	248	5	,	,	PUNCT
ejnm-305	248	6	contraception	contraception	NOUN
ejnm-305	248	7	,	,	PUNCT
ejnm-305	248	8	obstetrics	obstetric	NOUN
ejnm-305	248	9	and	and	CCONJ
ejnm-305	248	10	gynecology	gynecology	NOUN
ejnm-305	248	11	,	,	PUNCT
ejnm-305	248	12	2021	2021	NUM
ejnm-305	248	13	.	.	PUNCT
ejnm-305	249	1	10(8	10(8	NUM
ejnm-305	249	2	):	):	PUNCT
ejnm-305	249	3	p.	p.	NOUN
ejnm-305	249	4	3101	3101	NUM
ejnm-305	249	5	-	-	SYM
ejnm-305	249	6	3106	3106	NUM
ejnm-305	249	7	.	.	PUNCT
ejnm-305	250	1	https://	https://	PROPN
ejnm-305	250	2	doi.org/10.18203/2320-1770.ijrcog20212962	doi.org/10.18203/2320-1770.ijrcog20212962	PROPN
ejnm-305	250	3	[	[	X
ejnm-305	250	4	2	2	NUM
ejnm-305	250	5	]	]	X
ejnm-305	250	6	zeng	zeng	PROPN
ejnm-305	250	7	,	,	PUNCT
ejnm-305	250	8	z.	z.	PROPN
ejnm-305	250	9	,	,	PUNCT
ejnm-305	250	10	f.	f.	PROPN
ejnm-305	250	11	liu	liu	PROPN
ejnm-305	250	12	,	,	PUNCT
ejnm-305	250	13	and	and	CCONJ
ejnm-305	250	14	s.	s.	PROPN
ejnm-305	250	15	li	li	PROPN
ejnm-305	250	16	,	,	PUNCT
ejnm-305	250	17	metabolic	metabolic	NOUN
ejnm-305	250	18	adaptations	adaptation	NOUN
ejnm-305	250	19	in	in	ADP
ejnm-305	250	20	pregnancy	pregnancy	NOUN
ejnm-305	250	21	:	:	PUNCT
ejnm-305	250	22	a	a	DET
ejnm-305	250	23	review	review	NOUN
ejnm-305	250	24	.	.	PUNCT
ejnm-305	251	1	annals	annal	NOUN
ejnm-305	251	2	of	of	ADP
ejnm-305	251	3	nutrition	nutrition	NOUN
ejnm-305	251	4	and	and	CCONJ
ejnm-305	251	5	metabolism	metabolism	NOUN
ejnm-305	251	6	,	,	PUNCT
ejnm-305	251	7	2017	2017	NUM
ejnm-305	251	8	.	.	PUNCT
ejnm-305	252	1	70(1	70(1	NUM
ejnm-305	252	2	):	):	PUNCT
ejnm-305	253	1	p.	p.	NOUN
ejnm-305	253	2	59	59	NUM
ejnm-305	253	3	-	-	SYM
ejnm-305	253	4	65	65	NUM
ejnm-305	253	5	.	.	PUNCT
ejnm-305	254	1	https://doi.org/10.1159/000459633	https://doi.org/10.1159/000459633	X
ejnm-305	255	1	[	[	X
ejnm-305	255	2	3	3	NUM
ejnm-305	255	3	]	]	X
ejnm-305	255	4	quiroga	quiroga	PROPN
ejnm-305	255	5	,	,	PUNCT
ejnm-305	255	6	a.d	a.d	PROPN
ejnm-305	255	7	.	.	PROPN
ejnm-305	255	8	and	and	CCONJ
ejnm-305	255	9	r.	r.	PROPN
ejnm-305	255	10	lehner	lehner	PROPN
ejnm-305	255	11	,	,	PUNCT
ejnm-305	255	12	pharmacological	pharmacological	ADJ
ejnm-305	255	13	intervention	intervention	NOUN
ejnm-305	255	14	of	of	ADP
ejnm-305	255	15	liver	liver	NOUN
ejnm-305	255	16	triacylglycerol	triacylglycerol	NOUN
ejnm-305	255	17	lipolysis	lipolysis	NOUN
ejnm-305	255	18	:	:	PUNCT
ejnm-305	255	19	the	the	DET
ejnm-305	255	20	good	good	NOUN
ejnm-305	255	21	,	,	PUNCT
ejnm-305	255	22	the	the	DET
ejnm-305	255	23	bad	bad	ADJ
ejnm-305	255	24	and	and	CCONJ
ejnm-305	255	25	the	the	DET
ejnm-305	255	26	ugly	ugly	ADJ
ejnm-305	255	27	.	.	PUNCT
ejnm-305	256	1	biochemical	biochemical	ADJ
ejnm-305	256	2	pharmacology	pharmacology	NOUN
ejnm-305	256	3	,	,	PUNCT
ejnm-305	256	4	2018	2018	NUM
ejnm-305	256	5	.	.	PUNCT
ejnm-305	257	1	155	155	NUM
ejnm-305	257	2	:	:	PUNCT
ejnm-305	257	3	p.	p.	NOUN
ejnm-305	257	4	233241.https://doi.org/10.1016/	233241.https://doi.org/10.1016/	NUM
ejnm-305	257	5	j.bcp.2018.07.005	j.bcp.2018.07.005	VERB
ejnm-305	257	6	28	28	NUM
ejnm-305	257	7	copyright	copyright	NOUN
ejnm-305	257	8	©	©	PROPN
ejnm-305	257	9	2025	2025	NUM
ejnm-305	257	10	the	the	DET
ejnm-305	257	11	author(s	author(s	NOUN
ejnm-305	257	12	)	)	PUNCT
ejnm-305	257	13	.	.	PUNCT
ejnm-305	258	1	this	this	PRON
ejnm-305	258	2	is	be	AUX
ejnm-305	258	3	an	an	DET
ejnm-305	258	4	open	open	ADJ
ejnm-305	258	5	access	access	NOUN
ejnm-305	258	6	article	article	NOUN
ejnm-305	258	7	which	which	PRON
ejnm-305	258	8	licensed	license	VERB
ejnm-305	258	9	under	under	ADP
ejnm-305	258	10	the	the	DET
ejnm-305	258	11	terms	term	NOUN
ejnm-305	258	12	and	and	CCONJ
ejnm-305	258	13	conditions	condition	NOUN
ejnm-305	258	14	of	of	ADP
ejnm-305	258	15	the	the	DET
ejnm-305	258	16	creative	creative	ADJ
ejnm-305	258	17	commons	common	NOUN
ejnm-305	258	18	attribution	attribution	NOUN
ejnm-305	258	19	-	-	PUNCT
ejnm-305	258	20	noncommercial	noncommercial	ADJ
ejnm-305	258	21	-	-	PUNCT
ejnm-305	258	22	sharealike	sharealike	ADJ
ejnm-305	258	23	4.0	4.0	NUM
ejnm-305	258	24	international	international	ADJ
ejnm-305	258	25	license	license	NOUN
ejnm-305	258	26	.	.	PUNCT
ejnm-305	259	1	it	it	PRON
ejnm-305	259	2	permits	permit	VERB
ejnm-305	259	3	no	no	DET
ejnm-305	259	4	additional	additional	ADJ
ejnm-305	259	5	restrictions	restriction	NOUN
ejnm-305	259	6	on	on	ADP
ejnm-305	259	7	use	use	NOUN
ejnm-305	259	8	,	,	PUNCT
ejnm-305	259	9	distribution	distribution	NOUN
ejnm-305	259	10	,	,	PUNCT
ejnm-305	259	11	and	and	CCONJ
ejnm-305	259	12	reproduction	reproduction	NOUN
ejnm-305	259	13	in	in	ADP
ejnm-305	259	14	any	any	DET
ejnm-305	259	15	medium	medium	NOUN
ejnm-305	259	16	provided	provide	VERB
ejnm-305	259	17	the	the	DET
ejnm-305	259	18	original	original	ADJ
ejnm-305	259	19	work	work	NOUN
ejnm-305	259	20	is	be	AUX
ejnm-305	259	21	properly	properly	ADV
ejnm-305	259	22	cited	cite	VERB
ejnm-305	259	23	.	.	PUNCT
ejnm-305	260	1	acknowledgement	acknowledgement	PROPN
ejnm-305	260	2	author	author	PROPN
ejnm-305	260	3	’s	’s	PROPN
ejnm-305	260	4	declaration	declaration	PROPN
ejnm-305	260	5	author	author	NOUN
ejnm-305	260	6	’s	’s	PART
ejnm-305	260	7	contribution	contribution	NOUN
ejnm-305	260	8	statement	statement	NOUN
ejnm-305	260	9	references	reference	VERB
ejnm-305	260	10	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN
ejnm-305	260	11	https://doi.org/10.15218/ejnm.2025.03	https://doi.org/10.15218/ejnm.2025.03	PROPN
ejnm-305	260	12	erbil	erbil	PROPN
ejnm-305	260	13	j.	j.	PROPN
ejnm-305	260	14	nurs	nurs	PROPN
ejnm-305	260	15	.	.	PUNCT
ejnm-305	261	1	midwifery	midwifery	ADJ
ejnm-305	261	2	,	,	PUNCT
ejnm-305	261	3	vol	vol	NOUN
ejnm-305	261	4	.	.	PROPN
ejnm-305	261	5	8	8	NUM
ejnm-305	261	6	,	,	PUNCT
ejnm-305	261	7	no	no	INTJ
ejnm-305	261	8	.	.	PUNCT
ejnm-305	262	1	(	(	PUNCT
ejnm-305	262	2	1	1	NUM
ejnm-305	262	3	)	)	PUNCT
ejnm-305	262	4	,	,	PUNCT
ejnm-305	262	5	may	may	AUX
ejnm-305	262	6	2025	2025	NUM
ejnm-305	262	7	original	original	ADJ
ejnm-305	262	8	article	article	NOUN
ejnm-305	262	9	[	[	X
ejnm-305	262	10	20	20	NUM
ejnm-305	262	11	]	]	X
ejnm-305	262	12	cheung	cheung	PROPN
ejnm-305	262	13	,	,	PUNCT
ejnm-305	262	14	k.l	k.l	PROPN
ejnm-305	262	15	.	.	PROPN
ejnm-305	262	16	and	and	CCONJ
ejnm-305	262	17	r.a	r.a	PROPN
ejnm-305	262	18	.	.	PROPN
ejnm-305	262	19	lafayette	lafayette	PROPN
ejnm-305	262	20	,	,	PUNCT
ejnm-305	262	21	renal	renal	ADJ
ejnm-305	262	22	physiology	physiology	NOUN
ejnm-305	262	23	of	of	ADP
ejnm-305	262	24	pregnancy	pregnancy	NOUN
ejnm-305	262	25	.	.	PUNCT
ejnm-305	263	1	advances	advance	NOUN
ejnm-305	263	2	in	in	ADP
ejnm-305	263	3	chronic	chronic	ADJ
ejnm-305	263	4	kidney	kidney	NOUN
ejnm-305	263	5	disease	disease	NOUN
ejnm-305	263	6	,	,	PUNCT
ejnm-305	263	7	2013	2013	NUM
ejnm-305	263	8	.	.	PUNCT
ejnm-305	264	1	20(3	20(3	NOUN
ejnm-305	264	2	):	):	PUNCT
ejnm-305	264	3	p.	p.	NOUN
ejnm-305	264	4	209214.https://doi.org/10.1053/	209214.https://doi.org/10.1053/	PROPN
ejnm-305	265	1	j.ackd.2013.01.012	j.ackd.2013.01.012	PROPN
ejnm-305	265	2	.	.	PUNCT
ejnm-305	266	1	[	[	X
ejnm-305	266	2	21	21	NUM
ejnm-305	266	3	]	]	X
ejnm-305	266	4	cai	cai	X
ejnm-305	266	5	,	,	PUNCT
ejnm-305	266	6	a.	a.	PROPN
ejnm-305	266	7	,	,	PUNCT
ejnm-305	266	8	s.	s.	PROPN
ejnm-305	266	9	qi	qi	PROPN
ejnm-305	266	10	,	,	PUNCT
ejnm-305	266	11	z.	z.	PROPN
ejnm-305	266	12	su	su	PROPN
ejnm-305	266	13	,	,	PUNCT
ejnm-305	266	14	h.	h.	PROPN
ejnm-305	266	15	shen	shen	PROPN
ejnm-305	266	16	,	,	PUNCT
ejnm-305	266	17	y.	y.	PROPN
ejnm-305	266	18	yang	yang	PROPN
ejnm-305	266	19	,	,	PUNCT
ejnm-305	266	20	w.	w.	PROPN
ejnm-305	266	21	cai	cai	PROPN
ejnm-305	266	22	,	,	PUNCT
ejnm-305	266	23	et	et	PROPN
ejnm-305	266	24	al	al	PROPN
ejnm-305	266	25	.	.	PROPN
ejnm-305	266	26	,	,	PUNCT
ejnm-305	266	27	a	a	DET
ejnm-305	266	28	pilot	pilot	NOUN
ejnm-305	266	29	metabolic	metabolic	NOUN
ejnm-305	266	30	profiling	profiling	NOUN
ejnm-305	266	31	study	study	NOUN
ejnm-305	266	32	of	of	ADP
ejnm-305	266	33	patients	patient	NOUN
ejnm-305	266	34	with	with	ADP
ejnm-305	266	35	neonatal	neonatal	ADJ
ejnm-305	266	36	jaundice	jaundice	NOUN
ejnm-305	266	37	and	and	CCONJ
ejnm-305	266	38	response	response	NOUN
ejnm-305	266	39	to	to	ADP
ejnm-305	266	40	phototherapy	phototherapy	NOUN
ejnm-305	266	41	.	.	PUNCT
ejnm-305	267	1	clinical	clinical	ADJ
ejnm-305	267	2	and	and	CCONJ
ejnm-305	267	3	translational	translational	ADJ
ejnm-305	267	4	science	science	NOUN
ejnm-305	267	5	,	,	PUNCT
ejnm-305	267	6	2016	2016	NUM
ejnm-305	267	7	.	.	PUNCT
ejnm-305	268	1	9(4	9(4	NOUN
ejnm-305	268	2	):	):	PUNCT
ejnm-305	269	1	p.	p.	NOUN
ejnm-305	269	2	216	216	NUM
ejnm-305	269	3	-	-	SYM
ejnm-305	269	4	220	220	NUM
ejnm-305	269	5	.	.	PUNCT
ejnm-305	270	1	https://doi.org/10.1111/cts.12401	https://doi.org/10.1111/cts.12401	PROPN
ejnm-305	270	2	[	[	X
ejnm-305	270	3	22	22	NUM
ejnm-305	270	4	]	]	SYM
ejnm-305	270	5	yun	yun	PROPN
ejnm-305	270	6	,	,	PUNCT
ejnm-305	270	7	h.j	h.j	PROPN
ejnm-305	270	8	.	.	PROPN
ejnm-305	270	9	,	,	PUNCT
ejnm-305	270	10	s.r	s.r	PROPN
ejnm-305	270	11	.	.	PROPN
ejnm-305	270	12	ryoo	ryoo	NOUN
ejnm-305	270	13	,	,	PUNCT
ejnm-305	270	14	j.-e	j.-e	PROPN
ejnm-305	270	15	.	.	PUNCT
ejnm-305	271	1	kim	kim	PROPN
ejnm-305	271	2	,	,	PUNCT
ejnm-305	271	3	y.j	y.j	PROPN
ejnm-305	271	4	.	.	PUNCT
ejnm-305	271	5	choi	choi	PROPN
ejnm-305	271	6	,	,	PUNCT
ejnm-305	271	7	i.	i.	NOUN
ejnm-305	271	8	park	park	PROPN
ejnm-305	271	9	,	,	PUNCT
ejnm-305	271	10	g.-t	g.-t	PROPN
ejnm-305	271	11	.	.	PUNCT
ejnm-305	272	1	shin	shin	PROPN
ejnm-305	272	2	,	,	PUNCT
ejnm-305	272	3	et	et	PROPN
ejnm-305	272	4	al	al	PROPN
ejnm-305	272	5	.	.	PROPN
ejnm-305	272	6	,	,	PUNCT
ejnm-305	272	7	trabecular	trabecular	ADJ
ejnm-305	272	8	bone	bone	NOUN
ejnm-305	272	9	score	score	NOUN
ejnm-305	272	10	may	may	AUX
ejnm-305	272	11	indicate	indicate	VERB
ejnm-305	272	12	chronic	chronic	ADJ
ejnm-305	272	13	kidney	kidney	NOUN
ejnm-305	272	14	disease	disease	NOUN
ejnm-305	272	15	-	-	PUNCT
ejnm-305	272	16	mineral	mineral	NOUN
ejnm-305	272	17	and	and	CCONJ
ejnm-305	272	18	bone	bone	NOUN
ejnm-305	272	19	disorder	disorder	NOUN
ejnm-305	272	20	(	(	PUNCT
ejnm-305	272	21	ckd	ckd	PROPN
ejnm-305	272	22	-	-	PUNCT
ejnm-305	272	23	mbd	mbd	VERB
ejnm-305	272	24	)	)	PUNCT
ejnm-305	272	25	phenotypes	phenotype	NOUN
ejnm-305	272	26	in	in	ADP
ejnm-305	272	27	hemodialysis	hemodialysis	NOUN
ejnm-305	272	28	patients	patient	NOUN
ejnm-305	272	29	:	:	PUNCT
ejnm-305	272	30	a	a	DET
ejnm-305	272	31	prospective	prospective	ADJ
ejnm-305	272	32	observational	observational	ADJ
ejnm-305	272	33	study	study	NOUN
ejnm-305	272	34	.	.	PUNCT
ejnm-305	273	1	bmc	bmc	ADJ
ejnm-305	273	2	nephrology	nephrology	NOUN
ejnm-305	273	3	,	,	PUNCT
ejnm-305	273	4	2020	2020	NUM
ejnm-305	273	5	.	.	PUNCT
ejnm-305	274	1	21	21	NUM
ejnm-305	274	2	:	:	PUNCT
ejnm-305	275	1	p.	p.	NOUN
ejnm-305	275	2	1	1	NUM
ejnm-305	275	3	-	-	SYM
ejnm-305	275	4	10	10	NUM
ejnm-305	275	5	.	.	PUNCT
ejnm-305	276	1	https://doi.org/10.1186/s12882	https://doi.org/10.1186/s12882	NUM
ejnm-305	276	2	-020	-020	PROPN
ejnm-305	276	3	-	-	PUNCT
ejnm-305	276	4	01944	01944	NUM
ejnm-305	276	5	-	-	SYM
ejnm-305	276	6	0	0	PUNCT
ejnm-305	277	1	[	[	X
ejnm-305	277	2	23	23	NUM
ejnm-305	277	3	]	]	X
ejnm-305	277	4	al	al	PROPN
ejnm-305	277	5	-	-	PUNCT
ejnm-305	277	6	ghazali	ghazali	PROPN
ejnm-305	277	7	,	,	PUNCT
ejnm-305	277	8	b.s	b.s	PROPN
ejnm-305	277	9	.	.	PROPN
ejnm-305	277	10	,	,	PUNCT
ejnm-305	277	11	b.a	b.a	PROPN
ejnm-305	277	12	.	.	PROPN
ejnm-305	277	13	hashim	hashim	PROPN
ejnm-305	277	14	,	,	PUNCT
ejnm-305	277	15	and	and	CCONJ
ejnm-305	277	16	a.	a.	NOUN
ejnm-305	277	17	habib	habib	PROPN
ejnm-305	277	18	,	,	PUNCT
ejnm-305	277	19	calcium	calcium	NOUN
ejnm-305	277	20	and	and	CCONJ
ejnm-305	277	21	phosphate	phosphate	ADJ
ejnm-305	277	22	excretion	excretion	NOUN
ejnm-305	277	23	in	in	ADP
ejnm-305	277	24	preeclampsia	preeclampsia	NOUN
ejnm-305	277	25	,	,	PUNCT
ejnm-305	277	26	as	as	ADP
ejnm-305	277	27	markers	marker	NOUN
ejnm-305	277	28	of	of	ADP
ejnm-305	277	29	severe	severe	ADJ
ejnm-305	277	30	disease	disease	NOUN
ejnm-305	277	31	.	.	PUNCT
ejnm-305	278	1	medical	medical	ADJ
ejnm-305	278	2	journal	journal	PROPN
ejnm-305	278	3	of	of	ADP
ejnm-305	278	4	babylon	babylon	PROPN
ejnm-305	278	5	,	,	PUNCT
ejnm-305	278	6	2010	2010	NUM
ejnm-305	278	7	.	.	PUNCT
ejnm-305	279	1	9(4	9(4	NUM
ejnm-305	279	2	):	):	PUNCT
ejnm-305	280	1	p.	p.	NOUN
ejnm-305	280	2	755	755	NUM
ejnm-305	280	3	-	-	SYM
ejnm-305	280	4	3	3	NUM
ejnm-305	280	5	.	.	PUNCT
ejnm-305	281	1	[	[	X
ejnm-305	281	2	24	24	NUM
ejnm-305	281	3	]	]	PUNCT
ejnm-305	281	4	hannawi	hannawi	NOUN
ejnm-305	281	5	,	,	PUNCT
ejnm-305	281	6	s.	s.	PROPN
ejnm-305	281	7	,	,	PUNCT
ejnm-305	281	8	h.	h.	PROPN
ejnm-305	281	9	hannawi	hannawi	PROPN
ejnm-305	281	10	,	,	PUNCT
ejnm-305	281	11	f.	f.	PROPN
ejnm-305	281	12	alokaily	alokaily	ADV
ejnm-305	281	13	,	,	PUNCT
ejnm-305	281	14	and	and	CCONJ
ejnm-305	281	15	i.	i.	PROPN
ejnm-305	281	16	al	al	PROPN
ejnm-305	281	17	salmi	salmi	PROPN
ejnm-305	281	18	,	,	PUNCT
ejnm-305	281	19	variables	variable	NOUN
ejnm-305	281	20	associated	associate	VERB
ejnm-305	281	21	with	with	ADP
ejnm-305	281	22	subclinical	subclinical	ADJ
ejnm-305	281	23	atherosclerosis	atherosclerosis	NOUN
ejnm-305	281	24	among	among	ADP
ejnm-305	281	25	rheumatoid	rheumatoid	NOUN
ejnm-305	281	26	arthritis	arthritis	NOUN
ejnm-305	281	27	patients	patient	NOUN
ejnm-305	281	28	of	of	ADP
ejnm-305	281	29	gulf	gulf	PROPN
ejnm-305	281	30	cooperative	cooperative	ADJ
ejnm-305	281	31	council	council	NOUN
ejnm-305	281	32	countries	country	NOUN
ejnm-305	281	33	.	.	PUNCT
ejnm-305	282	1	saudi	saudi	ADJ
ejnm-305	282	2	medical	medical	ADJ
ejnm-305	282	3	journal	journal	NOUN
ejnm-305	282	4	,	,	PUNCT
ejnm-305	282	5	2020	2020	NUM
ejnm-305	282	6	.	.	PUNCT
ejnm-305	283	1	41	41	NUM
ejnm-305	283	2	(	(	PUNCT
ejnm-305	283	3	2	2	NUM
ejnm-305	283	4	):	):	PUNCT
ejnm-305	283	5	p.	p.	NOUN
ejnm-305	283	6	128.https://doi.org/10.15537	128.https://doi.org/10.15537	NUM
ejnm-305	283	7	%	%	NOUN
ejnm-305	283	8	2fsmj.2020.2.24900	2fsmj.2020.2.24900	NUM
ejnm-305	283	9	.	.	PUNCT
ejnm-305	284	1	[	[	X
ejnm-305	284	2	25	25	NUM
ejnm-305	284	3	]	]	PUNCT
ejnm-305	284	4	barat	barat	PROPN
ejnm-305	284	5	,	,	PUNCT
ejnm-305	284	6	s.	s.	PROPN
ejnm-305	284	7	,	,	PUNCT
ejnm-305	284	8	a.	a.	NOUN
ejnm-305	284	9	ghanbarpour	ghanbarpour	NOUN
ejnm-305	284	10	,	,	PUNCT
ejnm-305	284	11	z.	z.	PROPN
ejnm-305	284	12	bouzari	bouzari	PROPN
ejnm-305	284	13	,	,	PUNCT
ejnm-305	284	14	and	and	CCONJ
ejnm-305	284	15	z.	z.	PROPN
ejnm-305	284	16	batebi	batebi	PROPN
ejnm-305	284	17	,	,	PUNCT
ejnm-305	284	18	triglyceride	triglyceride	ADP
ejnm-305	284	19	to	to	ADP
ejnm-305	284	20	hdl	hdl	PROPN
ejnm-305	284	21	cholesterol	cholesterol	PROPN
ejnm-305	284	22	ratio	ratio	NOUN
ejnm-305	284	23	and	and	CCONJ
ejnm-305	284	24	risk	risk	NOUN
ejnm-305	284	25	for	for	ADP
ejnm-305	284	26	gestational	gestational	ADJ
ejnm-305	284	27	diabetes	diabetes	NOUN
ejnm-305	284	28	and	and	CCONJ
ejnm-305	284	29	birth	birth	NOUN
ejnm-305	284	30	of	of	ADP
ejnm-305	284	31	a	a	DET
ejnm-305	284	32	large	large	ADJ
ejnm-305	284	33	-	-	PUNCT
ejnm-305	284	34	for	for	ADP
ejnm-305	284	35	-	-	PUNCT
ejnm-305	284	36	gestational	gestational	ADJ
ejnm-305	284	37	-	-	PUNCT
ejnm-305	284	38	age	age	NOUN
ejnm-305	284	39	newborn	newborn	NOUN
ejnm-305	284	40	.	.	PUNCT
ejnm-305	285	1	caspian	caspian	PROPN
ejnm-305	285	2	journal	journal	PROPN
ejnm-305	285	3	of	of	ADP
ejnm-305	285	4	internal	internal	ADJ
ejnm-305	285	5	medicine	medicine	NOUN
ejnm-305	285	6	,	,	PUNCT
ejnm-305	285	7	2018	2018	NUM
ejnm-305	285	8	.	.	PUNCT
ejnm-305	286	1	9(4	9(4	NUM
ejnm-305	286	2	):	):	PUNCT
ejnm-305	286	3	p.368.https://doi.org/10.22088	p.368.https://doi.org/10.22088	NOUN
ejnm-305	286	4	%	%	NOUN
ejnm-305	286	5	2fcjim.9.4.368	2fcjim.9.4.368	NUM
ejnm-305	286	6	.	.	PUNCT
ejnm-305	287	1	[	[	X
ejnm-305	287	2	26	26	NUM
ejnm-305	287	3	]	]	X
ejnm-305	287	4	wang	wang	PROPN
ejnm-305	287	5	,	,	PUNCT
ejnm-305	287	6	c.	c.	PROPN
ejnm-305	287	7	,	,	PUNCT
ejnm-305	287	8	w.	w.	PROPN
ejnm-305	287	9	zhu	zhu	PROPN
ejnm-305	287	10	,	,	PUNCT
ejnm-305	287	11	y.	y.	PROPN
ejnm-305	287	12	wei	wei	PROPN
ejnm-305	287	13	,	,	PUNCT
ejnm-305	287	14	r.	r.	PROPN
ejnm-305	287	15	su	su	PROPN
ejnm-305	287	16	,	,	PUNCT
ejnm-305	287	17	h.	h.	PROPN
ejnm-305	287	18	feng	feng	PROPN
ejnm-305	287	19	,	,	PUNCT
ejnm-305	287	20	l.	l.	PROPN
ejnm-305	287	21	lin	lin	PROPN
ejnm-305	287	22	,	,	PUNCT
ejnm-305	287	23	et	et	PROPN
ejnm-305	287	24	al	al	PROPN
ejnm-305	287	25	.	.	PROPN
ejnm-305	287	26	,	,	PUNCT
ejnm-305	287	27	the	the	DET
ejnm-305	287	28	predictive	predictive	ADJ
ejnm-305	287	29	effects	effect	NOUN
ejnm-305	287	30	of	of	ADP
ejnm-305	287	31	early	early	ADJ
ejnm-305	287	32	pregnancy	pregnancy	NOUN
ejnm-305	287	33	lipid	lipid	NOUN
ejnm-305	287	34	profiles	profile	NOUN
ejnm-305	287	35	and	and	CCONJ
ejnm-305	287	36	fasting	fast	VERB
ejnm-305	287	37	glucose	glucose	NOUN
ejnm-305	287	38	on	on	ADP
ejnm-305	287	39	the	the	DET
ejnm-305	287	40	risk	risk	NOUN
ejnm-305	287	41	of	of	ADP
ejnm-305	287	42	gestational	gestational	ADJ
ejnm-305	287	43	diabetes	diabetes	NOUN
ejnm-305	287	44	mellitus	mellitus	NOUN
ejnm-305	287	45	stratified	stratify	VERB
ejnm-305	287	46	by	by	ADP
ejnm-305	287	47	body	body	NOUN
ejnm-305	287	48	mass	mass	PROPN
ejnm-305	287	49	index	index	PROPN
ejnm-305	287	50	.	.	PUNCT
ejnm-305	288	1	journal	journal	PROPN
ejnm-305	288	2	of	of	ADP
ejnm-305	288	3	diabetes	diabetes	NOUN
ejnm-305	288	4	research	research	NOUN
ejnm-305	288	5	,	,	PUNCT
ejnm-305	288	6	2016	2016	NUM
ejnm-305	288	7	.	.	PUNCT
ejnm-305	289	1	2016.https://	2016.https://	NUM
ejnm-305	289	2	doi.org/10.1155/2016/3013567	doi.org/10.1155/2016/3013567	NOUN
ejnm-305	289	3	.	.	PUNCT
ejnm-305	290	1	[	[	X
ejnm-305	290	2	27	27	NUM
ejnm-305	290	3	]	]	X
ejnm-305	290	4	biadgo	biadgo	PROPN
ejnm-305	290	5	,	,	PUNCT
ejnm-305	290	6	b.	b.	PROPN
ejnm-305	290	7	,	,	PUNCT
ejnm-305	290	8	s.m	s.m	PROPN
ejnm-305	290	9	.	.	PROPN
ejnm-305	290	10	abebe	abebe	PROPN
ejnm-305	290	11	,	,	PUNCT
ejnm-305	290	12	h.w	h.w	PROPN
ejnm-305	290	13	.	.	PROPN
ejnm-305	290	14	baynes	baynes	PROPN
ejnm-305	290	15	,	,	PUNCT
ejnm-305	290	16	m.	m.	NOUN
ejnm-305	290	17	yesuf	yesuf	PROPN
ejnm-305	290	18	,	,	PUNCT
ejnm-305	290	19	a.	a.	PROPN
ejnm-305	290	20	alemu	alemu	PROPN
ejnm-305	290	21	,	,	PUNCT
ejnm-305	290	22	and	and	CCONJ
ejnm-305	290	23	m.	m.	NOUN
ejnm-305	290	24	abebe	abebe	PROPN
ejnm-305	290	25	,	,	PUNCT
ejnm-305	290	26	correlation	correlation	NOUN
ejnm-305	290	27	between	between	ADP
ejnm-305	290	28	serum	serum	NOUN
ejnm-305	290	29	lipid	lipid	NOUN
ejnm-305	290	30	profile	profile	NOUN
ejnm-305	290	31	with	with	ADP
ejnm-305	290	32	anthropometric	anthropometric	ADJ
ejnm-305	290	33	and	and	CCONJ
ejnm-305	290	34	clinical	clinical	ADJ
ejnm-305	290	35	variables	variable	NOUN
ejnm-305	290	36	in	in	ADP
ejnm-305	290	37	patients	patient	NOUN
ejnm-305	290	38	with	with	ADP
ejnm-305	290	39	type	type	NOUN
ejnm-305	290	40	2	2	NUM
ejnm-305	290	41	diabetes	diabetes	NOUN
ejnm-305	290	42	mellitus	mellitus	NOUN
ejnm-305	290	43	.	.	PUNCT
ejnm-305	291	1	ethiopian	ethiopian	PROPN
ejnm-305	291	2	journal	journal	PROPN
ejnm-305	291	3	of	of	ADP
ejnm-305	291	4	health	health	PROPN
ejnm-305	291	5	sciences	sciences	PROPN
ejnm-305	291	6	,	,	PUNCT
ejnm-305	291	7	2017	2017	NUM
ejnm-305	291	8	.	.	PUNCT
ejnm-305	292	1	27(3	27(3	NUM
ejnm-305	292	2	):	):	PUNCT
ejnm-305	293	1	p.	p.	NOUN
ejnm-305	293	2	215226.https://doi.org/10.4314/ejhs.v27i3.3	215226.https://doi.org/10.4314/ejhs.v27i3.3	NUM
ejnm-305	294	1	[	[	X
ejnm-305	294	2	12	12	NUM
ejnm-305	294	3	]	]	SYM
ejnm-305	294	4	silbert	silbert	NOUN
ejnm-305	294	5	,	,	PUNCT
ejnm-305	294	6	b.i	b.i	PROPN
ejnm-305	294	7	.	.	PROPN
ejnm-305	294	8	,	,	PUNCT
ejnm-305	294	9	the	the	DET
ejnm-305	294	10	pharmacology	pharmacology	NOUN
ejnm-305	294	11	and	and	CCONJ
ejnm-305	294	12	oxidative	oxidative	ADJ
ejnm-305	294	13	stress	stress	NOUN
ejnm-305	294	14	effects	effect	NOUN
ejnm-305	294	15	of	of	ADP
ejnm-305	294	16	frusemide	frusemide	PRON
ejnm-305	294	17	in	in	ADP
ejnm-305	294	18	acute	acute	ADJ
ejnm-305	294	19	kidney	kidney	NOUN
ejnm-305	294	20	injury	injury	NOUN
ejnm-305	294	21	.	.	PUNCT
ejnm-305	295	1	the	the	DET
ejnm-305	295	2	university	university	PROPN
ejnm-305	295	3	of	of	ADP
ejnm-305	295	4	western	western	PROPN
ejnm-305	295	5	australia	australia	PROPN
ejnm-305	295	6	.	.	PUNCT
ejnm-305	296	1	master	master	NOUN
ejnm-305	296	2	thesis	thesis	NOUN
ejnm-305	296	3	2018	2018	NUM
ejnm-305	296	4	[	[	SYM
ejnm-305	296	5	13	13	NUM
ejnm-305	296	6	]	]	SYM
ejnm-305	296	7	lady	lady	NOUN
ejnm-305	296	8	aqnes	aqne	NOUN
ejnm-305	296	9	kurniawati	kurniawati	PROPN
ejnm-305	296	10	,	,	PUNCT
ejnm-305	296	11	l.	l.	PROPN
ejnm-305	296	12	,	,	PUNCT
ejnm-305	296	13	m.	m.	NOUN
ejnm-305	296	14	muhammad	muhammad	PROPN
ejnm-305	296	15	ilham	ilham	PROPN
ejnm-305	296	16	aldika	aldika	PROPN
ejnm-305	296	17	akbar	akbar	PROPN
ejnm-305	296	18	,	,	PUNCT
ejnm-305	296	19	b.	b.	PROPN
ejnm-305	296	20	budi	budi	PROPN
ejnm-305	296	21	utomo	utomo	PROPN
ejnm-305	296	22	,	,	PUNCT
ejnm-305	296	23	and	and	CCONJ
ejnm-305	296	24	a.	a.	NOUN
ejnm-305	296	25	aditiawarman	aditiawarman	PROPN
ejnm-305	296	26	,	,	PUNCT
ejnm-305	296	27	risk	risk	NOUN
ejnm-305	296	28	factor	factor	NOUN
ejnm-305	296	29	of	of	ADP
ejnm-305	296	30	preeclampsia	preeclampsia	NOUN
ejnm-305	296	31	in	in	ADP
ejnm-305	296	32	a	a	DET
ejnm-305	296	33	secondary	secondary	ADJ
ejnm-305	296	34	indonesian	indonesian	ADJ
ejnm-305	296	35	hospital	hospital	NOUN
ejnm-305	296	36	:	:	PUNCT
ejnm-305	296	37	a	a	DET
ejnm-305	296	38	casecontrol	casecontrol	NOUN
ejnm-305	296	39	study	study	NOUN
ejnm-305	296	40	.	.	PUNCT
ejnm-305	297	1	indian	indian	PROPN
ejnm-305	297	2	journal	journal	PROPN
ejnm-305	297	3	of	of	ADP
ejnm-305	297	4	forensic	forensic	ADJ
ejnm-305	297	5	medicine	medicine	NOUN
ejnm-305	297	6	&	&	CCONJ
ejnm-305	297	7	toxicology	toxicology	NOUN
ejnm-305	297	8	,	,	PUNCT
ejnm-305	297	9	2021	2021	NUM
ejnm-305	297	10	.	.	PUNCT
ejnm-305	298	1	15(3	15(3	NUM
ejnm-305	298	2	):	):	PUNCT
ejnm-305	299	1	p.	p.	NOUN
ejnm-305	299	2	34743482.https://doi.org/10.37506/	34743482.https://doi.org/10.37506/	NOUN
ejnm-305	300	1	ijfmt.v15i3.15839	ijfmt.v15i3.15839	NOUN
ejnm-305	300	2	[	[	X
ejnm-305	300	3	14	14	NUM
ejnm-305	300	4	]	]	SYM
ejnm-305	300	5	wu	wu	PROPN
ejnm-305	300	6	,	,	PUNCT
ejnm-305	300	7	l.	l.	PROPN
ejnm-305	300	8	,	,	PUNCT
ejnm-305	300	9	q.	q.	PROPN
ejnm-305	300	10	wu	wu	PROPN
ejnm-305	300	11	,	,	PUNCT
ejnm-305	300	12	q.	q.	PROPN
ejnm-305	300	13	li	li	PROPN
ejnm-305	300	14	,	,	PUNCT
ejnm-305	300	15	s.	s.	PROPN
ejnm-305	300	16	cao	cao	PROPN
ejnm-305	300	17	,	,	PUNCT
ejnm-305	300	18	y.	y.	PROPN
ejnm-305	300	19	zhang	zhang	PROPN
ejnm-305	300	20	,	,	PUNCT
ejnm-305	300	21	y.	y.	PROPN
ejnm-305	300	22	liu	liu	PROPN
ejnm-305	300	23	,	,	PUNCT
ejnm-305	300	24	et	et	PROPN
ejnm-305	300	25	al	al	PROPN
ejnm-305	300	26	.	.	PROPN
ejnm-305	300	27	,	,	PUNCT
ejnm-305	300	28	consecutive	consecutive	ADJ
ejnm-305	300	29	reference	reference	NOUN
ejnm-305	300	30	intervals	interval	NOUN
ejnm-305	300	31	for	for	ADP
ejnm-305	300	32	biochemical	biochemical	ADJ
ejnm-305	300	33	indices	index	NOUN
ejnm-305	300	34	related	relate	VERB
ejnm-305	300	35	to	to	ADP
ejnm-305	300	36	serum	serum	NOUN
ejnm-305	300	37	lipid	lipid	NOUN
ejnm-305	300	38	levels	level	NOUN
ejnm-305	300	39	and	and	CCONJ
ejnm-305	300	40	renal	renal	ADJ
ejnm-305	300	41	function	function	NOUN
ejnm-305	300	42	during	during	ADP
ejnm-305	300	43	normal	normal	ADJ
ejnm-305	300	44	pregnancy	pregnancy	NOUN
ejnm-305	300	45	.	.	PUNCT
ejnm-305	301	1	bmc	bmc	ADJ
ejnm-305	301	2	pregnancy	pregnancy	NOUN
ejnm-305	301	3	and	and	CCONJ
ejnm-305	301	4	childbirth	childbirth	NOUN
ejnm-305	301	5	,	,	PUNCT
ejnm-305	301	6	2022	2022	NUM
ejnm-305	301	7	.	.	PUNCT
ejnm-305	302	1	22(1	22(1	NUM
ejnm-305	302	2	):	):	PUNCT
ejnm-305	303	1	p.	p.	NOUN
ejnm-305	303	2	642.https://doi.org/10.1186/	642.https://doi.org/10.1186/	PROPN
ejnm-305	304	1	s12884	s12884	PROPN
ejnm-305	304	2	-	-	PUNCT
ejnm-305	304	3	022	022	PROPN
ejnm-305	304	4	-	-	PUNCT
ejnm-305	304	5	04960	04960	NUM
ejnm-305	304	6	-	-	SYM
ejnm-305	304	7	0	0	PUNCT
ejnm-305	305	1	[	[	X
ejnm-305	305	2	15	15	NUM
ejnm-305	305	3	]	]	X
ejnm-305	305	4	gao	gao	PROPN
ejnm-305	305	5	,	,	PUNCT
ejnm-305	305	6	y.	y.	PROPN
ejnm-305	305	7	,	,	PUNCT
ejnm-305	305	8	j.	j.	PROPN
ejnm-305	305	9	jia	jia	PROPN
ejnm-305	305	10	,	,	PUNCT
ejnm-305	305	11	x.	x.	PROPN
ejnm-305	305	12	liu	liu	PROPN
ejnm-305	305	13	,	,	PUNCT
ejnm-305	305	14	s.	s.	PROPN
ejnm-305	305	15	guo	guo	PROPN
ejnm-305	305	16	,	,	PUNCT
ejnm-305	305	17	and	and	CCONJ
ejnm-305	305	18	l.	l.	PROPN
ejnm-305	305	19	ming	ming	PROPN
ejnm-305	305	20	,	,	PUNCT
ejnm-305	305	21	trimester	trimester	NOUN
ejnm-305	305	22	-	-	PUNCT
ejnm-305	305	23	specific	specific	ADJ
ejnm-305	305	24	reference	reference	NOUN
ejnm-305	305	25	intervals	interval	NOUN
ejnm-305	305	26	of	of	ADP
ejnm-305	305	27	serum	serum	NOUN
ejnm-305	305	28	urea	urea	NOUN
ejnm-305	305	29	,	,	PUNCT
ejnm-305	305	30	creatinine	creatinine	NOUN
ejnm-305	305	31	,	,	PUNCT
ejnm-305	305	32	and	and	CCONJ
ejnm-305	305	33	uric	uric	ADJ
ejnm-305	305	34	acid	acid	NOUN
ejnm-305	305	35	among	among	ADP
ejnm-305	305	36	healthy	healthy	ADJ
ejnm-305	305	37	pregnant	pregnant	ADJ
ejnm-305	305	38	women	woman	NOUN
ejnm-305	305	39	in	in	ADP
ejnm-305	305	40	zhengzhou	zhengzhou	PROPN
ejnm-305	305	41	,	,	PUNCT
ejnm-305	305	42	china	china	PROPN
ejnm-305	305	43	.	.	PUNCT
ejnm-305	306	1	laboratory	laboratory	NOUN
ejnm-305	306	2	medicine	medicine	NOUN
ejnm-305	306	3	,	,	PUNCT
ejnm-305	306	4	2021	2021	NUM
ejnm-305	306	5	.	.	PUNCT
ejnm-305	307	1	52(3	52(3	NUM
ejnm-305	307	2	):	):	PUNCT
ejnm-305	307	3	p.	p.	NOUN
ejnm-305	307	4	267272	267272	NUM
ejnm-305	307	5	.	.	PUNCT
ejnm-305	308	1	[	[	X
ejnm-305	308	2	16	16	NUM
ejnm-305	308	3	]	]	X
ejnm-305	308	4	jovandaric	jovandaric	ADJ
ejnm-305	308	5	,	,	PUNCT
ejnm-305	308	6	m.z	m.z	PROPN
ejnm-305	308	7	.	.	PROPN
ejnm-305	308	8	,	,	PUNCT
ejnm-305	308	9	s.	s.	PROPN
ejnm-305	308	10	babic	babic	PROPN
ejnm-305	308	11	,	,	PUNCT
ejnm-305	308	12	m.	m.	NOUN
ejnm-305	308	13	raus	raus	PROPN
ejnm-305	308	14	,	,	PUNCT
ejnm-305	308	15	and	and	CCONJ
ejnm-305	308	16	b.	b.	PROPN
ejnm-305	308	17	medjo	medjo	PROPN
ejnm-305	308	18	,	,	PUNCT
ejnm-305	308	19	the	the	DET
ejnm-305	308	20	importance	importance	NOUN
ejnm-305	308	21	of	of	ADP
ejnm-305	308	22	metabolic	metabolic	NOUN
ejnm-305	308	23	and	and	CCONJ
ejnm-305	308	24	environmental	environmental	ADJ
ejnm-305	308	25	factors	factor	NOUN
ejnm-305	308	26	in	in	ADP
ejnm-305	308	27	the	the	DET
ejnm-305	308	28	occurrence	occurrence	NOUN
ejnm-305	308	29	of	of	ADP
ejnm-305	308	30	oxidative	oxidative	ADJ
ejnm-305	308	31	stress	stress	NOUN
ejnm-305	308	32	during	during	ADP
ejnm-305	308	33	pregnancy	pregnancy	NOUN
ejnm-305	308	34	.	.	PUNCT
ejnm-305	309	1	international	international	ADJ
ejnm-305	309	2	journal	journal	NOUN
ejnm-305	309	3	of	of	ADP
ejnm-305	309	4	molecular	molecular	ADJ
ejnm-305	309	5	sciences	science	NOUN
ejnm-305	309	6	,	,	PUNCT
ejnm-305	309	7	2023	2023	NUM
ejnm-305	309	8	.	.	PUNCT
ejnm-305	310	1	24(15	24(15	NUM
ejnm-305	310	2	):	):	PUNCT
ejnm-305	310	3	p.	p.	NOUN
ejnm-305	310	4	11964.https://doi.org/10.3390/	11964.https://doi.org/10.3390/	NUM
ejnm-305	311	1	ijms241511964	ijms241511964	PROPN
ejnm-305	312	1	[	[	X
ejnm-305	312	2	17	17	NUM
ejnm-305	312	3	]	]	X
ejnm-305	312	4	jo	jo	PROPN
ejnm-305	312	5	,	,	PUNCT
ejnm-305	312	6	y.s	y.s	PROPN
ejnm-305	312	7	.	.	PROPN
ejnm-305	312	8	,	,	PUNCT
ejnm-305	312	9	j.y	j.y	PROPN
ejnm-305	312	10	.	.	PROPN
ejnm-305	312	11	cheon	cheon	PROPN
ejnm-305	312	12	,	,	PUNCT
ejnm-305	312	13	j.w	j.w	PROPN
ejnm-305	312	14	.	.	PROPN
ejnm-305	312	15	ahn	ahn	PROPN
ejnm-305	312	16	,	,	PUNCT
ejnm-305	312	17	y.	y.	PROPN
ejnm-305	312	18	kim	kim	PROPN
ejnm-305	312	19	,	,	PUNCT
ejnm-305	312	20	and	and	CCONJ
ejnm-305	312	21	g.s.r	g.s.r	PROPN
ejnm-305	312	22	.	.	PROPN
ejnm-305	312	23	lee	lee	PROPN
ejnm-305	312	24	,	,	PUNCT
ejnm-305	312	25	pentraxin	pentraxin	PROPN
ejnm-305	312	26	3	3	NUM
ejnm-305	312	27	and	and	CCONJ
ejnm-305	312	28	lipid	lipid	NOUN
ejnm-305	312	29	profile	profile	NOUN
ejnm-305	312	30	status	status	NOUN
ejnm-305	312	31	in	in	ADP
ejnm-305	312	32	pregnancy	pregnancy	NOUN
ejnm-305	312	33	.	.	PUNCT
ejnm-305	313	1	journal	journal	NOUN
ejnm-305	313	2	of	of	ADP
ejnm-305	313	3	obstetrics	obstetric	NOUN
ejnm-305	313	4	and	and	CCONJ
ejnm-305	313	5	gynaecology	gynaecology	NOUN
ejnm-305	313	6	,	,	PUNCT
ejnm-305	313	7	2017	2017	NUM
ejnm-305	313	8	.	.	PUNCT
ejnm-305	314	1	37(6	37(6	NUM
ejnm-305	314	2	):	):	PUNCT
ejnm-305	315	1	p.	p.	NOUN
ejnm-305	315	2	727730.https://	727730.https://	NUM
ejnm-305	316	1	doi.org/10.1080/01443615.2017.1291596	doi.org/10.1080/01443615.2017.1291596	NOUN
ejnm-305	316	2	[	[	PUNCT
ejnm-305	316	3	18	18	NUM
ejnm-305	316	4	]	]	PUNCT
ejnm-305	316	5	agarwal	agarwal	PROPN
ejnm-305	316	6	,	,	PUNCT
ejnm-305	316	7	v.	v.	PROPN
ejnm-305	316	8	,	,	PUNCT
ejnm-305	316	9	b.k	b.k	PROPN
ejnm-305	316	10	.	.	PROPN
ejnm-305	316	11	gupta	gupta	PROPN
ejnm-305	316	12	,	,	PUNCT
ejnm-305	316	13	a.	a.	PROPN
ejnm-305	316	14	vishnu	vishnu	PROPN
ejnm-305	316	15	,	,	PUNCT
ejnm-305	316	16	and	and	CCONJ
ejnm-305	316	17	j.	j.	PROPN
ejnm-305	316	18	kiran	kiran	PROPN
ejnm-305	316	19	,	,	PUNCT
ejnm-305	316	20	association	association	NOUN
ejnm-305	316	21	of	of	ADP
ejnm-305	316	22	lipid	lipid	PROPN
ejnm-305	316	23	profile	profile	NOUN
ejnm-305	316	24	and	and	CCONJ
ejnm-305	316	25	uric	uric	ADJ
ejnm-305	316	26	acid	acid	NOUN
ejnm-305	316	27	with	with	ADP
ejnm-305	316	28	pre	pre	NOUN
ejnm-305	316	29	-	-	NOUN
ejnm-305	316	30	eclampsia	eclampsia	NOUN
ejnm-305	316	31	of	of	ADP
ejnm-305	316	32	third	third	ADJ
ejnm-305	316	33	trimester	trimester	NOUN
ejnm-305	316	34	in	in	ADP
ejnm-305	316	35	nullipara	nullipara	ADJ
ejnm-305	316	36	women	woman	NOUN
ejnm-305	316	37	.	.	PUNCT
ejnm-305	317	1	journal	journal	PROPN
ejnm-305	317	2	of	of	ADP
ejnm-305	317	3	clinical	clinical	ADJ
ejnm-305	317	4	and	and	CCONJ
ejnm-305	317	5	diagnostic	diagnostic	ADJ
ejnm-305	317	6	research	research	NOUN
ejnm-305	317	7	:	:	PUNCT
ejnm-305	317	8	jcdr	jcdr	PROPN
ejnm-305	317	9	,	,	PUNCT
ejnm-305	317	10	2014	2014	NUM
ejnm-305	317	11	.	.	PUNCT
ejnm-305	318	1	8(7	8(7	NUM
ejnm-305	318	2	):	):	PUNCT
ejnm-305	319	1	p.	p.	PROPN
ejnm-305	319	2	cc04	cc04	PROPN
ejnm-305	319	3	.	.	PUNCT
ejnm-305	320	1	https://doi.org/10.7860%2fjcdr%2f2014	https://doi.org/10.7860%2fjcdr%2f2014	PRON
ejnm-305	320	2	%	%	NOUN
ejnm-305	321	1	2f7901.4533	2f7901.4533	NUM
ejnm-305	321	2	.	.	PUNCT
ejnm-305	322	1	[	[	X
ejnm-305	322	2	19	19	NUM
ejnm-305	322	3	]	]	SYM
ejnm-305	322	4	tesfa	tesfa	PROPN
ejnm-305	322	5	,	,	PUNCT
ejnm-305	322	6	e.	e.	PROPN
ejnm-305	322	7	,	,	PUNCT
ejnm-305	322	8	a.	a.	PROPN
ejnm-305	322	9	munshea	munshea	PROPN
ejnm-305	322	10	,	,	PUNCT
ejnm-305	322	11	e.	e.	PROPN
ejnm-305	322	12	nibret	nibret	PROPN
ejnm-305	322	13	,	,	PUNCT
ejnm-305	322	14	d.	d.	PROPN
ejnm-305	322	15	mekonnen	mekonnen	PROPN
ejnm-305	322	16	,	,	PUNCT
ejnm-305	322	17	m.a	m.a	PROPN
ejnm-305	322	18	.	.	PROPN
ejnm-305	322	19	sinishaw	sinishaw	PROPN
ejnm-305	322	20	,	,	PUNCT
ejnm-305	322	21	and	and	CCONJ
ejnm-305	322	22	s.t	s.t	PROPN
ejnm-305	322	23	.	.	PROPN
ejnm-305	322	24	gizaw	gizaw	PROPN
ejnm-305	322	25	,	,	PUNCT
ejnm-305	322	26	maternal	maternal	ADJ
ejnm-305	322	27	serum	serum	NOUN
ejnm-305	322	28	uric	uric	ADJ
ejnm-305	322	29	acid	acid	NOUN
ejnm-305	322	30	,	,	PUNCT
ejnm-305	322	31	creatinine	creatinine	NOUN
ejnm-305	322	32	and	and	CCONJ
ejnm-305	322	33	blood	blood	NOUN
ejnm-305	322	34	urea	urea	NOUN
ejnm-305	322	35	levels	level	NOUN
ejnm-305	322	36	in	in	ADP
ejnm-305	322	37	the	the	DET
ejnm-305	322	38	prediction	prediction	NOUN
ejnm-305	322	39	of	of	ADP
ejnm-305	322	40	pre	pre	NOUN
ejnm-305	322	41	-	-	NOUN
ejnm-305	322	42	eclampsia	eclampsia	NOUN
ejnm-305	322	43	among	among	ADP
ejnm-305	322	44	pregnant	pregnant	ADJ
ejnm-305	322	45	women	woman	NOUN
ejnm-305	322	46	attending	attend	VERB
ejnm-305	322	47	anc	anc	PROPN
ejnm-305	322	48	and	and	CCONJ
ejnm-305	322	49	delivery	delivery	NOUN
ejnm-305	322	50	services	service	NOUN
ejnm-305	322	51	at	at	ADP
ejnm-305	322	52	bahir	bahir	PROPN
ejnm-305	322	53	dar	dar	PROPN
ejnm-305	322	54	city	city	PROPN
ejnm-305	322	55	public	public	ADJ
ejnm-305	322	56	hospitals	hospital	NOUN
ejnm-305	322	57	,	,	PUNCT
ejnm-305	322	58	northwest	northwest	ADJ
ejnm-305	322	59	ethiopia	ethiopia	PROPN
ejnm-305	322	60	:	:	PUNCT
ejnm-305	322	61	a	a	DET
ejnm-305	322	62	case	case	NOUN
ejnm-305	322	63	-	-	PUNCT
ejnm-305	322	64	control	control	NOUN
ejnm-305	322	65	study	study	NOUN
ejnm-305	322	66	.	.	PUNCT
ejnm-305	323	1	heliyon	heliyon	NOUN
ejnm-305	323	2	,	,	PUNCT
ejnm-305	323	3	2022	2022	NUM
ejnm-305	323	4	.	.	PUNCT
ejnm-305	324	1	8(10).https://	8(10).https://	X
ejnm-305	325	1	doi.org/10.1016/j.heliyon.2022.e11098	doi.org/10.1016/j.heliyon.2022.e11098	NOUN
ejnm-305	325	2	.	.	PROPN
ejnm-305	325	3	29	29	NUM
ejnm-305	325	4	copyright	copyright	NOUN
ejnm-305	325	5	©	©	PROPN
ejnm-305	325	6	2025	2025	NUM
ejnm-305	325	7	the	the	DET
ejnm-305	325	8	author(s	author(s	NOUN
ejnm-305	325	9	)	)	PUNCT
ejnm-305	325	10	.	.	PUNCT
ejnm-305	326	1	this	this	PRON
ejnm-305	326	2	is	be	AUX
ejnm-305	326	3	an	an	DET
ejnm-305	326	4	open	open	ADJ
ejnm-305	326	5	access	access	NOUN
ejnm-305	326	6	article	article	NOUN
ejnm-305	326	7	which	which	PRON
ejnm-305	326	8	licensed	license	VERB
ejnm-305	326	9	under	under	ADP
ejnm-305	326	10	the	the	DET
ejnm-305	326	11	terms	term	NOUN
ejnm-305	326	12	and	and	CCONJ
ejnm-305	326	13	conditions	condition	NOUN
ejnm-305	326	14	of	of	ADP
ejnm-305	326	15	the	the	DET
ejnm-305	326	16	creative	creative	ADJ
ejnm-305	326	17	commons	common	NOUN
ejnm-305	326	18	attribution	attribution	NOUN
ejnm-305	326	19	-	-	PUNCT
ejnm-305	326	20	noncommercial	noncommercial	ADJ
ejnm-305	326	21	-	-	PUNCT
ejnm-305	326	22	sharealike	sharealike	ADJ
ejnm-305	326	23	4.0	4.0	NUM
ejnm-305	326	24	international	international	ADJ
ejnm-305	326	25	license	license	NOUN
ejnm-305	326	26	.	.	PUNCT
ejnm-305	327	1	it	it	PRON
ejnm-305	327	2	permits	permit	VERB
ejnm-305	327	3	no	no	DET
ejnm-305	327	4	additional	additional	ADJ
ejnm-305	327	5	restrictions	restriction	NOUN
ejnm-305	327	6	on	on	ADP
ejnm-305	327	7	use	use	NOUN
ejnm-305	327	8	,	,	PUNCT
ejnm-305	327	9	distribution	distribution	NOUN
ejnm-305	327	10	,	,	PUNCT
ejnm-305	327	11	and	and	CCONJ
ejnm-305	327	12	reproduction	reproduction	NOUN
ejnm-305	327	13	in	in	ADP
ejnm-305	327	14	any	any	DET
ejnm-305	327	15	medium	medium	NOUN
ejnm-305	327	16	provided	provide	VERB
ejnm-305	327	17	the	the	DET
ejnm-305	327	18	original	original	ADJ
ejnm-305	327	19	work	work	NOUN
ejnm-305	327	20	is	be	AUX
ejnm-305	327	21	properly	properly	ADV
ejnm-305	327	22	cited	cite	VERB
ejnm-305	327	23	.	.	PUNCT
ejnm-305	328	1	https://creativecommons.org/licenses/by-nc-sa/4.0/	https://creativecommons.org/licenses/by-nc-sa/4.0/	PROPN